var title_f8_42_8864="Calcaneus avulsion fracture";
var content_f8_42_8864=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F77701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F77701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    Calcaneal apophyseal fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 190px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAC+Ad4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UpcUleu/Av4Z6P43g1O+8VahdabpkU0FjayW7oplupWwqfMrZxxkcfeHPWgDyPHvShc9xV/XtKudD1u/0u+TZdWU728o9GUkH8OKoD2oANvuKeISSBvXJ5xQvuQMjip+VGOwIHXNOwhq2TsMh4/xNSLpszYwU5+v+FSxkEkNGAF61dhZcAbGHfGadgM8aXNu274snpyef0qSPRLlzgPF+Z4/StZUAQno3DHtgVZiZyRnABP40WAx08N3rgFXgOe24/4VftPBGpXTKqT2alhuG52/+JretM7XXlinBOOa6PSneOT93GSR2x2osBy9l8Jdeu2xHdaYp/25XH/slaqfAnxQ2cXmj8cf66T/AON1674VhLyJJK+zHReuPqa7q0iy33sv/IYp2Qrnzd/woHxXn/j80b3/AH0nH/kOnx/s++LJG2re6JnGeZ5P/jdfTpVvl+YjIwMgcU6GLYzEREFhknP60rBc+aU/Zw8YuSFvdDz/ANd5f/jdTN+zR4zUZ+36AfpcS/8AxqvqW2uMgDjBwQCelaVpLuYZbIJyQKLDufIx/Zr8Zg4N9oIPp9ol/wDjdJ/wzb4yyAb7Qh9Z5f8A41X2T5G4blGSe5A4qhIhQld3I7mlYD5DP7OHjEEg32hAj1nl/wDjdRH9nXxfz/puh8df9IkGP/IdfWt0fLOc5YdM9azpZMxvvdvn53E9qLAfKknwA8VoCTfaJj1E8n/xuoj8BvFIj3G80b6efJn/ANF19OzFt4IUvnJAxwaz5ZWUhmwzk4ZQcU7AfNrfA3xOpAa70gEnA/fSf/EVFP8ABXxHAu6S80j6edJz/wCOV9Js5lYBvQ544A+tZt+HPyQtlVJfJp8qA+d4/g9r7k4vdJwCRkzSf/EUz/hUPiDBIutLIAyf3z8f+OV7tdN9mdlLbHKllB5wMVz76k1tbsvmjBYA5A60cqC547qvwy1rTdMub6a4094beMyOI5GJwBnjKiuFr3fxjeySeHtR3MAGt3yBx/CcZrwmpasMSlr6A8SfBzw5Y6RrJsZtUa/stEj1WE/2jbzvKxUFla1SMSogz/rCcc18/wBIAx70uOKQdaXtimAbeM5FOMZABOMHoaBwmT07exqQblZdw5707ARtGQT0OOuKcsBYjDLz0p3TaTnJ71Lbx+xLBsAdBRYAXTpWIAaPnnqanXRbhv44QemCT/hV61RmbOSRxxjFaEfycKMk89f0osBiLoN0xwHh+pJ/wrV0rwNqWpXCQxXFlEz9DK7AfmFNadmm4AtgnPXvz2rrdDQh1Yhvp/WnZAYkXwV1+Xbt1PROTj/Xyf8AxutMfs9eLGGV1DQ24zxPL/8AG69Q8PrcT3CxoCBkFiOiivZ9Ls8xJ9B81FkK58nx/s3eMnPF7oY+s8v/AMbqb/hmfxp3v9AH/bxL/wDGq+w4rQD7x75IJ6VN5QbJBbHHaiyFc+OB+zL40z/yENAHGf8Aj4m/+NUf8My+NN+3+0PD+f8Ar4l/+NV9llQGAHSmsi4+XnjPSjlC58cf8MxeNcZ/tDw/j1+0S/8AxqoZf2afGcahjfaCR7XEv/xuvskrl8IcYOdueRTXkXIWZTtH8R6UcqC58ZD9nPxeTj7doWen+vl/+N1HJ+zx4tjPN/oWOuRPL/8AG6+wL+BEjMiHg56Vyep6nHFFIsbbz0bnP0osgufLl38DfElpA0s2oaKFHJ/fSf8AxuuAvNCuLW4khea3YoSu5GJBwcccV9IfErWja2BiSQvdSDCjPCjuTXhl2nzck5Yk5B60WQ0co9nIvVkPY4PSoxCTj5lrWuI24LjHP41VeA7st82efpSsMoFSB2pMVK45OAQOuMU3aT+FKwDKSlpKQBXb6V8TfEujeD7Lw9oN3/ZNta3TXjXFi8kU9w7cfvWDYZQMDbgDgZziuJFOT09aAOg8ceJ7rxp4nvNd1C1tLe8ugrTLZqyxllULuwzNyQBnnrWCFyeMED8KXlht6YH509BtcnsODk9aYhoBHByDkdR/Kp1Rg21lDL0H/wCurcFsdxdVOccZ64qxhdvzL1PGO1MCnHGdvCEAcn3q0g3Kg7DkH1x61ZjRWJfbnnk+3pV21t1XykWIsCcGgCrDk5+XAPQn/Gtiw024mVWRWC46Nxn3qzZxgO2IlIzyQMgewrobfaqISrKmMAk9SfX2p2Ag03SY8bpGLZBLHOOfSulhh3x+XGgjXjPc8981X02zM0myMGUDjOOnFdTY2jRKIxCAMHOPX+lBLH6XbvaojktuU9CcjNdtpl05Rd4AJHGDzXNWlvJKmHYLz8wI6/SuhsYDHsUISRgc8imBvIcDOOpGOMgCriR7mAUk4zke+KrWykINw5Prz+FakJDRjy+pHOBQA2O3xtAGHPOeOvrVmJjGAGGWXkqRjNQSxzR4YZGPUdaw9Tu7qKQyRNJ5qfLs/vc0iju7GfdhSD6gn1pb2Dcr+Wc46EHvXnek+LR9oaO5zG6MANxPNd9BerdQgghs9QtIDNuoWj27ywx0GM5rGuY91yDLuUH5dqjP510Uw3cFmaqzrGceag4OS1AHL30hRFAbCLyN3Wsu5O9gzPkg5IPX8/Suru9Pt5yzKxZx1JrGv9LWJd9wwCKNxzyW96oDGbMrAxDCLwWOSBWbqCGMOVbhsbs8flWjd3MkqyRwcQdMp1ArKvhHJYoXZmYMVJIxgfUdaYGLdztcqjLG6yo5TnnAI9fTvWAqHz5FkXAxjacZP410d3ujYyqrbMbWI6H3HrWdqMBnRpYEZ404ZcDcOOT9aAOO8VWx/wCEdvpYpSyG3dj3xx0rxPtXvHiyDyvD2psjsIzaSHDk5OV/nXg/aokCPTL74xa1cyXNzDpWi2mqXGmjSZNQhSYzfZ8AbQGlZASAOQua8zoFGKkYU7rye9JSgkY596YCqM9MfiaewIGCMnrxSRDgseRjGKkkHQAAsBzVIAUbSAwOD3PPFWbVSuRnaM55PaoHBAAAIx+VW7eMluCCcYJzkGgZciyu3IOxhww9T/Wrsed6rjrzu7moYSNoPDN2wOK0VQZBydueO5pgXtOhV2ywDBuPxr0Lwdo0+qXLomNg5LEfKBxXPeD9Fn1G8iit4xnGWcjhV9TXuuh2MGm2y21pxEM7iern3oJZe0bR7axiRIcEZyzdyfpXe6Sp2ckBuw7fjXLWS4+vUH0rodOdF2EP1OMAUCNwKWCY57mgDqw7n8KYrZwcnHQGpDjqDkHtmgAYEjHHPX6Ug4UAJyvJUHOBSggMQOD70SErjIABOCQec0AG0Z3EKWPHAycVS1NC0BCHkdc8nFXySUwQBj8Kzr+UYCqw3dcgfzoA4nWr26gRkWRlCjBT1+teXeIdfubCUqqht3QseK9svrOHUw0U6jfklXXivNPGvgq4uLaYQDft5Df/AFqAR4jr1zLeXDzTSGWV8Akjt/QVzU8THg54J49a7PVNGvYZj5tpMmPRDzWZcaTOY3aVVUqvfkmkUcZKnLYPzZwM81DImQAAPQ81q3UCmXBB25wdoqnNGFLLzsBxnuaYGPdLtRmJyT6dhVUg7TjPvmtO4TCk7Sc9cVUEICHOQw9s0gKhptSOAG+XkVHUsBRTlHPPSmipUUEfxA56j0oAdCuBkgnPTvV23gE0hwWIA4z0qGPlRk5x26Vr2ULqSTwD1HrTESWiFXBk4z6Dj8KtLaHg4VuSR/T8aWFNjgA84wDnHFX7dAp3EBmwSRjIoAqwWqyOV8sKNxHua1ILRkKBVJBzyGxxU1vAJItoDdSNjHFbmnWoCDEKgkbCCT+tNAVrTT0dcsFBI+bIJJre020Ky48tinYbdoAqaytGYHeGBx0GAD/hXQWNqyoPKQlcc7e3NMVyGC0lRlEQjLq2MA4PTrW7ptk6M3mldh6qvJz65pbWOONNxfaw6HPJPrWjaGMOMq2O24k9f/1UCLltaqEUhCRnoe3vWjb2zAbdxIGSG7H61HBcAJ0IB/vHr25q9BLlNr5Kjg5GKALNtGeABuUjkqc81r2MbB0BbceBgDisdJGLAIxQnlQa2LIhRhWz6c9/WgDUS1HyuMMOeSenasy+0rzZTvUDBzleM1r2k+QBK25n/u9qurEjqN+MAgZqSjxvxxob2+67iTOAdwx+RApfBHikWUiWlzLvtzwDjlDXq2r6VDdwOj4KFThq8c1fR5NOvZIimAOAQORn+lNAepXuTGkiEEAE7h6Gszzwdz7un51z2l6tL/Zn2OUMpThSfT0PtVW/1u3tPmlmy/Iwg5/E0WA3Lm+W3BkdgoT7zHjd+FcrqmqyX+7bLhAOFNRvePqUe/cuQcBOwFZyho3AGUO3gtzk+n0qhMtMZYpN4cYxh1HP0FQtcme3kaJWUpyUc8k+nuKRgQGcECTbuGOcf/WqFBJIN8jcg85UA57UAVIbuQREXsHJJCgjoe2aZfWkjMrfNGwyMjoRwelWxMl5uj8qRXVTyeCahe3ZljSQ7j0TJyU980DOa8d2q/8ACKaq8gDMtq58wN1O08V84j7tfSfjrZb+EtYVnJma1dThRg/Kea+bBkr3xmokCAUAc0UvUnA4pDEzmnDhMjGSaAMnIz9aQD0NMCSMchgOc0/Ckg9OcetRxnnAzk/rUpcGQnPA7AcZpgTkZLZBfaefer0CZRT8gXGMdMZqkCrFdvAPByMZq9bHMW1wcdTgUxl62Gx1AOccgAVuaRZve3UEUMe6WRsBQKx4CR82TjoAOc1638MtI8m0/tK4BEkvyRDHT1NAjsPC2kJo1ittHtJ6zS45ZvT6CupsxuQOM8jA47VkQSq7rtPytwSRWzYyg5RR0HOaCWbdp8qZUjJwcY5+grYtf3aqNwJxjnrWRp8hLYCqCpzmtqH5l7UAaFs3YZ6cc9Ku7hnqB7+lVbVCB1VlxketTgkYBXg/lQBIy/KR0A5z3oBJ5PPP0/Gm7gd3TjjPtUN40irlGZfUd8UATTyKqkEgsB0FYt67O/mhgq9+9aTSlgcfMuMZ6FazJWA6jOMk5GcmmBVjlxIzyDoME4qO4vcx7kCMPRhVk+X5TltxB4xmudu3ZS3lMducYPAH1pARalcW11uDxAcHjbziuG1TTdOnEkUkIJ5LHoc111zGZEJL84696x7+AOgIUksvXGM0hnhni3w9NpV4WUMbZuUbHb0PvXKy27ZVjkjocdK981W0eUiEY+XjEgzkGvO/H2gi0mWW3jEUL/KR70wPO5oPMRh/F6Gs+eFuSQdvQGuguYG8sEHKg7fofTNZ8yDHODtx06UhmBNGVbLEdecVXb7x4xz0rYuYSDkKN2fmPasmX/WP9TSYDR1qaFSSMZ/CoR1xWvolo0szMwzGjZb0pICGKFgwD5J7L7etbtkoYAvw/buDTBGn24hxhScfKO1a8EaQSsygjbxxjApiI7O3Z9/yE5HOfrWkltIRlyMc/MtWLR0b+LCDBJwMn/69WVIdirKAgG5Sw6U7AW9NVB1CK3TBHPTqTW/YRqsSbx5ZPXByD6+5rHtnZ1XcAhbjp+P1re0+J3hRpDjb2A6/U+tMRpWtptRFCqI353n68cVs2kStCWLMMdVxjJFZls6puCYGcfeJODn0q6jO5RgxD7tylRnAHtTEbNu8RcGRFdh90Yx09a0Iij4YBMDPAHB9qyrYsVLiNmPTdtyzGrMDuSVWP5unzHgZ7mgZrQDLHed208Ec/wD6qtxIisSXOOqjPWs8PiIhmLnHyKoGPxNWbeRZGBdFAA5YjlqQjRV+NwOcctjtWpYy5iAbjHzAnk1jR7yTltqDopHb0qeB8usgVjjr6CgDp7KX5VB4OPvH/CtW3uEcdEJ6DPeuajuiI8QPvkz1XpVuxeQzKCRz1IPOfpSGjqAqsi4G4dOe9c74o0uG5Cl0528letbEExyEYED1X9amnhF1DyegwDSGeWPabGXIDrkgc8fnXL+KvDgk/wBKtE3Og+YHPPfpXpepWJVtkiHI98fjVVYNoaMJ8rDB9/8AGqQrHhVnqVxpd2DGTtXJdG5B9fxrs7Wa01aIT27FflAKk52mrvjbwf56tPYIFY8soXjNcromhaxBOhhjeFANrB8gHnNMR0z2O0MAoYdTye3pVJrUyKHkbaGOCB/dFdhp1ojW/wC+kLvnAB6ZqW40aGZMKMrnALdD7UDOJCqyMI0XcATvJ5XnsKqyRA7Wmck9VA6Y9/Wuvm0sJu3gdwB6d8Zqo1iEZhGpwwyFY9T3z6UDPO/HMcn/AAiGsltqqLOTIVcknaeua+ZQcD3r6u+JNr5XhDXVCYxZyMzbcnO096+URnGe3SokCAdPf3pejcc896AODSgEngE/SkMMFRnseKUAY+YHGaXAwMHGRnrS5Yfewox2qgHRbd44brS5+fawKryenIpqKQw3Hk8j2qXaAcEA8AD6UATRgkFnJB7A/pWlaY2xblIzwWz1rPjjLYBOEHGMZrasbWSbmNecAZJ4oGXNPj3XSbu5HOOn0Fe8aVG0enWkQICiMfMe+RngV5JpVlHC6Ojhjwu4jof9kV7DoTPd20RCk7FC7iPSglm1aQokSs24ORgF/X6VtWcYRTtiHt71WsbVVGW5wefrWxaW4JQL6dRTEW7KFMrxhm7jgfU1rxAqMkH8ar28HrtIHc9a0I1Rh8x5HQdKAJbafayhtpB6AjtWmArouMA9eOaywihPmUfe4OetW4pUjcRbTkk7cCgBzr5ZC5AJOORnIqKdmA2uwy361bIVsg888Z5xTAqIF2YBxxnrQBnSthdjgspP3m7elRPbeZFukITglQTzVy5MFmj3FwenQOelcxqOpi7c+W5WRDwo7CgBt/cNA7JyqjtjO6svc23KsHB5JPX6VcMryTGBwhjwdjelHkoc4UxBR9wmgCssXmqFA99p5xUD2iKA0u49gR1/KrhVo8YiVZF9Dwfxp24uCsgwMZ/GgZiXenwLIGOeMtjGe1cR8Q7Ef2IWYAEygjI55r0p/vbRz7AcVzviXTV1JLaEjMXmAnmgDhNF8Ere+FBPPEQ8jkhgMELXC6/4NnspH+zhmQHO08cen/1q+qbfTI7TRYYgOAmeehrh9b0yOZnT5lJ5yB096AufLF7aNG210IYH7pU1zdwMTyD/AGj/ADr6D8S+Excq7nlsYFeBanEYNSu4mGCkrqQe2CRUyGV169zXZ+HLdYbYGQAluc44FcZHy4+tej+FUWWyCFCd3Hpz160ITKFxEUnVRktu5IPWrxXzUGSVBYdgBn14prxNPftsIwjYGOpNaUEbFQBy+OAe2Ov1pgQQQyQkgc+uTWnbW+4bpJTnGCDUJZ8q0eFO7nnjFPinYktyzA4/+tQJm3bnY5EYZSeSoP8AM1rxSRlgsb84HmYOK5+3cnaXwHORwOtaun4KBJsRpyT82OD2+tNCNqCZMuuSQBkbFySe1aVux3AmSRGKkNgZP0xWPA+ZBH5pSLAIWNeQe1atkXOCC4ck4Pt60AbFm/kouA2AMDzcnPNaEKZUAlVXHLE9c1k2+52DliSM7CTnOa0o5VkIVwfLXgPjA98UAaEbCUukMMe1FweymrkZVkG8or4AO0cfQVnIQV2R7gDwef1qRgI1ABLMck98n1oA0toddwc564zUsDoqEufl7nd1x1rLQ70BkV9pyxKtwf8ACpo34DK52LztI4/OgDVhutyllBVvVeOPWtGC4CP5khVQFyxzWAkrbd0hVMDoO4+tSpcl/lQDoRh+RSGjsLK8JYABnVueT/nitm3uhkqcKo6Dr9TXDW9zLOyJHuBHGVPBHpWtbX8auFY9OGYcjPoKLDOju0jnUM2C3Tmqi2a/eK5qt9s8v96HVlI4PXHtUjXZYKysAD0NAmWobeGNzv2/3QMVW1Kxt5YyqKCDxgnp74qOK4JYsshLY/zwae7bk6demT15pgcvPpscTMySFW5G3Bxj3qeCQrEAhDA9Rnp7VLqTeXuP3ieoBrHyu4NHuDYxkn1piL5/eZG1gFwASOPrTJIooon+bHHO7HAp0LyrlnIJ9xWPrWqrF5sLDJ2E7fXFAzgfiq2/wvrm1iy/YpM9xnbXyWOlfTHje4uLjwprZcZDWcjHjPG0nJr5oUZ4qHuUhyKWBIxkU5QXLADBPpSRBW68d+nFSoBnpz1z70IBrABuB7jP86ckJOOMkntTzHuYlPwB42n6VeW2VQn9485pgUo4G3KuM5OM1ZW2BwB94fKT7VchgCqSDweB71ZjRtwwPnPtkmgYljZLGxYgF+Tz/hXS6Va/LhcfKAATwM+1Z9rHyPMwxxnkcD2rqNPVTFFvRm3DITp9KBGlY2yROrsBK5A+Ydj06V2OhNPFKoc7IipBjzhR6fjVDQrQ4DMAkzKeDjAHeupsrJIwJZV5IBBxk4piOl0x/wB0u5l2kc4PNalvMyq6xdScknuKxLIJklmwCD8vr/hWtaOEII5z696BGnCZmkXDsWHOB2/GtRC/XAI/2s9arWQDJliMdvQVowIWfaDxjv2oAiS5Me7Kdu1L9ujZMrL5bjtnrVmezDKxQcgY5/xrLudPLORsGDnpQBfg1BiP3hADHhhT3uI4yXJ+RTnd6eprhr5tQ0i6+TdJaSE5HUp9KsG+kuYc7uMdORTAk1zVRqFyc/6oDame1Z+VfbtQgq3XPWp0spJJFVFL/LwT0J9cVo2+jSIx8wsQ7BiM5A9vb8KQEVhubadisW6MwwOOasRWyPIrySbmJ3bWrUFjtIQJnA6e1TRWi79xXOBtx6igCkIFkQx4UrjGaybqIQkbi3Hy56kj1rsY7VduScZxxnpWHrECi+aM4ZVAxzQBkC13txnrzz2+lWFsBcX8aleEA6djWrBaFovNx83YfyrT0uxNqTI5zK3JHvQBS1sCK18tBhioC4PT3rjZ4Vm/1i5AHDYx+FdnqSfaJ8hsqvAzyKzzaAjDKhB6CgDjZ9HFyJGchUx0Ir4z8Vp5finWEP8ADeTD/wAfNffl7b+TaSggB9uBXwR41G3xlrwOMi/uBx/10apkNGOgywr1XwII309SyA7SCAeOfrXlsH+s4Ga9x+F0UMti0bp1Gct3464oiDKLW/8ApbTxIGclmKHgU9jHcQebBhJozkp3/CtfxPY/YL1JLf5U3An5uR6iqtmA7TO6gLjO/bn8aYjECs0kiy/JnmpbceWcKrJu43MMjP0qxJETJLFLkDsynIP4+lOWEtLsVycAcgZwMHj60AWrRduxm528BCeWPr7VqafHvkDhCdx3AHP6CqNpbBhtUBsnq3GB2zWraqY9roRnPBHGfqTTEbEEce8ts3N6kYA4q3CAEAY8EkcAj9aqWxLyGPJO3+LoPpVxVYOnoDjaBgdPSmM1bWOHyig37/8Ab9quK5YbVQBsZPPSs+ORSQcsWJ65P6elWIt/lsoPzg7vYGgDUibcmP4RgdeSfSlXeuC+1STx6t+NQ7pFhjV3DMw4wOQf8KmjlYTKCSDgZPt60gIpNw4b5d3YE1btnR49jZZ1OSAMKPr61Tmd5C2AdinAOeRUMsjOhbcy4I6HBbH8+KBGhPdpJkwozc7eV4BpY32MFIxgfMc1SZjFCJJJBGjEdOTSJKuQdp5HQ8n8cUDRtw3Q8rMLfuhwT0/XvUsV3uUbWyOMYHGa5/7QCQhfMeQGB7kf/XqeO5LBmj2CQnHHAGKQzonvJmVSCeO9X7e+DKCrjhP7vf8ACuaa4YuuXKdCR9at2lzulIUgEDG7PUUwOmhcSoC42kdcj+lSz3UNsmZJNp9AetcrqOu/YUw+WyvAH+NcxcanLqDuHLRsccHoR6UyTrL2/NxIxVCeMhgPu/jTbaVU3njc3OT0x0rmra4MRZmdhnrzx7VbGooR1KsB0XpQM37u/S3t5D0Cjn6V5rp1ydX8QyzXHGcrtBOFXniuj1JpprKdXJVZQFxnJI9qb4asI7W5Ekafw+nWgEVPHejLYfDPxHJIFEjadKACOR8pr40H619yfFK6WX4b+Jt7BmOnTAe3ymvhsdOlRIaJFGVIyADzyalXcQMrnHoahTIOR9ealjXcoA+8c4IpoZZhQ+ZyB14rYhj3nhcYGOecfgKp2tuTCjlcr1IHr2xWpHE4LlgBkYABxigY2C3JUBiw9DV63izuD7TjHIOM1HBGSoR/u9DzWhZgA9CVA6noMUCNGxtFjcfINx5GDx+ddVpVoJdu5SHyBkHHHt6Vg2bbYwrJtU87scn0rbsl2lBGzM33iB1+v0oEdTp8wt2UxJufO07hnHqfetqyld8Su288+wA965u0kkSYOW3g4xGq9Pc+n1rbgdn2KMY746AYpgb1hJ9ofIHyjoR0/Ct6FRtXc6knOCDzXK2aHYHaQu5yMY4HsBWvYuUi2Mcc8LnJx9O1NiOot5HUIATgZGAB2rSi1AxMAD1GOfSuYtnKyEKcKeTz1qWKaOJgfl3A8nvSA7eC6glwAfmP8JHX3qwiKxDDaF9SK4+K7kDCVpChOASPT0Arcs758/OVwTwCf1oAuXVhDcwssiL1yCKyF0ZY1zEgPHIxmt6N41HPUngk/wA6Q7WjjjY7trZPcGgCnZWcaJvI6dMfrV6SNQh6pgdMUzfHGdqjAPYVVnuyHYFgpzgHrigCWSFQAVPykYOetC221lwzBQuQDUK3IIyQznHUinxXYJCyEY6kj+VMC2qjhUPUYzXLXjfaNRkUEAmTByK6Fp0igZlbecccVgaHZyXGoNcOv7lCcAnqaQHRJENqBskLjjHH1qaVtoORk+wxxSkMBwAWJ7moZnLybB5irkhsY5NAEP2ZOW2455ANONmhiwB83Y5oiGSzkBTjHzHPFSSyiKPcFBGMBBQBzetQyPKtuudhbL+w9K+CviEoTx94mVei6ncgf9/Wr9D4bTzGaSTA3dTX56fEtQvxG8VKOg1a7H/kZqmQ0c9ESG+UkV7L8HbrDPCcHkHn6V43D9+vRPhpdfZ9SQGQAFiKEDPX/E9p9rgDJgZOenH1rnUt3hE8OTInfBx26fnXpK28dzZ7iowQBz6Vz1zZrDLNGkQDEkq5HGKok4q5sokKJGZFReGyeme2KjhgVCM7twPbr9cVuvaytI800UeDwAOlVp7bbJ5iklmBJQHpSGR2fLcEbXbqtbVvGpCowUA8Z7nHvVKyt8rEzKpycFhzj6+9bFvDGiBeWJyBvPI9qYidIwEXYTjPy+9XYUJULxt6sQOM/wA6rQBsKxTp8uSMYJq5ERCiIihY+eQetMZKVKlhGis2BgcYFWkcxkqnDKckZ6e9VJZgPL3LhDwTnk1OZsBThVDDoR/OgC9kRIWGM/xDNNRssPO5bG4D0/8Ar1XUjy1aRQyjgnpn8DSGeQk8bXXgsTyo9KAHSykFigJ3nK5PFO3lFWRsh15Occce/SolRlyWJXOCvFQearlzLlW7YP3jSEWVmNzC2NhfOFJOR61XE5VHTIEnqVqS1V2TaXCg4PTkcU2UfxSAdSQo7+9A0Ne4fe0soViTlR7dz9atwMFSR96N0ORWUq/vCxYuGbdxzj/CroVUuSQCx+vHPt+NIZoQMzQ+YNrZAxx396tR5Mkm5iCQR1wOP/r1Uik2LEUB3ZwdoOM1KCBlwfmPIZxkUwK+oyFZRuUylVI5PyisV3cybhlVxjPYVq3p863VwwCnqf5g/hWTIUYlipXacYxmgQLPJG53k9M9P6VJHdMxAYNgkD5lIyfSqU754BUKR0B5/GoreZlljw3Q5zn8KYjpL6XlFdlaMHOMdPStrT3ILlQqKQMEdOnT2rlrS5+0yqQg3NjGOmK3ReiGHYq/KBtOO4PcUAYXxJmWTwJrxfJb7DKBz32mvj8HFfVHxAuvL8H63GBkNZyg55x8pr5WqJFIkVTn045OantlZmARSzEE89O9QqCNoK5B9TjNb3hS3NxcSgH7qHgdqaGW7ZWe3UgYcAEr/Wr0IZ4SxhXd9057+9QpCFD/AMLKSTz2rStCPs+QGBAHfjNMCCIMAMjqM4I4PvWjZ4RslU2kcZzwKqI6qu7PzEfT8atQsVI6HOcAnk/4UgNaGRyodQCx43dce1atpI0aIownIYlucn/PasdJGMYO7HlpgqBy341qW2TEMtkZycjp7AUCOgtGxKC6nO4ZKHk57V0EW/eEDMiDnjr6VzlgVRzlmZ16t04Pp71vWQeNVaQtuPY9/eqA1IHaJQyLt5wF5z9frV60kZGXeBublx1z7VRSTayuQGwOp9KtxKJoM5UKcnaD1+tAjSjuQoPADswxg4FTpIRliq8HO7dxmsmNHmQIGbb1wv8AjT0m8pBFt3upyB169/woA3YLlm/euCegGf4fqP6VtW12gClnU4PXjniuKN4AQgBEca4Azyzep+tWZblmT5iUbHKqPX0NIDtUvBNgISVxxzzipVvfJhc8gkABR/OuP0278rA8zljwCfyH0rWa7ckluBwMdOPrQBuwyh+VyRjk5zj3rI1PU4/NZUX5B1ZT1+lVdU1doNLCQDLHhu2RXKpdzbygUnjnAzj/AOtTA6yHUSQAzEMB2POKtJe7Q2HBbOcmuYhkYLuyN3QBuv5VYS4ZQqkv8xxwOtIDs9KcXUqJ8pAHO01tWwKFo8bR1yDiuT0RvLTPXPXHauk0658//WcNjKtQAXV0BjywCBwSaz1dRIB82RyRnmp7xB843K+e2cVjyX9vAxBkDsOvOSKAN5ZRFAr7iADyCcc0y3ma5uV3DI68DjFY2n3bX2/KsEU/gea2baVI4wqnA7570AaaEHlMDGOvpX5y/E3/AJKR4r6f8ha7/wDRz1+holYs5PXIxivzx+JfPxH8VZ/6C13/AOjmqZDRz0Wd4I6iul8OXTWt2sg42kHOO1c1GSG4PPStOzZ0cHPTjGOlCBn0x4U1qB9OiDyLkDGT1I+lbbo14kjRrl0PHoRXh/gW6uGvVbOIyQMk8Zr6B01VgjV3PzleBniqJOJ2TQSujIxhblRjHJ609ETzJIsOyctk4yPQV2Gt6aLi3fYAJCud2eRgVw9ybjSpEW9iLxHjzQefbNABHAUYExYKn5mPQZ5xU8RZz+7ARSMgf41Ot1FPFvjAXPOwmoUjKqY1Y7WOeudv4etAGhExZF37WI698/hVwsMoQeCvPy8f/WrM89U+VAXxgHnpViG6RUyeVPVuwpjL6Iu9ZGVixGF56e9W1h3ASOAWJ9MZFZy3sRXcfmBG3bnqPan/AGvGcsMHCrzxQBcaFFwzttYDGAM1WlXemFBIJyMcGqn23zAhY4LEjDcHr7U+2mEYYrld3BDH9KALKo3lNjazenI47d6keNogp2fusZ+8DjioZLpImDeVJsxyQwGKkjuknI+QL2OGJoAVVkYyOGZu+4ccf5FBYyAAJg4wMjr/AI0j3IXhA6buo7UxJkkfgsSBk9qQDnJSHEkcYTdjcBzxQroGBKli2QDj8s01VO5ipYkkkEngU3ypQzZdy+MYbigZfjnKhwT83UD+lN+0iQxO2DnOdvQZqsWIT7+cgZGOAaqNIwZNrEqDn0NAFuaQFArR5UPkEk8j8KoToVZju+Vh0xjPoKS7vorWIOZQecbSaxptWWXfuBXAyDnIzmgRfYrIx3Lnb0PTj6etU9Rl8to4IgfNJx83QA9jVePVIlO7G58cBhis1H8y4TzW/eMS2c9TQM7bQpF+ZnIwuQBxz+PpU11dRKV2Bc+hPrWduFpYxoRGZMBn2n/Pasie8ZJZt6AoDyAf8aYDPHhX/hENYVDgfZpCQeQfl9a+Zq9+8Y3iv4a1LDYH2aRenX5ePrXgNRIaHofxrq/Ap/0qZSGO4YB7/hXJpycZx71u+FJ1t7wNnDMuMjtTQHS6hbFH8zGCT8vHUVejt0FshXG5ucKc/nT7tUu7ePZtLc5xVlYniswoywA+Y5x3oAzNiqYwyMUAxkjqKfmQyL0DKNqAdPxq9LCYlVXztOOc579KieESNiXhAei9DigCWLO9drDk9etbNl5fmAEneMEnqP8A9dZ9vFGAWZBtxxkflWzY7YwFhQ7s4LHoD70CNmyEisQFVmHAxzgf1rXgEiEKXyzY+UYyfasqxmQQAyEgZ5Hdia0IGCuu5j5hAAO3Bx3x6UwNRCVUphSchce/vVmN2ij2ICW9c9CaoKc524C98n7oz6VcRxIy/N90446dOtAF4XDRr5akmXoWxzyO1IrskJtYMeaRlmbtntVONwkjOXwf4MDJ+tSQzRQDbksxOSVHJJoEMgl2TStKrBEGBx1PrVuORWhaQswZAGIPf0FQyAzKADudjxk4wBUU5K4QA5HUnuaGMnjmePY28s5OWBP3R1roBNjYchSwACtk1z1pbebkKSSzDIcZrcjXdhpMMyDG7GD+FAh9w0nnbWXfGRxnpmmJC8Y3uAMA5285NTOURc/MVJBDYxz71DJKJG2gEDuCelAyMMzEEAA/xKR0qIyyebkBlDNjHT6VIy7gwB69yef/ANVOHmb8HC5x1GcUAWLW/a1O/JCYwyk11GmXiSdGwu0YPavO9WdiREOx5x3rV8P3brpzkScH5QOv1oA66/laWBlyApOCAPvCsMw/vwRtUM2RkdveoFv5Qowx2nOd1TG6VmR32rHgYzznPegRs2ZS3h8uHAHVvc1ehXeeRlWOcDnmsWDzOXwMfoa27MuD0ILHIBoAvRQsfmAIIOAxr89viSMfEXxSCc/8TW65/wC2zV+i0ZLL86EEYPX9a/Ov4m8/EnxZnr/a13/6OepkNHORkg8HGRitC0YfMV44wc9/Y1nRglsDrVuEgAFVI75waEB3HhDVEtLxVldAhOTntj+dfRPhq+j1CyjYFdvQg/TivlC2cemASepzivQ/APjGXRp0huPntMYz3GfWqE0fRaRjGAF4H92s7VtLgmibzUVg3b+lUdF8S29/AkkcqFCMEg1S1/xPbWztG0mDjgDoPegRgamBoc4iCGSBkwOeV9OabFcRsplQbVZc9eo+vrXL65rSXqu+SCTjJ6HNQWOoXdpLuVg6A7QpNAHaxqpyX3EdQuMbvqKkVyygk+WADhSPfNcqmtlZC0zlyCM+x7YrSTxBC2PMiU84yp/nTAv3c0iThsgIWDDaMZUDp9KkN2rRx/dAc4Ugc5rmLvW41kZTkh25wc4FVTrA+YpK6ryEHoe1AG1qGtRWMzqo82f7rc/LHVGXxDds2BIqknOF6f5xWA75eRmbJ75PXI71NHIAASuCF79/SkM2P7ZvdqbpiXxxxT49YuzjbMwfHK9M+tY4c+YrMgUgnHOamibbwCMkn5f/AK9AGsNZvgpZpCwbOVYY/Kn/ANu34Ukru6EEDpWQZGIw53MMAjGcd6czlmJDA9RycZA/yaYG5Hrl4qgxyZBbkYyR7Vb/AOEmuyWGI3JbbyDxXKlypJX7nbB5GPeiO5UnH8DcUhnUN4juWfGxOvUAjp6VFNrcrqGjYISuCc9/aueWVc/eBK/MOM1IJWO3DDGMnI4/CgCzczybg80hBJ3DHb2qssgLPt3gDqSOhqMSDBzJyARjGc/Wk2ZAVmjXPyk4z+NADxKUPysOOMZzlj2A/rWzo0AjIupQpRSCN3OTWExjwVCEMBgHgn6j8K2dLv4lt4reQMhGFGQMdePpQBsmYyKxmbCsPmOOcf0qjcxhhkHAbgbsZx7/AJVew4GU3KCCAc5B6dqYYRLv3BQ2BtP9aAOT8SHPhnUxuDKtq4Xj5vu968NA4zX0B40tCPDWpSOEVltZOQPvcHvXz+DxUyBDlU5xn/69XLOTy5VbHOPXNU+Tjj2qW1++TkqR39KaGem+F0+02oG4bc5O0cmtqCIiQrtEkZzk+nvWD8NL6C3aVJwSjLjn/Cuy1DSZIEa8tpMAHcwHOQaBGfLCqfcAZSBnI9emapCJWZsDdub7vpWiS9yjPvG8jnI6+3+fSqiurFiQQC3DjABNAE4h52E7SFyGPrmtGFBGwdh8pHyqB+tVBIq5GVOR0U/1/pU8ZJkCnJbqvfI6ZoA1rIKGUsGXaMsCe3tWkrBTySDt+U/xfWsqxYz4jxtjIy2O+DWh5iyS4IOF79aYF6KUnARCF6M34VZdx5WCWGRyB39qzkYBcDlQMnk/maQTMiiN2BU5yM5z9DQBoJhm+VWQEZ44z6GpY4tzAyIcNxndxmqdvMAvzPjjGz29DVmOQKSI34xggc0Aa1urRspVlKk45b0FSSYdsMkZbP8AdqgswOdjjAxkdhVkXJ6h8L+HX2oAuQ/IuYwVzxyPSpo24LZ+bqD/AI1ki9twd7ygsOCFan/b7ZQzCUMevPp3oA2JJ5OASSnBx2zVczF+XwDjtwOtZj6rAVK7wTxnPpVO5vZCzCMFRj5mFAGne6kPL8qAAID8zdz7VAl2QzAM2cdux9qyN+5zycEdyKejEFsttxyehzxSAuSH5GYnduPy88mtCxcMiA5XbkFc/wBKx4nYKPub8dM8/SpoSSoAJPfPoKYHR5fqB878H04qWKR8bZAApIAB6VhRahLCFBOVboCcnP8AhV6PVDjDQqxB4Ge1AHXaT6HGCfXp+HpXU2EIWIE8sScDNebadrk0f+rhQAAHnqBXW6LrBnXEgIYdQelAjqc/dBwcV+c3xN/5KT4s/wCwtd/+jnr9BTqXPKd+T1Nfnx8SW3fETxS3rqt0f/IzVMho55evSrMbnDFCePQVWXr2/GrEQOG7FuM0kBbjdxtCZ2jnnrWnbsUQ/wAXOcZ9azY2IAyFc/wnFXIzuGA4Uk/w9aYGta301tKDDK6MORtOKuSandTvvnldiQMknqM9vSseEAuCflUcHirMZCtwMoByPSgDT09zcSKrFmdj8qk12+l6BdTDcIyAfvZ9K5Lw4kbXKM7btvXivXtEvIWhA80ZXg84J71Qmcnd6NJbsFlHCEDIFVjpcmW3ICmNxr0R7m2nwSRIecqec1j3ctlGu84XBAYbsD3oEed39p5SBkU85HXpWaJUEjHL7cng8/rW74h1O3kaSK0IO4nLDsDWAThFCjjrtzzQMtRzBlP3QTycjPseaTeAxIwTjriocqUPBU8YHYj6Uuc7mAyvIPSkM0YG3r85IJwVb/ParEcoBK5DBfUdTWbGVK7uWUtjg8/lViCQMXUEdADuOcH1pklxzjKg579eQf8ACohKSz7Soyv0zSTBkbhV6dz1z2NQB9uRtEe0Zxnj/wDVQMub02BSw6Eb8fKPzqN9obYg5Yk5bHT8KQ7REoY4XGMYzmldAUPlbQOn/wBfNAyEkks0Y2kc5U9adFK+SzNkdMHnr/WkZNwYli2emMdPpUQJI+/znOR260gLMU+9XwOMFQc8mlYjBXyyCcHn09faqoLMpOckHcST/KmvLJv3Ng5HA6fhTAuFhsGMnKbdxOcf59alO7kqufVjVKFlZHLkbVHO0YHPtT8oCu5jzzjPTJ6kd6ANnS9XmtCq7vMQLjaxzwe4NbcWo2lxhldkJPAI5UiuLTKMAmV6HIbn/wCtUyE+Xhhjcflx/D/jQB1XjN4/+EP1gKA+60kIbrn5etfNo/nXtOs3bx+GtUjJYhrR1IHIztNeKilIEPX3P4VJCfmB6YHX1qPGQM5x0qReAVwc4xzSQzovDdz5F8GL4wcnnOa9s0jWYprEFpIkRgMhulfPts7LIp3KcccdK7LR9SZ9kbEbW6DPrxTA6eUGTUHCt+6Yb1Cnp6ZqUwxsxVTvwAMHoPp71csIIbi3aKLDOoxuJx17ZqtqOk3GmyGZJCw4JUnpn+tAiGSNog+UO0jOM8/hViGYw8nJkIxuPOBTftzPgyKMjgYPI/8ArVX8+JmPmOVbI3ZHI+lMDTtLor8g3hSpJYdT/hUq6iPlYkhRgZI5YVlrsfiNiW5Xd6VGSQ2VByB8ue/4UAdDJqKZ69fl69e35c0Xmu21iiqoQbeQeu71rlJrtIYXkTDBR0PTPt6VjCQ3L7pWy4BwQeTz0oA7KTxRcNIxgVI0YYyf6VANbvXLKJZFHbaMHmufR1V8HJ49elXYZfM2EMNo5Zu9AGoNQnZ+Z3Y9BliCtWY7mbOd7NgHAyaxkYZASMtgY/3TV2B1UMxVjt6ZP60AakVywBBXOf4Qeme+auC6I+UnPT7xGT+NYgnIQKAxAOARxj61YjmUEISOoAI/xpAbqXIkzsJO4DA7+9W1kymT0xj5hxWBHfqrHauAeM+gqQXwKqwOSDkk/wAqANo3AbbubAAwKkWfYuBnngmspboc4woBwvIBAqWK48xdu5S3Ayec0AaIuCCTIcY7nvU6TgAE42k8n2rJaY7V3dzyeg/zxSxktja+4sTknt6fWgDbjn8w5BUHOevOKtROrfcBL7sEDn8KxoiVfkHrg44xj+dXoZGA64PBwPSgDVRcEKpXkEEf4+1a2nTtFLv+YY5zjg1kW8iN3BIwCB0PvWxashUAH5RznHJ9qYjprHV42VVmQZJ++OlfC3xFZX+IPidk+6dUuiPp5rV9mxjBI75GFPGK+LfHXHjfxD/2Ebj/ANGtUyGjFXO4Y61IGx1zzwSe1RL156U8H2yetJDLqYG3dyo6ip4nPmncAoB+UY6fUVVUDcMDGeTjqKsIQHJIJb1GOnXHvTEaETZywcAqMY9amDBc8gLjrnk1RhlJHzDAI+vv+FTBiAAQckc+9AGhbyFCWjJwe44x7Vpx6lfRogWds5OCKxUclPk+9n1zU6ybWAY5T1FO4GwNUvmwPtbnB4+bAzRLezTBjJJM/wDwPk//AFqpQsoA27Se4wOKXeVYHjYDt6d6AJU6jaRgcdPvH1x6+9Pl2YJLdRjg/pzVdSQSxwB0HPI9xQxy4GQFJP4CgC4GBCkhR8w+UHj606Jh5jM5wBkHHSqquTF0JA+8enFPjfY2SD1zgDgGgC6Czsew9R0zU0ZA2scNt4JDGs6G4CyHAJZvWplmA271xk54PUeuKYi8zFvkRhtbPGelNdWaQjJzjp9Kg+0jByvU4BP9KGcsNrAEADLDvzQBcyxyytznHIwTx/n86dMXXOCdnQkHj6cVUSfKjaNhOdoaohduGIDZXr0PzY9qBl6MgPkkgrySTwaUorI2GDLng9Dis9bhxwW3KOBmrKTmNg247m4HGaAJgvAZgAnqe+PeoXUthBxjJDE8D2p7T5PzE7W5I6ComlVc5UbcYI/GgAZZFLgnCuAS3TntzSGadBtUkj7zADnHanB1wVySR26f/roBkAA2KWHX16UAKshYHgqDjPOealSXDL+IJ7VCwZFCsvJ6qOo96lbCAhwoB7Yzn3oANZZpNB1JSc7bds4+hxXkQr1nX3xol7wwzbOAR0IxXk1TIaHDjH504fXAHP40z6U9SxGB06UICyhAC84IHbmtCym8ljyeDisuMsZQclj0NWBIVHPyr1Pv/wDXpges+CNStswq0g355BPeu9lubaWxld8Ff7xOelfOdlcSwODvZHzuGOtbtr4ivUjWF2eRR0ycfrTCx6fcaZFLCRDkluRjr+dYGoaVdO6+WuTjBOOuPWsuHxgyOTtboAT9Ktr4v38ScIefc0gMmY31uCjxuD0yATn8aibU7hlAL/Njhh1x0rWufFUMsRURs7nj7o6Vzc8pkuC2CC38OOBTAlkdiB1O49z2p0b5PGQTwarl9pAxnoOO3+cUMXYnn5c8nHegZf8AMwdpYsw+7jirEUxVSVXAJJwfWs+JmwADjkDj+dPEuXJGTx160CNJJHc4UkYxzn+Y71ZEpJUMR8p4JJ/yKxklwVK4yT07Ht3qT7QyyncobA67etAG4krFhk/KDkZP+c1YST+I5z/EMDmsI3GWYgHaBkev0A9Kljum2BWO04P0oA3EmIZnB2g9DkdPWp4pfmPIyvc9D/k1zzTnKKoDccEnv9KfHOc4zyRxg9frSA6IOM7mYZ9+OPT9algu2jwwIxuOc9RWGLnAJb5gemaI50UjkL1+poA6m3vAwLPhV44HQfWp0uckMmdoyM9c9ea5hLk55XMgGR2Aq7b3Q2ZxlDzj3oEdJbXBUjeVOCW55rStp1bq3HXnHWuVtrpljXnp7dPzrQt7oqi5XndnBHUetAHWI3O5Q3Ax+Faltcsycv8AL15/xrk4NSCkdAOmM8g1o22oovJGeCT7UwOut7hOFfGehIr408cnPjbxAeedRuOv/XRq+rbe9j4IIyevUDFfJ/jQg+MddI6G/nI/7+NUyBGQoJPAzUkakuABn+VRAkHIODTvMf8Avt+dIZbXJfPO45698e1Oj5cFRkZ6cg1SEjggh2BHfNHmyZz5j59c0XEa0XygAZI65H8qsRqWIxnaRgdsVhedL/z0f/vo0ouJwMCaQD2Y0XCx0kUQGfXp8p6VaVGGCFJxxx/WuS+1XGc+fLn/AHzSm7uCMG4mx/vmi4HVxuRhsFSDjOOT+FSCRzg5LDPYY6muQ+13Oc/aJs/75o+13OMfaJsf75p3A7aGTlhkkg8ACngYdWzk7s9OB9a4f7Zc8/6RN/32aDe3WMfaZ8enmGi4WO/BMQIPzEj8OtNIJBIOAo+6BXBC9uh0uZx/20NL9uu/+fqf/v4aLhY7yNAz5CtuOeo9u9K4Dbd2OOMH2HX6VwQv7wdLq4/7+H/Gg394et1cH/tof8aLhY7zovX33KOo96USttBMhAJzt29K4L7dd/8AP1P/AN/DQb67wB9qnx/10NFwsd7DMvnhizDggE9qc82BxwCMgd+e9efm9uiMG5mx6eYaBe3Q/wCXmb/v4aLhY7/fgr7cbSc5470qSk7grAjPfuP8/wAq8/8Att1/z8z/APfw0G9ujjNzPx/00NFwPRTNyyx9CcYPTPcUocEbQoUjopPevOvt13nP2qfP/XQ0fbrv/n6n/wC/houFj0u2kIVjw3ck/wA6lR84dCSQeQe9eYf2je/8/lz/AN/W/wAaX+0b4DH2y5x/11b/ABo5gsenMFZHJBb25z+FMfYCQ+4J145P515odRvT1vLn/v63+NJ9vvP+fu4/7+N/jRzAei6zcN/Y18hI/wBQ2O/UevevM16dM1M99dupV7qdlYYIMhII9KrhiOhIpN3GPVTnofwpyggBh0x17Co97f3m/Oje/wDeb86LgTj5ScdeoANTxncSypyeAOv+RVEOw/ib86VZZFHyyOPoadwNEuQA2cj0z0FTQO5Axn5c4wcYrI82T/no/wCdL50uc+Y+f940XGbhll2DcpV1+XAqyknd23Ff4vQ1zZnlPWWQ/wDAjR9omxjzpMf7xouFzpo928cgkEnOakLkvgqWIHBIPTNcsLmcdJpf++zS/arjn9/Lz/tmjmC51LE527cDPcc1Kj7lyVcMTzk5HsK5D7Vcf895f++zSi7uQOLib/vs0cwXOx3HGSAB3I608HLHByDz1rizd3LdbiY/VzQLu5ByLiYH/fNFwudkr4bI+XOfvDp9KsqV2ndkAAEc5rhReXQ6XM3/AH2aPtlz/wA/E3/fZo5gO5427g7Z9D3pyscY698Z4BrhPtt1j/j5n/7+Gj7bd/8APzP/AN/DRzBc70PhcsGIyBzzVhJGPylRyMbRzXnf267x/wAfU/8A38NH2+75/wBKuOev7w/40cwj0gP8oIIU47DpzUcMp3DgDPJxzXnf2+8wR9quMHt5h/xpPtt11+0z/wDfw0cwHqEK5OGJIIBznoavQ4ZMB8g4yAe9eSDUb3/n8uf+/rf40f2lff8AP5c/9/W/xo5gPZIZj5YGfnI79/r71YguW3KM7SMjJJrxQanf/wDP7df9/W/xpf7W1H/n/u/+/wA3+NHMKx7ul2xJDZZlxwe/ritOK7AWNTknqdvQelfO/wDbGpjpqN7/AN/2/wAaX+2tU5/4mV7z/wBN3/xo5gsfRi3qqgYuN+47h/SvnbxOd3iXVmyDm7mOR/vmmf21qmMf2le4/wCu7/41RkdpJGeRmd2JLMxyST3JpN3Gf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) True avulsion injury of an inferior segment of the calcaneal apophysis, which was treated in a cast for comfort. B) Uninjured side shows normal apophyseal segmentation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Jarvis JG, Moroz PJ. Fractures and Dislocations of the Foot. In: Rockwood and Wilkins' Fractures in Children, 6th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8864=[""].join("\n");
var outline_f8_42_8864=null;
var title_f8_42_8865="Nimustine: International drug information";
var content_f8_42_8865=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"18\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Nimustine: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4303427\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acnu (CH, DE, NL);",
"     </li>",
"     <li>",
"      Nidran (JP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1979768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      ACNU;",
"     </li>",
"     <li>",
"      Nimustine Hydrochloride",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1979770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antineoplastic Agent, Alkylating Agent (Nitrosourea)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1979773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of cancer",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1979769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: I.V.: Refer to individual protocols: 2-3 mg/kg or 90-100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     as a single dose by slow I.V. administration; repeat in 6 weeks depending on hematological response",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1979772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Injection: 50 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10446 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-201.248.109.99-10E284DFB3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8865=[""].join("\n");
var outline_f8_42_8865=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4303427\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979768\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979770\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979773\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979769\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821098\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979772\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10446\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10446|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_42_8866="RV endomyocardial fibrosis";
var content_f8_42_8866=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F65132&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F65132&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endomyocardial fibrosis of the right ventricle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 434px; height: 216px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Echocardiogram showing&nbsp;endomyocardial fibrosis, a&nbsp;cause of segmental abnormality of the apical region of the right ventricle (RV). In this example, the disease, which is often bilateral, is limited to the right ventricular apex. The characteristic apical obliteration (O) is shown in panel A and is highlighted (arrows) by contrast injection (panel B).",
"    <div class=\"footnotes\">",
"     ivs: interventricular septum; LV: left ventricle; LA: left atrium; RA: right atrium; ias: interatrial septum.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8866=[""].join("\n");
var outline_f8_42_8866=null;
var title_f8_42_8867="Patient information: Neuropathic pain (The Basics)";
var content_f8_42_8867=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?24/33/25105\">",
"         Patient information: Alternative medicine (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?23/12/23746\">",
"         Patient information: Chronic pain (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/57/12179\">",
"         Patient information: Depression (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?19/47/20208\">",
"         Patient information: Nerve damage caused by diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/21/6483\">",
"         Patient information: Reducing the costs of medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?14/0/14338\">",
"         Patient information: Shingles (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?23/55/24435\">",
"         Patient information: Stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?19/41/20116\">",
"         Patient information: Depression in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/5/21587\">",
"         Patient information: Diabetic neuropathy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/12/13507\">",
"         Patient information: Shingles (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Neuropathic pain (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/neuropathic-pain-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H18836185\">",
"      <span class=\"h1\">",
"       What is neuropathic pain?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Neuropathic pain is a type of pain caused by nerve damage or a problem with the nervous system. Neuropathic pain is usually burning, tingling, sharp, or stabbing. People can have the pain all the time, or the pain can come and go. Neuropathic pain is usually worse at rest and at night. Sometimes, people feel a lot of pain when they are touched gently.",
"     </p>",
"     <p>",
"      Neuropathic pain can be severe and affect daily life. For instance, neuropathic pain can keep people from sleeping or eating well. This can lead to depression and anxiety.",
"     </p>",
"     <p>",
"      In some cases, neuropathic pain goes away on its own. But in other cases, it can last months or years.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18836200\">",
"      <span class=\"h1\">",
"       What causes neuropathic pain?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Different conditions can cause neuropathic pain, including:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Diabetic neuropathy &ndash; This is a form of nerve damage that can happen in people with diabetes.",
"       </li>",
"       <li>",
"        Postherpetic neuralgia &ndash; This is a condition that can happen after people have a painful rash called &ldquo;shingles.&rdquo;",
"       </li>",
"       <li>",
"        Stroke &ndash; A stroke is when part of the brain is injured because it goes without blood for too long. People can have neuropathic pain after a stroke.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      But sometimes, doctors can&rsquo;t figure out what&rsquo;s causing a person&rsquo;s neuropathic pain.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18836215\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. Your doctor or nurse will ask about your symptoms and do an exam. He or she might do:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Nerve tests to check whether your nerves are working normally",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18836230\">",
"      <span class=\"h1\">",
"       How is neuropathic pain treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments for neuropathic pain include both medicines and activities. No single treatment works for everyone. Your doctor or nurse will help you find the right mix of treatments for you.",
"     </p>",
"     <p>",
"      The medicines used most often to treat neuropathic pain are ones that are also used to treat other conditions. Doctors treat neuropathic pain with medicines for depression, because they work on areas of the brain that process pain. Doctors also treat neuropathic pain with medicines that prevent seizures, because they help with overactive nerves.",
"     </p>",
"     <p>",
"      Other medicines doctors sometimes use to treat neuropathic pain include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Prescription pain medicines called &ldquo;opioids&rdquo;",
"       </li>",
"       <li>",
"        Pain-relieving or numbing medicines that go on the skin as a cream, patch, or spray",
"       </li>",
"       <li>",
"        Injections (shots) of numbing or pain-relieving medicines that go into the spine or the area with pain",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Other kinds of treatments can also help with neuropathic pain. Some of these include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Physical therapy",
"       </li>",
"       <li>",
"        Working with a counselor",
"       </li>",
"       <li>",
"        Relaxation therapy",
"       </li>",
"       <li>",
"        Massage therapy",
"       </li>",
"       <li>",
"        Acupuncture",
"       </li>",
"       <li>",
"        Devices that affect nerve signals",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      To find the best treatment for you, you should be open to trying new treatments or combinations of treatments. Sometimes people have to try a few different things before they find the one that works best.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18836245\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Use a heating pad or cold pack on the painful area. Check with your doctor before trying this to make sure it is OK for your individual condition.",
"       </li>",
"       <li>",
"        Learn ways to relax your mind and body, such as doing deep breathing exercises. Relaxing your mind can help with how the body feels pain.",
"       </li>",
"       <li>",
"        Stay as active as possible. If you haven&rsquo;t been active for a while, start slowly and increase your activity slowly.",
"       </li>",
"       <li>",
"        Tell your doctor or nurse if you feel depressed. Neuropathic pain and depression often go together, and each can make the other worse. Getting treatment for your depression can help you cope more easily with your pain.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18836260\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/12/23746?source=see_link\">",
"       Patient information: Chronic pain (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/47/20208?source=see_link\">",
"       Patient information: Nerve damage caused by diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/0/14338?source=see_link\">",
"       Patient information: Shingles (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/55/24435?source=see_link\">",
"       Patient information: Stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       Patient information: Reducing the costs of medicines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/33/25105?source=see_link\">",
"       Patient information: Alternative medicine (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/57/12179?source=see_link\">",
"       Patient information: Depression (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/5/21587?source=see_link\">",
"       Patient information: Diabetic neuropathy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/12/13507?source=see_link\">",
"       Patient information: Shingles (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=see_link\">",
"       Patient information: Depression in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?8/42/8867?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82819 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-629A639819-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8867=[""].join("\n");
var outline_f8_42_8867=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18836185\">",
"      What is neuropathic pain?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18836200\">",
"      What causes neuropathic pain?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18836215\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18836230\">",
"      How is neuropathic pain treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18836245\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18836260\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/33/25105?source=related_link\">",
"      Patient information: Alternative medicine (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/12/23746?source=related_link\">",
"      Patient information: Chronic pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/57/12179?source=related_link\">",
"      Patient information: Depression (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=related_link\">",
"      Patient information: Depression in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/5/21587?source=related_link\">",
"      Patient information: Diabetic neuropathy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/47/20208?source=related_link\">",
"      Patient information: Nerve damage caused by diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/12/13507?source=related_link\">",
"      Patient information: Shingles (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/0/14338?source=related_link\">",
"      Patient information: Shingles (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/55/24435?source=related_link\">",
"      Patient information: Stroke (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_42_8868="Micafungin: Patient drug information";
var content_f8_42_8868=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Micafungin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/31/44532?source=see_link\">",
"     see \"Micafungin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/29/9686?source=see_link\">",
"     see \"Micafungin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F196257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Mycamine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F5505640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Mycamine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691491",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat yeast infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702523",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to micafungin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012167\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697869",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10012166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10012171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11353 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-08BE826B45-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8868=[""].join("\n");
var outline_f8_42_8868=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196257\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5505640\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012163\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012162\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012167\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012168\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012170\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012165\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012166\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012171\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012172\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?43/31/44532?source=related_link\">",
"      Micafungin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/29/9686?source=related_link\">",
"      Micafungin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_42_8869="Melanoma in transit met";
var content_f8_42_8869=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F51740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F51740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 592px\">",
"   <div class=\"ttl\">",
"    Cutaneous melanoma: management of in transit metastases",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 572px; height: 429px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In transit metastasis. A) Prior to treatment. B) Six weeks after isolated limb infusion. C) Three months after isolated limb infusion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Douglas Tyler, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8869=[""].join("\n");
var outline_f8_42_8869=null;
var title_f8_42_8870="Piebaldism - forelock";
var content_f8_42_8870=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F52591%7EDERM%2F71514&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F52591%7EDERM%2F71514&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Piebaldism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A congenital depigmented patch with white hair is present on the scalp and forehead of this man with piebaldism. The patient also had depigmented patches on the trunk and extremities. Multiple family members had similar lesions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Piebaldism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5YooopjCiiigAopaKl7gJRS4oxQAlLiiloATFLRSigBKWjrSgUhmz4SXOsJn+6a9b0i2AiXNeUeEl/wCJgzei/wBa9a0Us8ir2xRK3Kjooo3bNMEYwR61u2zbUrMtogqKBV63OOPSsnqdMVY1oGzjHPvWtbcKD3rHtTkg1rwckd6ykao0IHOPer8Tcf1qjCo696uQg5qGVYtLIFx82M9qnjfcvXNZdzbvKco2DVmwiliBEhzWV3e1iraXL2fao3UEYP1p4z6YpDnIwAasgZGijJApzRBwCyjNHJIwMU5t3GDU2GULxp41xBgf4VJaXDyIFcNuA61bAzgn0qORCoyo/Sp5Wne5V9LATmoJCSDUu7A6VC/XmqAYx44FV5eB0OalJx+PaoZCD9aljRC7VDJKACMGlY856Cse+uv3hCtz6UrpFqN2WndWOMjP1pJojJC23r6VmwtuIPU9zWzbH5RzxSUlIbjYwotOlaUtLwo7UzVYytnKq9NprdncKDWHq8p+zykDI2n+VVCKi9ByblucRbKOPlzg9604uMAVm2pH4VoxnI561zPc7FsWoiW5zVpSNuFqnAQBnn3q0nQEfjQA2fkDmsu5IOc1ozMcZ421k3JwTigaMy6z0ArFvzwcdK2bluGGOKxb45yaqO5hV2OP1z7v41hXv3E+tbeudM/7VYd4eE+tfU5X/CfqfN4z+KQjmjigUGva6HIJQaKKVwIPIHajyB61NSc1z/VaX8pfMyHyB60eR71PRS+qUuwczIPI96PI96nopfU6XYOZkAh9TR5HPWp6KX1Ol2DmZB5HvSiDnrU3NLR9Uo9g5mQ+R70CD3qalo+q0uwczIfI96UQe9S04UvqlLsPmZteELf/AEuQ+wr1jTglvAJSOgrzLwYMzSn6V6dZL5tsUHWvIxSUZNRR24fbU3rVxJErL0IzVmAknAqlYxmOADPtWhbKCOK5FsdZp2i57/lWxa8dOtZNrwB7VsWvTJrORaNCM8gCrkTYHI6GqcJ56Zq5CATjHWs2UPkm8tGbGahtdR3ybCM1aCKy7WXioU06MyblYqazkpX0Li4pamh1XOTQc8dhSxggdKdjPaqIQwdakGMECmsAcAdaaynBweaBkhIIGKryuwJwRihty96jc+/NIdiNnO4DFByaqXV4kJw5NKtwrplTke1TzLYfK7XHSAjmoXJI/wAKe0uRg4qPI70wQ1k+TjGSK5+8tXjlLEqQa6QhSpAqpeweYuABUSV0aRlZmBbxM8wAYbe+K1kQRR4zk+ppsFssIJ6mpDknkUoRsOcrsrTDf0zVK9izA+R1U1sCLPJqreqBGfpWiJb0PNbdcMR3Bq/FxzVYqVnkA6bz/Op42HHuea55bnatkWkBJwCOvarKDA4NQQ4XOcAmrCNjpUjIJ8leTgVlzqea1rgEg4rLuuCQP0oC5j3YABAOaxb1wFNbV2cZP86wNQOB9KuG5hW2OR15gR071jXYwifWtXXWGVA9azLvpHX1WWq1L5nzeLd6hX9KDRS165zCdqSg0UAJRRRQAUUGigAoooqWACloFJQAtFA96KQC0Ckpc0ALSikpRUsaOn8G8PKTzyK9P0joMV5l4PHyuc9Wr03R8+WM14eKf7xndQ2NeaTYihetX9P3GPLVU8sMBxwKspOtsUT19a4JaO7O2OuiNy0GRWpCCO1ZliQ6Bh1IrTjB4K5NQyzQgyMDtVuNsHiqUWexq8naoGTxfMOTViM5OBUEQHSpl4/OkMmz74o3Ad+ax9Whu3kRoGIXPIBpWeQKqAnP61k6lnaxooaJ3Ngbcc9aYGQMRnFVo5hFFl26Vm3MzTsxjkx9KbmkgjTbZsSDccgjFRtkjnrVTTlm43gge9aDqM5xRGXNqDXLoUbm3jl+8oJqBYFiBCLxWgw7Y5qKQA9KdkHQoPGQetVZNwyOetaDoT2NVpFzn1p27AQxTEMQelPaRSOTmmeX1IpjoWUjocdqkLFe/ErxEW5Cv79qfYRSR24FwweTuay7PTb62vTI9xvhJOUatbLDNSld3KemiY53P5VQvJB5bk9QOlWGPXmqGqyFbSU9PlP8qsLHCBt0jt6sasxqck+1QW+Nmasg4Jrlk7s7ktCVH9atRkEZyKqow3AfpVqIc89KTAVwCvrntWVdjk4GMdK2JUyCB6Vk3Q5I/OmCMO9HHXNc5qJ4IrqL4Dn0rl9Txg4FaU90c9d6HF64R5sYGeuaoXQIEZPQ9Kt60c3SD8ao3LlmjQ9FFfVYG6pK3c+ar61GMooPSkNesc4lFFFACUUUUAFFFFTcAooooABS0CjNIAooooAKXrSUopALS+lJS0ijrvCA/wBFY/7Vel6MPkX0rzbwd/x7YPrXo+knaF9K8HEfGzuo7G9DjoalNr5sm4de1VUb5gT2rVtDyPQ1xyV0dcHbY0bFTHEoPatW3IPFZkD479a0LY/Nismao0YTnjvVuEcVSiPI7VehORUjLKZx0+tTrjbwOahjbOCO1WAwHPSkMeOmCMCmGBDlsU7KkgngDpT1ZeD1qWrjRVurUTJgZGBVW005o8eYQeeorXUqTg018A554qXBN3LjJpWGL8nAHTvQ7g9MZo3cE1Fu+bp/9amCQxj81QS4XLZxmrDsPoKrz7XXGRihsdijjNzvEuRj7madJjGeKjWzCyeYhPNOYDPOaUb9QlboMxkEGkTGcdKcfSg4xk9apkjGAxgVWfvirLDIORx61BKATuB5oBFVuuay9aINpKO+0/yrWk6ZNYuswtLEQp7Ui0cdaMPLFWMEA8EL71UtSIkbzOoJFLLcbuBkL/OudrU7ObQtLIARirsMxKjAH41kpOFAAAFOS7ZM/MKloL3NwOduG49Ko3pXaTnmq39ouwxuGfpUFze5QBgAfUUCMu+kwSRXManJndxW/evnp0/nXMapJye30raktTlry0OP1Nt99j0qnMf34+lSTP5t7K3vUT83Br6rCq0IrzPm6jvJsdSUtIeleoZCUUUGgBKKKKACiiipAO1FFFIAooooAO9LSUopAFL0pKUUDQtL0FJSnpSGdV4NlHzIf71em6XjAFeQ+GZCJ3RTgnBFer6VITCm7GcV4OI+NndR2NzzApGcVpWz/u9w571h3Cs6Ky5GBWhYu32chuuK42+h2RRaW+LP8p6Vp2t46uT24ArmUQ+blW71s2wV1G4ciuNt3OtRR1tlL5i7uAa0YmA479K5zTZigAOAK3YTux+dWndESjqaUZHaphtI96qx565FTKemaZJL26VIgA5OeajXGT6UvXv+FIpMsKMDgE0nUkEfSmLJgd6kyGXNALQQ8AZAz0qO5ISMkcsB0p7ck56VBIcnp1pMpGVcTuH+o6VJbOWGW6EdKna3jJyc81Wupkt1yAKySa1Zo3dWROcdBUDgEnp71FBeCWNj0xVaW+QPtGSa05la5HK72LD4yPSmK2Tikjk81MgU4DB7fWhO4rCNzxnFV7vd5Z2Dn3qZ/Q9DUUhORRYNmVFyE+cc1k6rcCO2kYnGBWrcNgGuO8SXe5xAp925o2Vyl72iMFwWHzdepApo4bj8qMEn6VMiAkd652zrUSA7utHPBNW/KzjikaMdxU3NLIpuxHQVBI+4ZJxVqYYGDxWdMeufypozkyneOQvbFcnrU22KQ5xgV0t6+M9x3riPEc22LZnljXXQjqeZip2izDtiS5Y0DmViKSAHYTSxdzX0+FWkUeHIfTacetJXomYlJS0hpNgFFFFK4BRR60UAFFFFIAIooo7UAFLSYoxSAWiiigB1L2pKO1Syi7oc3laihJwDxXq+iThohzzXjCOY5kcdVOa9O8MXgliQg9RXh4j4mddBnYzzSpAGj5wea19Ll823RiMEjkVlWjh1CsAR71s2IAAxwK4nvc74vQfcQ7TvUZqa3yWIHbFWogCMEZBq5awRk7lGCTzXNOF9jojPQit1kLKCDgdxXS2QPkjFUreBc5xwKsxzFGAxxUJcu5TfNoaiHsalUnPFQQuHAOKkHy81ZLROGp6HHGenvUKtTWYBjzz6UCRZzkc9aXecj0qsrnr2pwJOcduKBltWGKjfAzTMk9+lOUHadxoHsRk57ce1VJokk+8M46Zq4yjtULx8dalopMx72WOAbV446AVmLiSQkHPpWrqFg8kuY/unqKit9MEZBkP4Vi07mqcVG9yWzUhcsMHtVg9aQgKMDgCombIwDW0VYxbu7hIwUe9VJJOfb3p0rgA5P4Vz2va1HZQuA2ZD0pvQEmxuu6zFaDYW/eHgAc1xkkjTSO7k7mOc1TFw99dNNKScGrA4NZSk2dFONtRwyRxUsYPQH8aSMjip0KnkHn0rFs6Yiru74wKc3I5X604fl70kmSDSGyjd9P0rHumxk5rVu36gHrWLfPg1UdTCpojKvpMA89a4TX5d9wFB6V1eqTABj6Vw95J51yze9elhodTxsZPoPhGI2+lMi4QVIBiBvpTIx8or6WhGzXoeS2OPvSUUV1khSUUdjUtgIKWjNFABnmik70tABRRRQAfSilPtSdqQAKWkpaACilooAWkopaGMgkroPDGqNbSrGxO2sCSkico4ZeorwsQvfZvB21Pb9MvlKIcjnpXVWUoZeteOeGdXVgIZicHjOehr0zRLgrGquQR2NcUj0ack1odhBjHrWhAMciufM4ij3luBWvpN4sw5wawbV7HVFaXNm3yT1q8iDjcKqwAbeKvRgEDH41myieIBRgcVKSM5zTYRkdBUyxjH4UXCxXfHUcVEZCDzVxkwvHNU5lYKSAR6ZouJIFmDNgEGpkcjn1rDlaSGQkY98VoWVx5uAetJTTG4tGkjMafnI6U2Pj8qk69e1FwQznPvStnGTUvAUc0xyBz1pajsQsMnk1XkI6dKmmYqvTnrWYvmu7GUBVB496GxpBdTxwqTI2B3zWW2pws21DkHvUWupK5IUHb7Vzt5usrZpGGHIwB6VDm09DWNNNXZd1/XUtEKRkF+mM151ql/LdyFpCSamu5Wd2aRix96oR4lnGBxnJpNuWoWUdEX7JNkKjHPc+9WeoHrUSnAHNTxDnI/CoZtFD419B071bjQgccH6VHGpq0MBe/NZs2Q3gDnpUM5AOVJ445qR5MDAFUrqbg00TIo3b8kE1h6jNtBGeK0Lubrnmuc1OcYJ9ula01dnLWnZGBrt1tQgHlq5pAS1W9UnM1ycHgdKr265avaw0NUj5/ET5m2WJvlhHvTF4Ap91wqCmele7S+JnJ0FpDS0hrcQHpTaXNIRSABR9aKKQB3paaetKKAFo3GiigBQaKQUpoATvS0neloAUUtIKWgAopKUZoY0RS1FU8gzUNePi42nc1iWLaRo5AUOMc16X4O15biMQzMBKuOveuD8NWkd5qsUUoyhBJ/Kr2oadNpl7G9ux55BHb2rjnFWXdm9Oo4vyPcLd1uINueDV/R4JIJxk5XtXm3hbxNwsN2Nsg4z0Br0TT71ZUBVgT7Vx1Ia6nrUql1odjE7AAqPwrWtmBAxiuasrsFQCetbVvcBSMdO9ZtFm0hB7dasqQCRkVmxzehzmsDUb/U47wpGG2k8YHas5OxUYOTsdZcXttaxl7hxGo9TxWc/inSkTMhmKD+IQMR+eKoSQPcxRyTuMLydw61fhRFgCqRs7npUcxooKxXh1HQ9Ycpa3kJl6hQ21vyNWorUQE4596o33hrSbm2fzbVA+MiROGB9QRWBYX99pcwtzO1xbKdo8zlgPrTuk9SnC6907aM898+lT571iW+qGRxhflI61qxTK4GDz3qlJMycWtyTJznsaYxwfQVIxHeonwuSTTuSQyck9T+NV35PJ4qZ26VSnlCE4OKaAjvJERCT0ArzbxJqxuJmjUbUX1ra8SeKbCzlFsJkkuH4Eatk1gWnhvXvEUu60094IGOTJINo/M03TlLYn2sKau2chqN+kYbLCptKQtAsr9X5GfSuw8RfDvTvD2lfatXuTcX8vywwocDPcn2Fc9EgAA7CpqQVPQuhN1nzdCZOvy81ai5xkVDGhHap0jO7OfwrmbO1Isxr0wcZpHyp6+2RTQahmc/40h2sJPJgnqKy7qb15qzO5K1kXTkEjqDT5TOUijfzhWODXK65d7ImOeTwK1tRl9TXGatcedcFQflWu7D09bnlYutZWKDHJJqzajnNVh1FXrVeOa9nBxvO55E9ht1zIopPSi45mHtRnivWpbtmQlIaU0hrRiJltLh/I2QufPJWLj759qS7VUuXRI5ItvBSQ5YHv8ArWsy22pwWzvcz27wxLEyCBnX5e6ketZ+tXIutSkkVZFXCqPMGGIAAyfc1CYypRQaKoQnelpKWgAooopDsKKOlJS4oHYM0UYpcUCsAFLSUtAWAUtIKdQPQY4qEjmrPUVC61w4ym5K5UGdH4EVf7TnkddwjhJH1zXe6Rpz6vMdqbdvqOOT0/KuD8BRvPrQt0OBKArcdRmvoHSdOFpAsdrACRyQBjNeY6Slyyk9jZSaukcb4t8KwQ6O93Cm2fcqLjgEk4Gay4tP8Q+HtqlUulVlU4b+90A75r0bxPpt/qenxQRRMkO/dJjG4Y6H86pafdWa3pGp79xKFCSV8p14D/hzVTjGSLhNxd0YeleLYJgFn328g6hx0rr9M1iKWMYlSQeoOar+Ko/D93rNsyR2l1CwZmaKTDE9uByOTk5qtovgzTL+OXyb6W0uzMAsanzDs9gOpOOtediI+yXNuejSrOSuzrLbUUPRselaMOoRFgSwzUuhfC6Z7BHfUJI2JJCyp8wGeM81pS/C64MLeXqgVxyMR9f1pKlKSvYHiqa6lAahARhypHYHtTbjVrLyjHJt2dxW7bfDKFYVN5qErNt+YIuKwtD0DRbe/nt7hxqF2YfNEDPgxNn5VOOxz3qlhZNNi+vU1a1yA+INOEXlqgI6fL6ViXV1asWKKwHUV6zpKaPBAQ+jR20qHG3yw+foelXQ2i3PyXFlbpnpuiX+lT9Wv1BY9raJ4vBfxDAD4+tbFhqlqrfPIi+5avQbnQtJublPsukQNEpyXIKg/wCNTp4W0gHdJY2ir6Kn9TS+qtdR/X094nAzeIdLQhDdqzn+FAWP5CklvrySMNY6Nqt0G+7tg2j82xXptrDYWeI9Ps4Ub1jQD9anaN3OZSAOuM1oqHczeLfRHi0ieNb2YR2nhwWkZ/5aXM6k/kKjPw48Uavka5q4ghzu2WmQT7GvacxDAiy5/wBkcfnTSJH5yqKPxrSNOKMpYiUjzDS/hHplobmYwRtcyqFS6lctJGQchh2BrrNSA03TpLm+1OOOGBMsyqOcf1NbFxJBErO7b9g3M7H5VHv2FeE/EPxbL4iu/stmxTTIWyoAx5rf3j/SnOoqcbipUZVp2Oc8RatPruqPc3Ejsg+WJWP3E7CqkMfTjk0scPp2q5BF0J615dSbk7s9+nTUEkhFjC//AF6lKDaM9qkwF6Y96ax+XHSsjUruAep6VWlb5c1LIcVUnbg8+1UhPQp3LYOQRWNey4BJ6VoXb4DHODXN6pchVbJwBzmtYRuclWVlqZGuXflxMc/MeBXJscnJPNdLFam/n8+4yIR91T/FT7rS7ebouxsdVr06fuqx4tZSqPmOZiXLVoRjatLJYyW7fMMj1FP7D2r2cJBKNzhqNrQpSHNwaKQ8zMaca7KPw3JYh5pKWpbW4a1uFmRY3Zf4ZFDKeO4rRsRvtNPJZ2X2PWLe0RYFVofOKbWHU8DvWDqHmG8k864W5k4zKrbg3HrV7+3Z/wDn1sP/AAGWs26na5uGmdY1LdRGu1fyrNXQyKlpaK0EhO4paKWkMSlxRRQAUUuKXFAxMUuKWlxQITFLirVnY3F2wW3id/cDium03wdeyYaRVU/7Rrnq4mnSWr1NIUpT2OWgtpJjwuF9TWhBpidZGJ+ld9ZeCmKjzZgD6KK2bPwlDCcyAuPpXlVcfUl8OiOyGFS3PNYtPtx/yzB+tWF0q2k4MS4Nd9qVnp1sNrW2G6DisOWGPd+6XAFcMsRN7tnSqMUtjL0KyXR9UhvrdDlP4c9a9u8IeJLKW3Vt484HDK/WvJljapod8MgkiYq47iqhXa0lsZzwya90+hE8QwSRlI7RJSRjcxAArJu9A0rU7/7ZeCR5CB+6gGF49zXO+FNVhuYFEo8phwTnIzXfWG5gCAGX2rq0tp1OJxaepz9z4L0G6cN/ZJ4OQTKd2fqK0dI0C10qVZLGKS2dTncrEn866WBUYBiD+FWwEAwBn3rNpFxm1sFprOoR4VWVwO5Wte01a/lwSkQHuMVnKpIBAGKniYgkd6mwPXoakt3NPG0TFF3DDbAc4P8AKq1jpGn2G+WG3iSR/vOF+ZvqamTakJOOTUoUzbR0QdfekxKyIxCZcu+Ag6A1NFaQ5MgjTP8AeIpshEjqg4jFTOrOnzkrGO3c0h3I3vfLUrCMkd+1QJHJcPvnY7fQdT/hU8UYZsYCqPant8/yg7Yh1I6mlqw0WxGjSD5LYJGo6nqaQhN3O+Z+9TFVC4APso4zTSpUfMAx/ujpQFyB5HbJyFA9BmlWESLukBYf7bf5FSPECN8rbcDPTgV5b8RvG0Rt5tL0OUyO3yTXAPAHdV9frRKSgrs0pU3VlyxMf4n+MG1GaTR9MfFhG2JpE/5bMOw/2R+tcHDaEnIXiprcqrAOoGO9a0CK4BArzKtRzlc+gw9GNKPKjKSDH1p4wBggcdK0p4flJFZ8qYUkflmsLm6IpHK8ryOlV2k+Tk+1Odvlxzmqkz7V60wvYbNJ81Z1zOBnJ6Uy+vAgyaj0zS7rV5QxJht+7HqR7VpGDZjUqpaGXd3LSv5UCM8h6Koyafa+E7m82yXvyjqI/wDGvRNO0i00+MLBGoPc9z+NWyoA+VB9a7KcOU8+o+fc89fws6nCIMeu6oX8LMBzJg+lehMhfOAKqXO2MkSbF9s1smkQ4eR5hqGhXMGfkLr6gZrmry1aEscY9sV7FIYZCQjKfYGud13TopAWkiIOPvqP5100a7pu8WctWhzbo8nUfM31pT1rX1bTDbMXi+ZD6Vldq9zD1FOF0edOLi7MYaSnU01tcRYgsbq5eJYIJGMgLJxgMB1OfSk1AIkxiFq1tJGdrKXJOcd81upcedpO9Le7y8Udo8gTKIoYZK+pPHFY2szi41KVwjxhQsYWT73ygD5vfis7tsCrikpQaK1JQneloHWlHWkMBRS4rT0nRrzVGAto8Jn778L/APXqJzjBXk7FRi5OyM3FWLS0uLtwltC8jeijNdzB4HhtYPMvJjLJ2RRgVoaZaXFqypZoq/7Krj9a86rmdOOkNTqhg5v4tDlrLwXqs+DJGsKn+8ea6XTPAEaENdO0p9OgrTX7StwDctIzD+HtW1BfXvUABB2xXn1Mwqy0vodsMFBakdroSwIEjTao7AYq7Hp7p0LVat76WdCQuCvXjrV+0kaQkOoFc3teZ6m3seXYztz2y5c8euKpS6m6ZKT8emK3tR8gRlJSoJ9646/jRJDsORUSdyoxsrk97cC7wTtb14rMlg2klRxUkW5AGU5B6ircYWUY71m9C1ZmaE4z0NSLFk5FXJYMHI6VEoKt1pXHylvSrqTT7pZYwpHR0PRh6V614Y1CMwrNCd9pIendD6GvIUIYcDmt7wxrb6Jd+YQZLZ+JY/b1HvXRSq8uj2OWvRUlzR3Pb4wGAkhIK+1WUAYYxisLTbuGSKGexmD20w3Lzx9PrW9bSbwN1dVzz2rE8ceMY5qzHFuI2jkUkA6cc1cRMcrU3EMKFjyTx1qxHkJ8vNPCd8dacF54P4UgGxDLAkVM6tIAWA9hSoACDjrT8EnJoAYFG3bn60HGMKOnQU8DCnPH1rO1fVbLSLGS6v50ggQcsx5J9AO59qALZ+Uk9WPGawfEvizSfDkLG/nVrjGVt4zlz/h+NeUeMPine6i7W2hBrO16GX/lo4/9lrzyVppXaSR2dicsWOSfxrCdZR0R20cFKes9Edn4s8fanr5aEP8AZLE8eTGfvD/aPf8AlXLq3P8AnFUFJ3enarET4HHJrinJyep6tOnGmrRRfjJHofersEvlkH17VnwSjHb/AAqXzsHjp61k0bo0WuQQT0HoKqXDK2CvcVUebqCajMp+Woa1NFsJPgZAx0rGvblY88+1Xr6URxEk1z0rmSQswz3ArSnC5hVqcqBIxPKJJ87M8KK7LRC5t9+BBbL6965/RbQ3l6qqpKg5Jr0GLR0uERJslF6IOBXXFWWhyXvuV7F0usiPcyj+LHFS3GnPcDaswQDqBWw9iUtPLtVCdqxJNGvopS0e5yffgUpSfUqEY7oltdGit2DFmc0t9p1oylp1UYHU9a2NNtLkQAXZHme1Mv8ATHnQpwUNTfQdrvU4y507SnyIptjepPFZcllfIGWGWGZPQ+ldTc+FJS48sqRnmpZvDciWYUOS49Kam0EoRZ5drWkh9zNA1tIevdG/wrzzVrJ7O5ZWUqK9uuIbqxlMc4Jj6FW5BFYPijQ7bULFng2ow6ex/pXo4PF8ktTz8Vhbq8Tx8jFNNWLuCS3meGZdrqcEVAeK+gUrq6PIt3OjintbvTWj/tCG2P2aOHy5SRsZWySMdc9frWNrVzHd6lLLAzPHhVDkYL4AG4/XFb6yak1pYf2SlvLAsKhmKISH7h89Kg8QvHPa3EjfZztnVIHjABPy/OBjqoPc1mnZgc7iiilroEAFLj3pMYNaGi2qXV6izZ8pfmf6elZzmoRcmVGLk7I2fDnh2S8jW6njZo8/KmPve59q7e002SBUMq7EUcAcVc0i5L2yJbxBB91QB2roBaOLMu6B5QOM9q+YxOJlXld7Hu4fDxpx0MeC5ZZAHx5Y7EZrfgutPjQOqAMe4WsSK2Z5wroST1yK6FbCH7MUZOMc9j+dcnMzq5EJFp6alN5qTkDP3cVoxeHYEkDsGYg9M8GsnSpbew8xIpXLnpuOa04NdeMFbhAW7EUJrqJxfQ1lso1jO2Jc49K5ttUaC6eJ7UDBxkCuo0/UYbpARx7VV1ySBYWIVCT3qm1a6IV07NHEateG4cgDisopz3I960LiLc5I4z2qq6ED9KUXcqSsRhNv3aUDawZeCO1SxnaAD09aR0yMrjPY1rZNGLdiyhWSPpzUMtsRhhgj2pIJNrA4Hv8AWr8eHQ4wF96waszoi7ozthXJB9qdG+Rx2qxNCN3p7VXZCjfLV6Mho6LwJrE+m3z2pPmWkvzeSx4z32+hr2LTLmOe3Se0lMkJ6jup9DXzv5hSQOOGU5yOorvfB3iN/tG1XEdyB86n7sg/vY/n6VvSn9lnFiKP2ontVpIGA9RWhEAcZ6iua0fUors7V/dzd0P9PWujt2PQ10HBa25bQH1yKeUBORRGeOCMVLnIoFcZ/CMdqQHAxk5p+z8qjY4YZOCKQXMXxd4gtfDelNf3+SPuxxD70jdgK+b/ABT4j1LxNqL3F/IfLXJjhX7ka+w/rXWfHTUJbjxhbWQcmG2twVTPAZiST+WK4doGj0u4bb87YUfia5a1R83Kj1MJQXJ7R7kNgink8k1pCAMnbmqNvA0Cgk9easC4A57CuOV7npwikiKeIL/D06mq5bIDA89KvOy3ELMpG4dcVnTHapzzSuW0rAsxU9cGn/aM55rPnkww54pjTfLQyOaxf+0kjBqaJxt5PWsTz8Hrx1qObUCBtQ8mmoXE6tizqU/my7E6CqKKZH2Jk5phfPf5jW94atFe4VnAO3nmuhLlWhyXc2db4P0v7PahmTazckmuxgh2rx19TWLaX8alUjXPvXSW6bolJHUVSatoDVmCBV/GszWb+S0AECEt/exW0iDHIqRreKT/AFiKfrWcrvYuLSepydle3coDuSDmprnVZozjaDjriuk+xQKpxGPyrDvtGd33QsOTms7NG8XGT2JLC/FxgMCGrRIVhjAz2rOsbBocFjlu9aAOD0zjinHzFJK+hzPi2yhngw/ynsRXCtY+SzfvCUYYYHvXqOqW63MBUgZ6ivONSdYbpoZSRzjpTV07ismrM8x8Y6bkNNEPmj6+4riyOK9g1e2V2Py5Xofoa8r1S1NnfSwn+E8fSvocurc0OR9DwcZSUJcy6m3BDaQWgVdMjuH+yLcK7lsynI3Dj0z+lYuvxJDqsqRxrEhCsqKMbQVBwfetFGt7KGydIL64cxiRZopiiqx+8q4HGO9Y2oOJbuV1SWMMclZXLN+JNdyOMhp2aaKWtedCHCuu8FaW97ICFwjNyfYVyI969W8CoINGjkA5xxXn5hWtT5V1OrBw5pne6RYQW0apGqjbW3Gi5yK4qHU3tFMsrMzN0U1paLqlze3OMZj7kV4N7ntpW2OmljXy28qFWftUdpYT3EbrdhUB6BOtWhKIU3NyfSiHUJHOFTjPas5NXBczREPDVqTuTcCOapX2hurYRwRU+tajdQjEalQeh6Vn2NxPOjF2Jf3NS2uhpGMt2yJoZIPlXK/Sm3LsYcO+T2FdFpaNOdsyBqr67o5TLxDAHXFSlfUvmSdmcky881DMnyDHSrsibSQ2TiomQA+1XEmSMlw2eaj811PJq7cA44P4VQlXk1qjCSHLIM5HFXoJCFB5xWTnnirtg+5Sp6rzU1NVcdJ2di9LJ5g4UZz0qN1K5NLHlBz+BpznevbNJFyKk2Dz3qrLJLFJHNbvsnjO5H/ofY1YlJU4x2qrMpIHI4pO6dyWrqx6r4H8QRavaxliEuIztZGPKt6H+hr1PSr9mjAcmRQeS331Pv8A418o2d/caPfpqNnksgxNGD/rE/xFe7eCPElvrNlFd2k2cYBOfmQ/3W9q7ac1JHl4ilyu56rE+4blIPtVqMgqOKxbG43KCOD3Ga1YJMj2PStDmLQ6Adaq3fygsThV5JPQetTK5DEZ6muU+KWpNpngTWbmNiJTF5Sc9Cx2/wBaV7ISTbseDa7fHxD4v1HUODE8pWP/AHF4H6CotcVoba1jQZLvyPoKTw5GPsqkgBsVNd3Cy6l5PLGNQBj35NeXz803Jn00aXJBQRUjgYoS1Zl2GgctzgH9K6QqoQg5XA9Kw9UBUMGHB6VNzRw0IUBiKSxEtFJyPb1qK9HAb14qTSFLaKrPziVtufTNV9TceSQnU/pQxR2M2dshuDx3qBpcDHerEq9FzkY5rLu5PLkPOKqKMKjsNuLxYIJXY9OPqap2AkYvJO3zH+H+6PSqU0okugrDMcY8xh6nsPzqzHIRGADyx6iuqELI4ZT5ma1oDI+49+ldz4ds2a2ZwMD1rkNHhMskaKMk16nY2Jh06NFHbJrOWp0Q0VxtnCI2DAgsOeOlddZv5kCnmuds7dnfgcZ7101pF5cYXrUxvcuZYQAACql9qKW64Uhm6YqDUrt4X2pxWTIDNzJmolPojSFPqyy2qXG7dgFDVmG4ku7cpnY/ZqoxWoZSxYhR2oy0f3OBUXZo0uhqaXFcQq4uHD5ORV0rxkCucbUXhx82STwM1f0/Vo7lynQjse9NMUovctT4CHP515x4xslmujcQnP8AeWvR7hgyHIrktSsmW9Eg5VjzmtEZnGWcImsWaYcj5frXlvjWLbqJYepXNe16nHHAjKgAByeK8n8ZyC1vIp0jjkIP3ZF3KeD1FergvdmjysZrEzftRezsxb64lmEhVWhXeACOp4HU1g6izPdyF7r7WxxmYZ+bj35q82tP/wA+Gnf+A4rNu5zcXDymOOMt/DGu1R9BXso8wbiiloAqhCqOcV7F4QQRaVErYPHSvHl4r1nw3IXggIPAQce9eZmHQ7cG9WdFPpn266Rmbag4wK6jSLO3sYQFUBe5NZumL90nmo9VkneVYkJ2D+Fe9ePO0dT1IXlodMt/aFghO41sacIHAMaAfhXD6dAy7GYYrqNKvQkqpt4rHn11NJQstDR1DTBc/eGfqKjttBijUZHNb0YBXIFK5wCSOK05FuzNVHayKMFlHbnKgZx1rI16/WBSnHvmn6rqEkUhA4A71z+qypqNoZAcSJ+tQ2tkXGLveRj3twkk2QMH0qpIw2k1BK7BWPpSCYPFwaIo1bGTEMuRVCbAPQemKsSPjP61UdlJP61ojGRXkO18c+lT6ZIFuQD345qtL93PcHoaigl8u6iOepptXTRnzWkmdMU4O7mo/mIJ6GppmG0Y5yM9arCTB9qygzpkVrlySQeTniqxcHNTXjDOVrOaTcxHTHSqauZ3sAbbKPrU2hapceEvEcF9bMfsMzBLiL+HBPXFUyxDDJwc5qe7QT2skbYO5cc0Rbi0yZRU4tM+otIvEmhjmhbMTAMCDng101tJuUc9elfP/wADvFD3djLpl2w+0Wg2AnqQOhP+Ne1abcbkUg4r0VqjxZLldjodx4KkivL/AI/3rR+ELe3X/l5u0VvXCgn+deh3l/a2doZry4igiAyWdsV438W9f0/xPZ2dlpU5ka3nMruEIGMY4JrOpZRZvhqcp1E0tDjLDdb2MbswO7hF7mtDTrGRpHmfl35LYqta27O8fmtnACj0AroWnigtwiHLYxmvL02R9G7rVlK58qLbu+YDqAe1c14jKpavL0QDI7VpanfJErFiuPWuPnnn166EMe77CjZkk7NjsKFuOTSVupo2hMOgW6kkMwL49MnNUZg0gBPSrN5KGYIgwo4A9qJImVAT37UiFtYzrkhdv5c1zWpykXDAnGOtdFclS43HCrya4jXbg+bNsPLHYv8AWt6Ubs4sTPljcjgfcjyE/wCtfd+A4FX42Pmxj0qpJH5PlRjoqAVOGAmT612PZWPPi9dTu/CSqbyNj2r1SCQBVUY4FeReFHxcocmu4m1QIpCsS5OBisVpdndvY6o6hFBKsYBLH0FdDaEOob2rgbabzSm7sOTXW6NepsVGNZc13qaSjpdGhe6cLn5l+9VVNHlzg/nW7EM4wPeraIABUypxeolUa0OI1AXdkxRIwV9SKrSPJMinZtHf3rupkRxghT7YqhPaxsuPLAHtUOm+hrGsuqOKliyh4OR6VBay29tPmR9r1091YAIxjPOK4jVIW8w70KuDU2tuaKSlsdY9yHgDRtu4rKv58RMzdhmqeiNIsD7iSP5VFrU2LeTLD7uK2i7mU1bQ5nU9RE8TyJwOh5rzDxXdql7EzwpMoJJjfO08e1dXLIyQyljwWxivPfEsu+/K9dor1cEryVzyMXLSxpW9o1xbrN/ZekxqyhwJJmU7ScAkZ4zWBq8XkalNEY4YmQgFISSqnHQZrUim84Wq3FrOFu7f7KWVgN+0jay5+g61m63KZdTmJieHbhNkn3htAHPvxXrR1Z55W7UUoo61oxCgGvVvC4WG3gWQ4dgMCvMLOMSXMSn7oOT9K9A0N5FlEhUmRvuA9hXk5hOzR24SN22eq6XCNgPU+ta8emwyfM+Nx6ZrnLC4exsFeb/WuOAaii1O5mlB3YHc+leXOa6npQhJ7HSS6Y8R+Qg1q6VaQQMGmYbq5n7fI6jLHIoFzLn75wPeua6Tub8kmrNno6XERG1WGe1Ep+QnJ4FcBa6pNG4+YnmuosNQNxDz1raNRS0ZhOi46mdqeXkbzBweMGsaeOOKKQImMjqK6bUQjQO7LnbyK5qS8hkDoF2sBwD3qeWzLU20cNe3Ox2HUVHZTboz2w3NQa82ZJCoweaztOvAEcHrxWnL7pLnaVjWmbgnPFUZJPm6mo5rwEY4rMubwDcSeB71cImc6hoLJuRj2z61Wjl3XkK/7WarxTbbZc9T8xp+i5mv93YVUo2TZCd5JHXqR5Q+cZPb0qvJLyA350wODnBzVaaXaCAea5oo7ZS0Fun55OazXc5JB24NSSThmwapTTDztoORWnKYOWo5pA0i7eattIAv3ufSsln/AHuVqcTBh34/OlKIRkaXhvVD4f8AEqXUblPtKeXwON3avdJ/Et1F4YW73eVKsO9toxuPavm/WomnstyEbkORXoHhbXl1zwHPaXEhFzGhhbnn6/nzXZQd42OWSSqpstTanLeqzz3DzTSNgu7EnJovXbTY42wpjbjIP8689jvbqITwBsXKOCo9SKuLd6rqaNFFaOoc5cnu3rz0rkdNK6k9T0oYnZRWh2Q1mLyjzggcVmXXiEKQu4s7H5UXkmqdn4SunUPe32xe6x8n8629PtNN0qVfs8IL5wZHO5jWDSNueUiKHQru+QXGslobfqtuDhm/3j2qxeyxW9sI4VWNFHAUYAq7qepDyMlwexrntOtbrX9Q+z2wPlA/vJOyiptcr4V5lrw5pcur3RcHbAhy7kd/QVb8XLHZqEXAAFdxDa2+j6UtvCu0IOuOSfWvKfGl417qEdpE+GkPLf3V7mmld2M3LlTkzm7zUN5k2n5EGWb0rkhI1zqURcYQEkCt/V5IWYWdmp+zRn5iOrmt3T/BL3mgyX8IYXCDei/3h3FehRou10ePiKvNKxy2on98j9Bio7iTasbg/wAVPvELwYP3kPSqTv5lq6HqBxVKOhnKWrOy8M3Wy4TB68V0FlO73bksCN2a8+8P3bvLEseTJnAA7mvTtE05oxl+ZGOT7VhV907aEubU3rJmWP5R+Fb+iGRpM7enpUGkaY0sq7hhPpXXwWkVvD8igHFcvK3qdjqKKsU/7XeFwDgAetbumalHeJjPzjtXFXs0Ruipz1xmtjQ4nilDLlgecis4zaZUoR5bnVuAR0/Kqs0i7eDVtVO0deRXL+IpZYPmQkCt5y5Vc5oR53Yt6hMI4Xk/uiuCvNWElwxZFcCtyy1CSXfDN8ytxXK69Yy2l0/HyHkGs3Lm1R0U48rcWb1lNDcW5MQ28cisLxAN8LKCR61Bos8iXW0NhCKfrEgZXPatqeplV0ZwGsTANIoPC9q82vWe6vpiis7EnhRniuz8U3IhWcg9a4OKR0bcjsjc8qcGvYwnus8XEyu7G61vDqNvayTi+hdIVjIjtzIrgdCp7ZrN1qY3GoyuYpIgAqhJOGwAACfetZpbaxt7OO4vNVV3hV2WKUbUB6YqvrthCgnmgnuJXidFk88glgy5Vgf6GvRjucxk0Yo5p4HNaMRu+ELD7XqBJGVX2717J4f0eCMq8gBcDqe1cP4NtBp2mieUDzH+bFdBDqNxLKNhIPpXhYuqpTuephab5TstS00XAWQuQq/wisplWJtioVX3rbsllGnIZydxGaynRnmYkEivPqrW56FJ9GLGSRjpTnBPQ1Jb2k0j4AIrVtdIkJ+bP41jyt7Gjmo6spWVqzyDPT3rrLCERR4AwTTbSxjhUZA3dqu4A5NdFOny6s56lXm0QyQKVIPQ8GsCbRoxI0oY8nIHpXRH5lqvOuAT2rXkT3MuZrY8m8T2JhuHOCAa4Gef7FLKjHHpXsXimAlnLAlT0rx7xxa+Wizrn5Dg49KVPflJq3UeZFJ9SDZ+bioIrj7RMAvKKcsfX2rCjikl5J2p1zV1bgRoI4gAorpUUcftG9zYmusqQDgV0Ph1PJtt5HzPzmuR09GnlBc/KO1dQLpYYgoPGKyqq6sjooy15maUtxsz6VRnuwMk4rOuL8/3uO1Zs98CME1EaZrOrY05rkA9eaqGb5txPNZj3gOTnAqBr8E8cAetachg6yNyKQEnmnG429DmsBtTVRgHn6VH/awX3pOk2Ht0jo5Lj9385wDWXo+qPYam6wyFUdux71Qtbr7beRxTOYYGYBpMZ2j1rpNe0CwtrNJ9JuEulQ4eVTyfqOxropUJJc5hVrKTSJ7gfbp/PmlZZf73rVm01S7syFA81R6Vn6eyzWKybwzrwy9xUsbgPz09TWs6Eai1JhiJ03dG/F4ojdCjSlWHBB60LcXmonbp9vLMx/iA4H41hqxtbkzRIjk4JVh/I10+neL0hULInksBjBGK82rh3TeiPTo4lVF70rMsWHhfWb11F9PFbQnrhtzGvS9Cg0/RtP8AJtkGIx26s3qTXll740VR8j7jj+GqI8azyLjZLz2C4/WsFSnJ6I6fbU47yO48VeJNquX+Qc9T0rx681OS+uriaLIVjtDdyvtVnV7y41Ry1w22L/nmD1+pqGxtGuLhIYlyTwABXbh8K4+9Pc8/FYzn9yGxe8IaS2papEjITEpy3HaveFt7S1t0js4TGVTlkPX6qetcv4T0kaVZrlFMp6mtudpSPfrxXowp2R5snc8n+ImlJZX3221RRbTNh9nRX/mM+lcBL8kmV+6a948Q2KapYzQXEUW5hxJ0Knsa8l0zQZH1p4LofuoW+Yjue2Kxrw5PeNIXm1FHR/Cvw+GuGvZ4yWI+TPRR/jXslhpcMfO3JPNUfDlhFb2cSxptGAeldPbpgDj868+Xvbnpwj7NWiPQJbxZAwAKy5tTcynaSo6da2nhEkRXHUVgz2TpNgg461y1W1sdVFJ3uIsEV5KCflc8k12WmRRw26Kp3bRjmuNiASXlsYrWsr51mVV6VlCSTuzWrFyVkdXuAHfFZWpRw3KFHIxU1xcqIOuCR0rjtRv5RKQrHFbTmkYUoNu5dg0ryJy4cMnaq3iG3aW1OwbnXn61BYao4mCucrWlO+QGPenTtJWQ6nNGV2cBZhmkkjdMMvYiq+qyEWx3/eArptRjSOVnUAN3IrjfEE22GT6VvShZmNWpzI8l8X3W+5MQPfNc9HVrXJfO1GZs5AbAqvCB+FerhledjxqjuzqLaZLSyto9RuovMKB4la1EpiU9MkkfXHNZGsS3kUs1nczLKDJ5xdR/rCRw2foeB2qZdSgaCJbyxjuXiUIr+YUJUdAcdah1zzm1BzcFPMYK2EHygFQQB9BivTS1MrlMDg561qeH7Br/AFKOPb8gO5vpWao9a9G+H2l7IPPkX55Dn8KwxNTkgaUoc8rHV22i/aII0U7QBXRaN4et7Vgz5dhzz0qfTocEDpx+VayEAYHavDcU3dnrRbirIseUGjCnp0p0dlESMqPc4qMyrGgJOB3pyahFuwGqJNdS436GhFBGn3QOKsoucYqlZXUcr7ADn1NaaLx0xQmnsJp9RNnHP0oKjFTEZFNx60xWK5Xk4pkq/Lg1YbjNV5CckZ/GncVjF1W1W4hZWH0NeX+NNIYWcilcggjOK9buu+K5XxHCs9rIh9Dj2oS6obelmfNkk7bih4wcGpLcAn5iAtLrdpJBqt1Go4DmqGybs3611qnKS0R5baTOjjvIoFARgMelV5tWHO0kmsQQyE5L0C39XJq1hZvoP27Lk+pFuCePaqj3bMeMn2pRbqOxJqRUCjAGK2jhH1Zm6hXaSZ+MHFRyB1xk9fSrwUcioLlCYz6jmrnhVGLa3FzlXPPPNXEjXaCoFUxVy1O6L6VnhbNtMU9iZDt6dRT3nlU70Zsn7wB4amhaUfeAxXdKKasR5nRf2Rew6bb6lEAbW4OI3Ru/cH0NCXLBR5yg+4rGS5u4rYxW9zIkJbcUB+Un1xVB7i8SRn3sT/OuWVP2fS5pzXOxWdWUNnI6VITkYPNYPhu5lvbw2jKN8gymO5rakSS2lMcwKkccihWlqhXHBAOaaeOSc+1J5ig9aikmXPBolAExk0hycYFdD4Zje2P2h0jb6tzXKx3NubkGeeONB/eBNas+u6aINluZLhhx+7iCL+JOTSgrsGztn8VC3ABZhjsDmsm/8eKgO2YqfavPbuZ7lmY5RD/AD/WoFhReQv510KnIjmOou/F17qDrFbGVmc4GeOa7rwZoMsmyW5JPOWY9WNcZ4G05Wmkvp1zHF8qA9zXr/hXfOhYqVTsK8nHVPfVO+x6mCpWi6h01jEFQD0rWgUtgVUt044HFaVsmB65NcZ0smij6VK1okoIYc06JcVaiQjv+VK1xqVjmb7SSJd0Y+tRWFtIs2XQnFdcUVhlgB71FthXkAVzulZ7myrNqxyurzurkJkVjYW4Vlc4frmt7xJBJvzEvB7iuTBlS4BwSM45rGW9jphrFDxbvHMNpyM9a3GJFuobqBUdrAVAY5IPrU1yRsIrooqxz1p30MHUXypyfzrgvFEoW1lOexrt9UIAPPJrzvxfKFs5z/sn+Vd1NanFVdkeQTHzJ2Y9yTViyMENyv2uN5ID1VG2n86hhUs1aOnWgvryOAtsUgktjJAAycDucCvWw9L3ObqeVOVyw0+jYP+gXeP8Ar4H+FVNUulvb5p40aNCFUKTkgAAdfwqcS6MCVaC+2DjzPNXP5YqvqlqLK8eEOXUAMrEYJBGRkevNdkGnqZsdp1v9pvIo+zMM/SvZdA8mCFEBA4/KvKvDybbgynGRwK7vTJyXUDOO5rxsfiPf5V0PSwlLTmZ3ralFbRgL8xx0qSz1Yysc9B7VzKoJG3FsVq2TxomAOPU15jqSuekqcbFu6v3nYBSQvan2OScsR1qjMGkfjhPUVesl6BQSBWMndmySS0Ow0YxlAQBmttORntXO6NCwZSQcV0ca4XIrem3bU5qiVx+3Oc1E+Md6f0PvTWOK1IsQueOelVZyB71NKTk9BVWR89aEK5VmPy4Nc3rnEbc810NxIFByRXM682YWNXBCbPCvGKga9OR0IBrCIrc8Xvu1yX0AArE9a92j8CPHqfExAKAKWgda2RmN20uOadgd6QfrTC4baay5BB78U/6kZo5xSeoGQwwxB7cVZsziXHYimXqbJj6NzUcbFWVvQ15Uf3dT0Nd0a22msOeKkX5lB9eaawr1EjIRDg+1PIBpgqRfSqRIkRa3uI57Z2injO5HXqpqxd6rqt0264vPMJ7lRULDNG3FS6UZaj5rB9qvSMeYn/fNQzC5kU7piT6Cp/5UnrUToRtYFLUxsknn9at6fIFl2N0bpTL2PZLuH3X5qAdQQa8yLdKp6G7tJG0O9ORSxCgZJOB9aZG4ljVl645+tbPhi0+1avCpyVU7z+FepOolHm6GMYty5T0/wloyR6XBC69AC3ua9D0uBIYQqqABWDokW2NcCuotFAAr5ybvLme57sdI8qNC2WtGLCjJ6CqluBkcVbfAibHpUMZDJqcMbEAgkU+11eNztJArlr1v37EZ61XSVlbINcntZXOpUItHZXN2QcqxKdqz3mcnIY4JzyarWEjTRsnP1qWZSq45qZNvUElHQ1rOSO4hKSAHtUE+mWwbJjA/CotIjbccggVrSAEEA5ran7y94xm+V6GLPGFXCjgdqxrrIDHPSuhuhgEEVz2qHy4nOegrVKxFzmtVf5SW715n41l22U5z/Ca7i/1FJHdBjivOvHE26wk568V1UHd6HPXukcHAuBV2wjuGu4hZbjc5ym0gHNVYwNtS20Us08cdurNMzYUL1zX0EFyxSPIZ0DprpBJ0+280/wAZhiyD61zt59pF3KuobvtQOX3EEn8q17vT7i6uGklutP8APb7yrOASf5ZrGu7WSGZ4pkKTocEHtRytPmiF+jN/Soj5aAV1unLtUAde9YGlRfd4rprQAbQBya+XrSc5Nnu0I8sUjSibAAxVuNyBx1p+naNqd8M21nM6jqduBW5Z+DNamxi3CZ/vNWapTlsjpVWEd2ULOQk/NjHc4rfsHgBUjFJ/whWtr/yxQqOPlehvD+q2hAmtJBgdV5pOlUW6H7SnLqdJYzBgNuB+NasbHaDXLaZHKj4ckfUYrp4uEGeeKqEm9GZTilsSFiSMVE7kexNPfrUMhGOlaEEE7ZWs+aXAxVmZsAg1mXLYY5q4kmNr168MuBnFYt5debZMSecVtarEtwv+0K5rVytvauPaqhF81yZzXLY8e12TzdZujnOGx+VUtookk828uHP8Tn+dKDzXu0fgR48/iYhWgDFP6igCtyGNPWlxTqMUEjNgOMgcdKfgdqUCl4NAFDUo/lR/Q4qgPetm6j327gdQMisavNxUbTv3NoO6NWxfdbgd14qQnnFU9NfDsh781ePFdtCXNBMzkrMZinrSdelPAIrZEgM5pW5wKKMZqxAOBSGnYpKTAguY/OiZQPmAyKzF54raAO4cVm3sXlT/ACj5WG4V5uLp299GsHfQk0+XZKEb7rV6J4BtgbiSXHcKK80Xggjr1FeufD1CdPhkYYLc1hKr+5cDoowvUTPTtKQgLXSWi7gPSsDTBhVI4rorQcCvOkeojRhAGKuIqlSAM9qqw89KuRjGMHAqBnP6xYlHLqDg1i+Q+eAa714kk4fByMVXXToFbO2ueVF3ujeNayszE02J4YyzAjilFyC2W55rT1ZBHaEovTsK56Nw6bhwPes5Lldiovn943oLyNSIxwTVhVYMW3Zz0rIskimKkt8y+la5PygVtTTe5hUsivdMNpyfrXG+JL5Y4WTv0NdbcNhWzXnPjQOs52g7SM57VpNtImmk2cRdysLwkHgmuO8XzkweXn7z11bMDK2QTjniuE8UyZu44/Qk10YOOpz4uWljMUYUVa024NrexypH5vVSg6sCMED35qt2FXNHuEtdSimmJVBkbgMlMggMPpnNfSpaHjlu5tdMtWAuYtUhyMiN1UZH1qlq8kk1+7SwmEkKFjPJVQAB9eMVaiukBlsb+Y3NmxO2YZJjb++uefqKi1+aKbVJHgkWWPagDjocKB/SmtwPTvBfgu/1rY4XyLY9ZX6fhXr2h+GNG0dF3Ri5nHV2GeaWOY+SsVuohgThVXgACrEc0OfvZI6ntXiwoRgek6jkbkd70SFVUZ6KKmW5m+XbgBTge5rOt2B5RXwOBhcfjVyOQI4Y9F/vcZNXoIvxyyBihcYHLe9Ti5k8pndQ+7gDHSqqBWQKfvSHOamC7HO45VBgY6VLGhs9naXQKPFtYDJfpWTcabPbN5kDeZEf4T1xWx5m2MIwHmOcn6VIjgFpDyiDAWs5U4y3LjNxOaZh/FwagmJA9q37+yW4TdGAtzjdx0P1rnbjKMUdSHHBFc8qbibxncp3DELWPevg571pXMme31rE1CTA4pR1G2VJ5v3Z5riPGd6IdOncnoprorq4wG54rzH4hajuiW2VuWOSPat4K2pzVHY4+1JMbMf72Kl7VXsifnX8atdK9XD600edLcVaf0pq9alArcgaKCKdilABzTENFKB6U4LRjpTAaRnIxWFOpjlYHsa6DnGKx9Uj2zBscNXJi480ObsaU3Z2ILdtkqN2zzWyR37GsMfdPtWxaP5sCHuBg1GClvFhUVtSVRT8DFKFPejGOteiYjMc0tKfbmjmmAYoIxTlA5LHFNbqc85pMBOM81Hcwie2YD76fMvv6ipQpIyBxQu5WB9KxqR54uLKi7O5kKQUX1HFe1+CodljbJ0IQV428Oy9CKPlZht+hNe8+ErXZBGSOQAK8SomtH0PSw2rudrpkXyrkZNdHaJwD2rI05QFBrbtuRXIztsWogAc8Yqwz7IiRgkCq0jiOEswzjt3ohuo5MAcHHes20tC4xZU/tCc5bptPT1rXs5/PgVyBms66sDIwaNsAnnFX7WEQQhc9KzpqSepdTla0JpEVwVYDFczrlskCExjAJ7V1OQQABzVS9tkkUhhkGrqR5lYmE+WVzkNNDpMCNwroxJlORTfsUacqOlMmyBjtU04OO46k1PUhuWG32rlPE8H2i1cY+YdK6O4YbcE1hag+Yzmt+W+hinbU8ultzHvYjsa8y1uTztZlwchTgV7B4kZIrWVhx1NeK7vMuZZDzlic13YOnZpHFip3JCKdBC9xMkUS7nc4AppPNWtMkSO7HmNsV1aMv8A3dykZ/WvbTXQ88lFjbljELt/NC7i3kny8eu7Oce+MVQuIXgneKUbZEOCK6P7PJ9vN3sufMKbdm0eV93H+szjZWLqjpLdt5TblRVjDf3tqgZ/Sqi7iZ9TaYgnnKyE7V4ABrsIraGKNQkS/dHOKKK8pnfE2bCJGL5UfdFWxbxu6hlBHpRRWTNEQTWUJiZwpVx3U1nLI0c0UAO5GPO7kmiikMuYBMpIGR0OKgCgPGo4DcnHeiihANlYqruOGJxWb4kjX7IJQMOB1FFFTLYcdzjJXYjOetYWpMfnGeBRRXPE3kcvqLsFbntXjviWd5tVm3n7vAoorfoclYp2J/en6VeYc0UV6WF/ho4ZbhHyBmpl6UUV0kjgKUUUUkDE70vpRRVCDvVDVlBiz3BoorKr/DkNbmZFyWHsa0NJY7XHbIoorgwv8Q1nsafSkeiivWWxziLzmnlQDxRRVAJKBgHHJpnaiihgIsjRklDinby4BIHI7CiismMdaRrJqNiHGQZQK990BFEK4FFFePjf4n3Hp4P4WdfZgDA7VrQADGKKK86R3oi1KRlAAPFZsEr+cBmiiuSrudVNe6dZYfNDk1J0zRRXRH4Tke7G+9MZiSQelFFMRDJyDmqEw60UU0BmXRIU1z2pE+WaKK0gSzzfxpKy6fcYPRTXk1uPkoor0cLuedidyXvS0UV6sDkYoZtpXcdvpnik70UVqtyD/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple depigmented patches are present on the trunk and legs in this patient with piebaldism.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8870=[""].join("\n");
var outline_f8_42_8870=null;
var title_f8_42_8871="Ravitch repair pectus";
var content_f8_42_8871=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75569&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75569&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 540px\">",
"   <div class=\"ttl\">",
"    Modified Ravitch repair for pectus excavatum or carinatum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 520px; height: 438px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An Adkins strut is placed across the lower anterior chest, posterior to the sternum and costal cartilages, with the tip emerging on each side through a small incision in the perichondrial sheath. The strut is attached to the anterior surface of the appropriate rib on each side with fine wire. The xiphoid and each of the deformed costal cartilages are reattached to the sternum with nonabsorbable sutures. The lateral ends of the costal cartilages are sutured back to the ribs. The periosteum is sutured over the wedge osteotomy. Finely minced segments of the cartilage chips are placed in all sites where the costal cartilage is reattached and around the sites where the strut emerges from the chest.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fonkalsrud EW. Open Repair of Pectus Excavatum with Minimal Cartilage Resection. Ann Surg 2004; 240:231. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8871=[""].join("\n");
var outline_f8_42_8871=null;
var title_f8_42_8872="Approach to therapy in multiple endocrine neoplasia type 2";
var content_f8_42_8872=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to therapy in multiple endocrine neoplasia type 2",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/42/8872/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/42/8872/contributors\">",
"     Cornelis J Lips, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/42/8872/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/42/8872/contributors\">",
"     Marc K Drezner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/42/8872/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/42/8872/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/42/8872/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple endocrine neoplasia type 2 (MEN2) is subclassified into three distinct syndromes: MEN2A, MEN2B, and familial medullary thyroid cancer (FMTC). Affected patients have germline mutations in the RET proto-oncogene.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MEN2A is a heritable predisposition to medullary thyroid cancer (MTC), pheochromocytoma, and primary parathyroid hyperplasia.",
"     </li>",
"     <li>",
"      MEN2B shares the inherited predisposition to medullary thyroid cancer and pheochromocytoma found in MEN2A, but there is no parathyroid gland involvement. Patients with MEN2B tend to have, in addition, mucosal neuromas, intestinal ganglioneuromas, and a Marfanoid habitus.",
"     </li>",
"     <li>",
"      FMTC is a variant of MEN2A, in which there is an equally strong predisposition to medullary thyroid cancer, but not to the other clinical manifestations of MEN2A (or 2B).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In all three syndromes, there is an occurrence of multicentric tumor formation in all organs where the RET proto-oncogene is expressed. This topic will review the therapy of these endocrine tumor syndromes. The classification, genetics, symptoms, and diagnosis of the MEN2 syndromes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/33/41495?source=see_link\">",
"     \"Classification and genetics of multiple endocrine neoplasia type 2\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22794?source=see_link\">",
"     \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\"",
"    </a>",
"    .) Treatment of sporadic medullary thyroid cancer is also found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/23/38263?source=see_link\">",
"     \"Medullary thyroid cancer: Treatment and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ESTABLISHED MEDULLARY THYROID CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with medullary thyroid cancer (MTC) can be cured only by complete resection of the thyroid tumor and any local and regional metastases. The American Thyroid Association has published guidelines on the management of patients with either the inherited or sporadic forms of medullary thyroid cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/1\">",
"     1",
"    </a>",
"    ]. Our recommendations are largely in keeping with these guidelines. The treatment of MTC is discussed briefly below and in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/23/38263?source=see_link\">",
"     \"Medullary thyroid cancer: Treatment and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Thyroidectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is currently the only therapy that can reliably lead to cure, reduction in tumor burden, or effective palliation. The multicentric and bilateral nature of MTC (and its precursor C-cell hyperplasia) in all the MEN2 syndromes means that total thyroidectomy is mandatory in inherited MEN2, and the only way to cure MEN2-related MTC [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Even patients with apparently sporadic MTC should undergo total thyroidectomy, because some will subsequently be found to have a hereditary form of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cervical nodal metastases are common in patients with palpable or surgically detected MTC [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/4\">",
"     4",
"    </a>",
"    ]. Thus, a comprehensive prophylactic (ie, in the absence of clinical or radiologic evidence of nodal metastases) central lymph node dissection is recommended for all patients with palpable primary tumors or recurrent disease [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/2,3,5,6\">",
"     2,3,5,6",
"    </a>",
"    ]. A lateral neck dissection is indicated when preoperative imaging reveals disease in the lateral compartments. Prophylactic central lymph node dissection should also be considered in patients who are undergoing preventative operations, if the baseline calcitonin level is already elevated. A more limited central node dissection, taking care to avoid disrupting the parathyroid glands or laryngeal nerves, has yielded good results in children who were regularly screened biochemically for MTC with a calcium infusion test, and operated on when the test first became positive [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/3\">",
"     3",
"    </a>",
"    ]. One would expect similarly good results from this surgical approach in patients who carry the gene for MTC and are operated on before they have any clinical or biochemical evidence of MTC. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Prophylactic thyroidectomy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients with MTC should be evaluated for possible pheochromocytoma and hyperparathyroidism",
"    <strong>",
"     before",
"    </strong>",
"    thyroidectomy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22794?source=see_link&amp;anchor=H1590908#H1590908\">",
"     \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\", section on 'Evaluation after diagnosis'",
"    </a>",
"    .) If pheochromocytoma is found, it should be removed first. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link\">",
"     \"Clinical presentation and diagnosis of pheochromocytoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MTC in patients with MEN2B is more aggressive than in MEN2A or FMTC, and surgery is often not curative [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. In one large follow-up study published in 1985, for example, death from MTC occurred in 50 percent of those with MEN2B but only 9.7 percent of those with MEN2A [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Adjuvant therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although data are limited, standard chemotherapy and radiation therapy are not effective in the treatment of MTC. Palliative radiation therapy may be used to diminish the tumor burden in the neck and to prevent local recurrence. Whether morbidity or mortality is improved remains questionable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/23/38263?source=see_link&amp;anchor=H9#H9\">",
"     \"Medullary thyroid cancer: Treatment and prognosis\", section on 'Radiotherapy for residual disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Newer target-directed drug therapies are promising and are being examined in therapeutic clinical trials. An obvious approach is to target RET signaling, since this is the primary defect in MEN2 syndromes. This topic is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23288?source=see_link\">",
"     \"Chemotherapy and immunotherapy for medullary thyroid cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Postoperative management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The postoperative management and monitoring of patients with MEN2-associated MTC is essentially the same as that for sporadic MTC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/23/38263?source=see_link&amp;anchor=H4#H4\">",
"     \"Medullary thyroid cancer: Treatment and prognosis\", section on 'Postoperative management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Thyroid hormone therapy to",
"      <span class=\"nowrap\">",
"       restore/maintain",
"      </span>",
"      euthyroidism; suppressive doses are not necessary as C cells are not TSH-responsive",
"     </li>",
"     <li>",
"      Serial monitoring of serum calcitonin and CEA concentrations",
"     </li>",
"     <li>",
"      Periodic physical exams",
"     </li>",
"     <li>",
"      Neck ultrasound, especially if serum calcitonin is elevated",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Neither postoperative radioactive iodine nor TSH suppressive therapy with thyroxine is recommended for patients with MTC in the absence of concomitant epithelial cell-derived differentiated thyroid cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PROPHYLACTIC THYROIDECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hallmark of MEN2 is multicentric hyperplasia of the parafollicular C cells of the thyroid gland, with a penetrance approaching 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/2\">",
"     2",
"    </a>",
"    ]. A very high proportion of MEN2 patients are destined to develop clinically apparent MTC, and it can occur in young children. C-cell hyperplasia is clearly a precursor of MTC in these patients. Thus, an important issue is the optimal timing of prophylactic thyroidectomy in children identified as carrying a RET mutation by genetic screening. As an example, in an analysis of 50 children identified through genetic screening who had undergone a previous total thyroidectomy, 88 percent had undetectable stimulated serum calcitonin levels 5 to 10 years later; children with undetectable levels had undergone their surgery before age eight years [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the rarity of this disease, and the potential complications of a total thyroidectomy in young children, all patients should be referred to academic centers with expertise in MEN2, where an experienced pediatric or endocrine surgeon can perform the required surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Timing of surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there is not universal agreement, our approach is based upon the specific DNA mutation in the RET proto-oncogene occurring in the family (",
"    <a class=\"graphic graphic_table graphicRef71392 \" href=\"UTD.htm?32/12/32972\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/10\">",
"     10",
"    </a>",
"    ]. This approach is consistent with clinical practice guidelines published by the National Comprehensive Cancer Network [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/11\">",
"     11",
"    </a>",
"    ], and similar to that suggested by the American Thyroid Association [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    RET mutations can be categorized as highest, high, intermediate, and low risk, referring to the potential risk for local and distant metastases at an early age, as follows (",
"    <a class=\"graphic graphic_table graphicRef71392 \" href=\"UTD.htm?32/12/32972\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/10,12,13\">",
"     10,12,13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Highest risk (D) &mdash; Thyroidectomy during the first year of life is recommended in children with a predisposition for MEN2B, most commonly associated with a germline mutation in codons 883, 918, or 804 tandem mutations (804-805, 804-806, 804-904) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/14-20\">",
"       14-20",
"      </a>",
"      ]. Total thyroidectomy and central neck dissection during the first year of life is advocated, given that metastatic disease has been reported in one-year-old children [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/8\">",
"       8",
"      </a>",
"      ] and that later surgery is often not curative [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/8,21\">",
"       8,21",
"      </a>",
"      ]. Typical physical features are not necessarily present in an affected neonate within an MEN2B family [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/7\">",
"       7",
"      </a>",
"      ], so the absence of such features does not obviate the need for early diagnosis.",
"     </li>",
"     <li>",
"      High risk (C) &mdash; Thyroidectomy between ages two and four years is suggested for mutations in codon 634, based upon evidence of age-dependent and codon-specific progression of early medullary thyroid cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/12,13,22\">",
"       12,13,22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intermediate risk (B) &mdash; Patients with RET mutations in codons 609, 611, 618, 620, 630, and 804 tandem mutations (804-778) should undergo total thyroidectomy before the age of six [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/23-26\">",
"       23-26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Low risk (A) &mdash; Patients with mutations in codons 533, 649, 666, 768, 790, 791, 804 (single mutation), 891, or 912 may postpone surgery until the age of 10 years or after an abnormal calcitonin stimulation test result is observed (ie, an abnormal calcitonin response to calcium or pentagastrin) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/20,24-26\">",
"       20,24-26",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22794?source=see_link&amp;anchor=H3039235#H3039235\">",
"       \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\", section on 'Biochemical testing'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Patients with a single mutation on codon 804 are thought to have atypical MEN type 2B [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/16,27,28\">",
"       16,27,28",
"      </a>",
"      ]. This mutation has low penetrance. While initially thought to be associated with late onset of MTC and an indolent course [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/29\">",
"       29",
"      </a>",
"      ], early onset with metastatic disease has been reported, and these MTCs are associated with a second germline or somatic (tandem) mutation [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/20\">",
"       20",
"      </a>",
"      ]. This author therefore recommends that these individuals undergo surgery by an age depending on the identity of this second (tandem) mutation (",
"      <a class=\"graphic graphic_table graphicRef71392 \" href=\"UTD.htm?32/12/32972\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      If no genetic information is available to show a specific RET mutation from an affected individual in a known MEN2 family, some uncertainty would still remain in the interpretation of a negative test, since perhaps fewer than one percent of MEN2 families have no detectable RET mutation [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/7,20\">",
"       7,20",
"      </a>",
"      ]. This uncertainty must also be considered when a possible index case tests negatively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The outcome of patients based upon genotype is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/33/41495?source=see_link\">",
"     \"Classification and genetics of multiple endocrine neoplasia type 2\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PHEOCHROMOCYTOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pheochromocytoma occurs in approximately 40 percent of patients with MEN2A and an apparently similar percentage of those with MEN2B [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. There is, however, large variability in the penetrance of pheochromocytoma among different reported kindreds, depending upon the specific RET germline mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/2\">",
"     2",
"    </a>",
"    ]. Periodic monitoring for pheochromocytoma is necessary, and the timing and frequency of monitoring depends upon the specific RET mutation (",
"    <a class=\"graphic graphic_table graphicRef77855 \" href=\"UTD.htm?30/60/31691\">",
"     table 2",
"    </a>",
"    ). Details of biochemical screening to detect pheochromocytomas, including in MEN2 patients, is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link\">",
"     \"Clinical presentation and diagnosis of pheochromocytoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The disease tends to progress slowly from its precursor, adrenal medullary hyperplasia. There is an increased likelihood of bilateral pheochromocytoma in patients with MEN2 versus the unilateral and unicentric tumors that are almost always found in patients with sporadic pheochromocytoma [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/30\">",
"     30",
"    </a>",
"    ]. Extraadrenal pheochromocytoma is rare in MEN2 but does occur [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, once the biochemical diagnosis of pheochromocytoma is made, appropriate imaging studies should be performed to detect possible bilateral disease. MRI, with T2-weighted imaging, or MIBG imaging appears to have the highest sensitivity in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/2,31\">",
"     2,31",
"    </a>",
"    ]. However, MIBG scans can detect preneoplastic adrenal medullary hyperplasia that may not progress to pheochromocytoma for many years. As a result, adrenalectomy is not necessarily indicated solely on the basis of a positive MIBG scan [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/31\">",
"     31",
"    </a>",
"    ], but this test can be a useful adjunct. Functional imaging with 18F-fluorodopamine PET is an alternative to MIBG and may be particularly useful in patients with recurrent disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link&amp;anchor=H24#H24\">",
"     \"Clinical presentation and diagnosis of pheochromocytoma\", section on 'Radiologic tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Adrenalectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bilateral adrenalectomy has been advocated for MEN2 patients with apparently unilateral pheochromocytomas [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. However, we and others think unilateral adrenalectomy in those patients who have a normal-appearing contralateral gland is more appropriate [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/31\">",
"     31",
"    </a>",
"    ]. The rationale for this approach includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately one-third of patients undergoing unilateral surgery eventually require surgery for pheochromocytoma in the remaining adrenal [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/31\">",
"       31",
"      </a>",
"      ]. However, the second tumor may not appear for many years, and initial unilateral surgery obviates the need for glucocorticoid and mineralocorticoid replacement (with its attendant risks and morbidity) in the interim.",
"     </li>",
"     <li>",
"      No deaths from catecholamine crisis have been reported in patients with MEN2 who underwent unilateral adrenalectomy, were followed, and then developed contralateral disease [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Metastatic pheochromocytoma has not been reported in a patient with MEN2 after unilateral adrenalectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bilateral adrenalectomy should usually be limited to patients with bilateral pheochromocytomas. It should also be considered in a patient with unilateral disease in whom other family members have had unusually aggressive bilateral adrenal medullary disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Partial adrenalectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;One technique that has been used in an attempt to avoid causing adrenal insufficiency from bilateral adrenalectomy is to perform adrenal-sparing surgery (partial or cortex-sparing adrenalectomy). However, because of the diffuse medullary disease in MEN2 patients, many groups advise complete bilateral adrenalectomy when bilateral disease is evident on imaging. The choice of cortex-sparing adrenal surgery should be balanced by the consideration that this will increase the risk of recurrence. This topic is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/54/32616?source=see_link&amp;anchor=H9#H9\">",
"     \"Treatment of pheochromocytoma in adults\", section on 'Familial pheochromocytoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PRIMARY HYPERPARATHYROIDISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary hyperparathyroidism occurs in 10 to 25 percent of patients with MEN2A and is almost always multiglandular [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/2\">",
"     2",
"    </a>",
"    ]. The hyperparathyroidism in MEN2A is often clinically occult. The diagnosis is established by finding high (or inappropriately normal) serum parathyroid hormone concentrations in the presence of hypercalcemia (",
"    <a class=\"graphic graphic_table graphicRef77855 \" href=\"UTD.htm?30/60/31691\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Indications for surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the biochemical diagnosis of primary hyperparathyroidism is confirmed in a patient known or presumed to have MEN2A, the indications for surgical intervention are similar to those in patients with sporadic primary hyperparathyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/35\">",
"     35",
"    </a>",
"    ]. These include symptomatic or marked hypercalcemia, nephrolithiasis, major hypercalciuria, and evidence of bone loss. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/47/8954?source=see_link\">",
"     \"Management of primary hyperparathyroidism\"",
"    </a>",
"    .) Evidence of pheochromocytoma should be sought before parathyroidectomy and, if present, the pheochromocytoma(s) should be removed before the parathyroid surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Preoperative localization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative localization studies are not indicated in patients with MEN2A who have",
"    <strong>",
"     not",
"    </strong>",
"    had previous neck surgery. However, we recommend preoperative localization studies (such as ultrasonography, sestamibi scan,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    neck and chest CT) in patients who have had previous neck surgery for MTC and for those with recurrent or persistent disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18377?source=see_link\">",
"     \"Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Surgical approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bilateral neck exploration in an attempt to find all glands should always be performed in patients with known or suspected MEN2A. Beyond that, controversy exists as to the ideal surgical approach. We prefer subtotal parathyroidectomy (usually removal of three and one-half glands, often with cervical thymectomy) with forearm grafting. Alternative options include total parathyroidectomy, which carries a higher risk of hypoparathyroidism, and resection of the visibly enlarged glands only [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Owing to the risk for MTC recurrence and the need for subsequent neck operations, at which time the remaining parathyroid tissue in the neck may not be identified and preserved, most experts advocate placement of a small parathyroid autograft in the forearm during the initial parathyroid surgery, irrespective of the type of surgery performed and even when functioning parathyroid tissue remains in the neck [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/1\">",
"     1",
"    </a>",
"    ]. In patients who require repeated neck surgeries for MTC, early forearm parathyroid gland autografting may reduce the risk of subsequent permanent hypoparathyroidism.",
"   </p>",
"   <p>",
"    When performed in centers with major experience in parathyroid surgery, as surgery for MEN2 patients should be, results utilizing the different approaches are equivalent and complication rates are low [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. In such instances, institutional preferences should be followed.",
"   </p>",
"   <p>",
"    The recurrence rate after apparently successful subtotal parathyroidectomy, performed by expert parathyroid surgeons, appears to be low; in one report, as an example, none of 18 patients had recurrent disease after a mean follow-up of 5.8 years [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/36\">",
"     36",
"    </a>",
"    ]. In comparison, a retrospective study noted recurrence in two of eight patients treated with subtotal parathyroidectomy at a mean of 11.5 years after surgery; however, the initial surgery was not necessarily performed at a specialized center [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some centers have described a markedly diminished incidence of hyperparathyroidism in patients with MEN2A who have undergone early total thyroidectomy for cure or prevention of MTC [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. In one report, as an example, hyperparathyroidism developed in none of 22 patients treated with early thyroidectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/39\">",
"     39",
"    </a>",
"    ]. Why this might occur is not known. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22794?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\", section on 'Primary hyperparathyroidism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Whether or not there is a decreased incidence of hyperparathyroidism after successful treatment or prevention of MTC, the already low penetrance of hyperparathyroidism in MEN2A, and the success of treatment if it develops argue strongly against prophylactic total parathyroidectomy with forearm autotransplantation at the time of thyroidectomy. This approach would have a substantial risk of hypoparathyroidism with a low likelihood of benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain medications, particularly estrogen plus progestin and bisphosphonates, inhibit bone resorption and can increase bone density and possibly lower serum calcium concentrations in patients with hyperparathyroidism. Others, such as calcimimetics or vitamin D analogues, suppress parathyroid hormone release, or counteract the effects of hyperparathyroidism at the level of the PTH receptor. None of these medical therapies have been rigorously studied in patients with MEN2. Medical therapy in patients with sporadic primary hyperparathyroidism is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/47/8954?source=see_link&amp;anchor=H16#H16\">",
"     \"Management of primary hyperparathyroidism\", section on 'Drug therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     CUTANEOUS LICHEN AMYLOIDOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of cutaneous lichen amyloidosis (lichen planus amyloidosis) includes moisturizing lotions and creams, local corticosteroids, systemic antihistamines,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/44/14022?source=see_link\">",
"     capsaicin",
"    </a>",
"    , and phototherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8872/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Thyroidectomy for MTC",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend total thyroidectomy for patients with hereditary forms of MTC (MEN2 and FMTC) (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Patients with MTC should be evaluated for possible pheochromocytoma",
"      <strong>",
"       before",
"      </strong>",
"      thyroidectomy; if one is found it should be removed first. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Thyroidectomy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link\">",
"       \"Clinical presentation and diagnosis of pheochromocytoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A number of strategies for adjuvant therapy after total thyroidectomy have been investigated, all with limited success. We suggest that adjuvant chemo- or radiation therapy not be used routinely in patients with familial MTC (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Post-operatively, we suggest monitoring patients with serum calcitonin measurements and neck ultrasound for evidence of recurrence. We monitor calcitonin at least yearly, and in intermediate- or high-risk patients, every six months (",
"      <a class=\"graphic graphic_table graphicRef77855 \" href=\"UTD.htm?30/60/31691\">",
"       table 2",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      We also monitor serum CEA levels, which often take several months to normalize postoperatively, because it is a large glycosylated molecule. Calcitonin is a more sensitive test, but at a later stage of the disease, due to dedifferentiation, the ratio between calcitonin and CEA may change.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Prophylactic thyroidectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;We time prophylactic thyroidectomy in family members based upon the specific DNA mutation in the RET proto-oncogene occurring in the family (",
"    <a class=\"graphic graphic_table graphicRef71392 \" href=\"UTD.htm?32/12/32972\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Prophylactic thyroidectomy'",
"    </a>",
"    above.) These mutations can be categorized as highest, high, intermediate, and low risk, referring to the potential risk for local and distant metastases at an early age, as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Highest risk &mdash; For children with a predisposition for MEN2B, most commonly associated with a germline mutation in codons 883, 918, or 804 tandem mutations (804-805, 805-806, or 804-904), we suggest thyroidectomy during the first year of life (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      High risk &mdash; For children with RET mutations in codon 634, we suggest total thyroidectomy between the ages of two and four years (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Intermediate risk &mdash; For patients with RET mutations in codons 609, 611, 618, 620, 630, and 804-778 (tandem mutation), we suggest total thyroidectomy before the age of six (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Low risk &mdash; For patients with mutations in codons 533, 649, 666, 768, 790, 791, 804 (single mutation), 891, and 912, we suggest postponing surgery until after an abnormal stimulation test result is observed (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22794?source=see_link&amp;anchor=H3039235#H3039235\">",
"       \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\", section on 'Biochemical testing'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Screening for pheochromocytoma and hyperparathyroidism",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest that annual screening for pheochromocytoma begin at age five years, using plasma fractionated metanephrines measurements (",
"      <a class=\"graphic graphic_table graphicRef77855 \" href=\"UTD.htm?30/60/31691\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link&amp;anchor=H28#H28\">",
"       \"Clinical presentation and diagnosis of pheochromocytoma\", section on 'Approach to diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest that annual screening for primary hyperparathyroidism begin at age 10 years using serum calcium measurements and, if elevated, serum PTH (",
"      <a class=\"graphic graphic_table graphicRef77855 \" href=\"UTD.htm?30/60/31691\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5545?source=see_link\">",
"       \"Diagnosis and differential diagnosis of primary hyperparathyroidism\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The management of pheochromocytomas and primary hyperparathyroidism is reviewed in detail elsewhere. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Pheochromocytoma'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link\">",
"     \"Clinical presentation and diagnosis of pheochromocytoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/47/8954?source=see_link\">",
"     \"Management of primary hyperparathyroidism\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/1\">",
"      American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009; 19:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/2\">",
"      Raue F, Frank-Raue K, Grauer A. Multiple endocrine neoplasia type 2. Clinical features and screening. Endocrinol Metab Clin North Am 1994; 23:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/3\">",
"      Gagel RF, Robinson MF, Donovan DT, Alford BR. Clinical review 44: Medullary thyroid carcinoma: recent progress. J Clin Endocrinol Metab 1993; 76:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/4\">",
"      Scollo C, Baudin E, Travagli JP, et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 2003; 88:2070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/5\">",
"      Moley JF. Medullary thyroid carcinoma: management of lymph node metastases. J Natl Compr Canc Netw 2010; 8:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/6\">",
"      Machens A, Hauptmann S, Dralle H. Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Surg 2008; 95:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/7\">",
"      Wells SA Jr, Dilley WG, Farndon JA, et al. Early diagnosis and treatment of medullary thyroid carcinoma. Arch Intern Med 1985; 145:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/8\">",
"      O'Riordain DS, O'Brien T, Crotty TB, et al. Multiple endocrine neoplasia type 2B: more than an endocrine disorder. Surgery 1995; 118:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/9\">",
"      Skinner MA, Moley JA, Dilley WG, et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 2005; 353:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/10\">",
"      Frank-Raue K, Rondot S, Raue F. Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC. Mol Cell Endocrinol 2010; 322:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/11\">",
"      Clark OH, Ajani J, Benson AB 3rd, et al. Neuroendocrine tumors. J Natl Compr Canc Netw 2006; 4:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/12\">",
"      Marini F, Falchetti A, Del Monte F, et al. Multiple endocrine neoplasia type 2. Orphanet J Rare Dis 2006; 1:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/13\">",
"      Machens A, Dralle H. Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma. World J Surg 2007; 31:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/14\">",
"      Gimm O, Marsh DJ, Andrew SD, et al. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab 1997; 82:3902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/15\">",
"      Smith DP, Houghton C, Ponder BA. Germline mutation of RET codon 883 in two cases of de novo MEN 2B. Oncogene 1997; 15:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/16\">",
"      Cranston AN, Carniti C, Oakhill K, et al. RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B. Cancer Res 2006; 66:10179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/17\">",
"      Miyauchi A, Futami H, Hai N, et al. Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res 1999; 90:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/18\">",
"      Kameyama K, Okinaga H, Takami H. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. Biomed Pharmacother 2004; 58:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/19\">",
"      Iwashita T, Murakami H, Kurokawa K, et al. A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations. Biochem Biophys Res Commun 2000; 268:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/20\">",
"      Menko FH, van der Luijt RB, de Valk IA, et al. Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918. J Clin Endocrinol Metab 2002; 87:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/21\">",
"      Duh QY, Sancho JJ, Greenspan FS, et al. Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy. Arch Surg 1989; 124:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/22\">",
"      Machens A, Ukkat J, Brauckhoff M, et al. Advances in the management of hereditary medullary thyroid cancer. J Intern Med 2005; 257:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/23\">",
"      Lips CJ, H&ouml;ppener JW, Van Nesselrooij BP, Van der Luijt RB. Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines. J Intern Med 2005; 257:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/24\">",
"      Yip L, Cote GJ, Shapiro SE, et al. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Arch Surg 2003; 138:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/25\">",
"      Machens A, Niccoli-Sire P, Hoegel J, et al. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 2003; 349:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/26\">",
"      Cote GJ, Gagel RF. Lessons learned from the management of a rare genetic cancer. N Engl J Med 2003; 349:1566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/27\">",
"      Lesueur F, Cebrian A, Cranston A, et al. Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients. J Clin Endocrinol Metab 2005; 90:3454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/28\">",
"      Learoyd DL, Gosnell J, Elston MS, et al. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Clin Endocrinol (Oxf) 2005; 63:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/29\">",
"      Lombardo F, Baudin E, Chiefari E, et al. Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804. J Clin Endocrinol Metab 2002; 87:1674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/30\">",
"      Webb TA, Sheps SG, Carney JA. Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrime neoplasia, type 2. Am J Surg Pathol 1980; 4:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/31\">",
"      Evans DB, Lee JE, Merrell RC, Hickey RC. Adrenal medullary disease in multiple endocrine neoplasia type 2. Appropriate management. Endocrinol Metab Clin North Am 1994; 23:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/32\">",
"      Utiger RD. Medullary thyroid carcinoma, genes, and the prevention of cancer. N Engl J Med 1994; 331:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/33\">",
"      Jansson S, Tisell LE, Fj&auml;lling M, et al. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers. Surgery 1988; 103:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/34\">",
"      Lips KJ, Van der Sluys Veer J, Struyvenberg A, et al. Bilateral occurrence of pheochromocytoma in patients with the multiple endocrine neoplasia syndrome type 2A (Sipple's syndrome). Am J Med 1981; 70:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/35\">",
"      Bilezikian JP, Khan AA, Potts JT Jr, Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009; 94:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/36\">",
"      O'Riordain DS, O'Brien T, Grant CS, et al. Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery 1993; 114:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/37\">",
"      Wells SA Jr, Donis-Keller H. Current perspectives on the diagnosis and management of patients with multiple endocrine neoplasia type 2 syndromes. Endocrinol Metab Clin North Am 1994; 23:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/38\">",
"      Herfarth KK, Bartsch D, Doherty GM, et al. Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Surgery 1996; 120:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/39\">",
"      Gagel RF, Tashjian AH Jr, Cummings T, et al. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. N Engl J Med 1988; 318:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/40\">",
"      Scholten A, Schreinemakers JM, Pieterman CR, et al. Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Endocr Pract 2011; 17:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8872/abstract/41\">",
"      Verga U, Fugazzola L, Cambiaghi S et al. Frequent association between MEN 2A and cutaneous lichen amyloidosis. Clin Endocrinol 2003; 59:156.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7866 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-89.32.226.102-E9F4F161E5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8872=[""].join("\n");
var outline_f8_42_8872=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ESTABLISHED MEDULLARY THYROID CANCER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Thyroidectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Adjuvant therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Postoperative management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PROPHYLACTIC THYROIDECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Timing of surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PHEOCHROMOCYTOMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Adrenalectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Partial adrenalectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PRIMARY HYPERPARATHYROIDISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Indications for surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Preoperative localization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Surgical approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Medical therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CUTANEOUS LICHEN AMYLOIDOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Thyroidectomy for MTC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Prophylactic thyroidectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Screening for pheochromocytoma and hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7866\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7866|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/12/32972\" title=\"table 1\">",
"      MEN2 timing thyroidectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/60/31691\" title=\"table 2\">",
"      Monitoring MEN2 FMTC",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23288?source=related_link\">",
"      Chemotherapy and immunotherapy for medullary thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/33/41495?source=related_link\">",
"      Classification and genetics of multiple endocrine neoplasia type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22794?source=related_link\">",
"      Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=related_link\">",
"      Clinical presentation and diagnosis of pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5545?source=related_link\">",
"      Diagnosis and differential diagnosis of primary hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/47/8954?source=related_link\">",
"      Management of primary hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/23/38263?source=related_link\">",
"      Medullary thyroid cancer: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18377?source=related_link\">",
"      Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/54/32616?source=related_link\">",
"      Treatment of pheochromocytoma in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_42_8873="Basic case 1 with answer";
var content_f8_42_8873=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    LVH with repolarization abnormalities",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Precordial leads in a hypertensive patient with left ventricular hypertrophy (LVH). The ECG far exceeds commonly used voltage criteria for LVH in the precordial leads: the S in V1 plus the R in V5 equals 50 mm (upper limit of normal 35 mm). Voltage criteria alone may not be diagnostic of LVH. However, the associated repolarization abnormality (formerly referred to as a \"strain\" pattern) in leads V5 and V6, characterized by downward sloping ST segment depression and T wave inversion, make LVH highly likely. Left atrial abnormality consistent with enlargement is also present as shown by the biphasic P wave with a broad negative deflection in lead V1. These changes can be induced by a chronic pressure load (hypertension or aortic stenosis) or a chronic volume load (aortic or mitral regurgitation or dilated cardiomyopathy).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8873=[""].join("\n");
var outline_f8_42_8873=null;
var title_f8_42_8874="Risk factors for brain tumors";
var content_f8_42_8874=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Risk factors for brain tumors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/42/8874/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/42/8874/contributors\">",
"     Dominique Michaud, ScD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/42/8874/contributors\">",
"     Tracy Batchelor, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/42/8874/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/42/8874/contributors\">",
"     Jay S Loeffler, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/42/8874/contributors\">",
"     Patrick Y Wen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/42/8874/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/42/8874/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/42/8874/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary brain tumors are a diverse group of neoplasms arising from different cells of the central nervous system (CNS). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/17/36117?source=see_link&amp;anchor=H7347120#H7347120\">",
"     \"Classification of gliomas\", section on 'Histopathologic and molecular classification'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although uncommon, there is evidence that the incidence of these tumors has been rising for as much as 50 years. Among the factors that have contributed to this phenomenon are the introduction of noninvasive diagnostic technology including computerized tomography (CT) in the 1970s and magnetic resonance imaging (MRI) in the 1980s, better health care access for the elderly population, and a 3.6-fold increase in the number of neurologists in the United States from 1970 to 1987 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/1\">",
"     1",
"    </a>",
"    ]. However, other sources contend that improved diagnostic capability cannot fully account for the magnitude of the observed increase in brain tumor incidence [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/59/2997?source=see_link\">",
"     \"Incidence of primary brain tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These data, in conjunction with evidence suggesting the increase may have been occurring for many decades, leave open the possibility that environmental exposures may account for the increasing incidence of brain tumors. A number of putative risk factors for brain tumors have been examined (",
"    <a class=\"graphic graphic_table graphicRef69121 \" href=\"UTD.htm?19/43/20156\">",
"     table 1",
"    </a>",
"    ). A shortcoming in many reports is the tendency to group all brain tumors together; this approach may miss important exposures for specific histopathologic types of tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    General risk factors that have been associated with brain tumors are discussed here. The epidemiology of meningioma and its associated risk factors are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/54/20328?source=see_link\">",
"     \"Meningioma: Epidemiology, risk factors, and pathology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OCCUPATIONAL STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large number of studies have been conducted in cohorts of workers presumed to share common exposures. Standardized incidence or mortality ratios are compared to expected rates in the general population. However, these studies are prone to detection bias as working adults with health insurance may be more likely to seek medical attention and have diagnostic tests than the general population, leading to overestimates of ratios of incidence and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. In general, the data are inconsistent and limited by small numbers of cases, imprecise methods of exposure assessment, and potential bias. Moderate risks cannot be excluded by these studies and well designed case-control studies would be necessary to properly address these issues.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     White collar professionals",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been suggested that workers in certain white collar professions, such as laboratory researchers and health professionals, have an increased incidence of brain tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/6\">",
"     6",
"    </a>",
"    ]. The possibility of detection bias was minimized in a study from Sweden, where health care is free and available to all citizens [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/7\">",
"     7",
"    </a>",
"    ]. In this study, higher rates of brain tumors were reported among professionals with the use of the Cancer-Environment Registry, which linked cancer incidence for the years 1961 to 1979 with 1960 census information on occupation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Electrical workers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Possible exposures to electromagnetic fields (EMF) have led to occupational cohort studies of electrical workers. A number of studies have suggested that individuals in electrical occupations were at increased risk of brain tumors with relative risks ranging between 1.5 and 2.5 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/8-14\">",
"     8-14",
"    </a>",
"    ]. However, other studies have not confirmed these findings [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/2,15,16\">",
"     2,15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The data showing increased risk among electrical workers are usually interpreted as evidence for a role for EMF, and an apparent dose relationship was shown in a large cohort study with direct measurement of electromagnetic fields [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/14\">",
"     14",
"    </a>",
"    ]. There are, however, several issues that complicate this interpretation. As an example, electrical workers are exposed to a number of potential carcinogens; thus, an increase in risk cannot be simply attributed to radiation exposure.",
"   </p>",
"   <p>",
"    This possibility was illustrated in a death certificate-based, case-control study of brain tumors and occupational risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/9\">",
"     9",
"    </a>",
"    ]. A relative risk (RR) of 1.6 for all brain tumors was found among men exposed to microwave and radiofrequency",
"    <span class=\"nowrap\">",
"     (MW/RF)",
"    </span>",
"    radiation; the increase in risk was significant among men exposed for 20 or more years. All of the excess risk of brain tumors in",
"    <span class=\"nowrap\">",
"     MW/RF",
"    </span>",
"    radiation-exposed subjects was derived from jobs that involved the design, manufacture, repair, or installation of electrical or electronic equipment (RR = 2.3). The risk of brain tumors among",
"    <span class=\"nowrap\">",
"     MW/RF",
"    </span>",
"    radiation-exposed subjects who never worked in electrical or electronics jobs was not elevated (RR = 1.0). The risk was also increased for electronics workers who were considered to have no exposure to",
"    <span class=\"nowrap\">",
"     MW/RF",
"    </span>",
"    radiation but may have been exposed to soldering fumes, solvents, and other chemicals.",
"   </p>",
"   <p>",
"    A second problem is that failure to detect a significant association with the risk of brain tumors may be methodologic. In one review of 17 studies, for example, few were of sufficient size and design to completely ascertain EMF exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Oil refinery workers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The questions of whether petrochemical, petroleum, and oil production industry workers are at increased risk of brain tumors is unresolved. At least 10 occupational cohort studies have reported an increased risk of brain tumors in workers in the oil refinery industry. However, a working group from the International Agency for Research on Cancer (IARC) concluded only one of these studies was without significant methodologic or statistical limitation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/18\">",
"     18",
"    </a>",
"    ]. This single study found an increased risk of brain tumors only among oil refinery workers who had been employed in the industry for a short duration of time, raising doubts about the validity of the results. Furthermore, at least two meta-analyses have found no significant overall increase in brain cancer mortality in petroleum workers [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No specific chemical exposure has been identified as a risk factor in these studies and the weight of the evidence to date does not establish employment in this industry as a risk for the development of brain tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Agriculture workers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Agricultural workers are exposed to pesticides, herbicides, and fungicides, each of which may consist of many different combinations of chemicals. Similar to other occupational cohort studies, an important limitation of studies among these workers is the use of job classification as a proxy for nonspecific chemical exposures; in addition, biological markers of exposure are usually lacking.",
"   </p>",
"   <p>",
"    Farming as an occupation and place of residence has been associated with a 1.3 to 3.6-fold increased risk of brain tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/21-25\">",
"     21-25",
"    </a>",
"    ]. This has been described among Italian farmers exposed to fungicides and copper sulfate [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/21\">",
"     21",
"    </a>",
"    ], Swedish horticulturists [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/22\">",
"     22",
"    </a>",
"    ], and Chinese farming women exposed to pesticides [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/23\">",
"     23",
"    </a>",
"    ]. However, no consistent evidence exists to implicate any particular chemical exposure as a risk factor for brain tumor among agricultural workers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Others",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased risks have also been reported for workers in the vinyl chloride, petrochemical, and rubber industries [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/26-29\">",
"     26-29",
"    </a>",
"    ] and with occupational exposure to lead [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Other studies have found that aircraft pilots, firefighters, welders, glass manufactures, tile makers, and metal cutters develop brain tumors at a higher rate than the general population. However, these findings have been inconsistent over time [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     RADIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three types of radiation have been studied in relation to risk of brain tumor: ionizing radiation, electromagnetic (EM) radiation, and radiofrequency (RF) radiation. Meningeal cells appear to be particularly susceptible to the effects of ionizing radiation. In contrast, the data do not support an important role for EM and RF radiation as risk factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Ionizing radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exposure to ionizing radiation, as occurs from therapeutic radiation therapy or among atomic bomb survivors, has been established as a cause of brain tumors, including meningiomas, gliomas, and nerve sheath tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/32\">",
"     32",
"    </a>",
"    ]. The latency between irradiation and the development of brain tumors may be as short as five years or as long as many decades. Higher doses of irradiation are associated with both an increased risk of developing a secondary brain tumor and a shorter latency period.",
"   </p>",
"   <p>",
"    Effective treatment of primary brain tumors, acute leukemia, and other tumors has allowed patients to survive for extended periods, thereby placing them at risk for secondary malignancies. This association has been demonstrated for both meningiomas and gliomas.",
"   </p>",
"   <p>",
"    In the Childhood Cancer Survivor Study, glioma was diagnosed in 40 patients (0.3 percent), with the diagnosis being made at a median follow-up of nine years [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/33\">",
"     33",
"    </a>",
"    ]. Gliomas occurred in 24 patients who had leukemia and eight with a previous brain tumor. The primary risk factor was antecedent radiation (OR 6.8, compared to survivors who had not received cranial radiation). The risk of developing glioma was greatest in children who were irradiated before age five years, and was not related to other forms of treatment or the underlying diagnosis.",
"   </p>",
"   <p>",
"    The combination of prophylactic cranial irradiation with antimetabolite therapy has resulted in a much higher incidence of second tumors in survivors of acute lymphocytic leukemia. As an example, brain tumors occurred in 6 of 52 children (13 percent) treated with combined therapy, compared to no brain tumors in 101 children who did not receive radiotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/34\">",
"     34",
"    </a>",
"    ]. Three of the six children had a genetic defect in thiopurine metabolism that resulted in higher levels of the active metabolite of 6-mercaptopurine.",
"   </p>",
"   <p>",
"    Lower doses of radiation are also important. The relationship of exposure of the brain and skull to lower doses of irradiation (eg, dental x-rays, treatment of tinea capitis) is clearly linked to the subsequent development of meningiomas and other brain tumors. The relationship of irradiation and meningioma is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/54/20328?source=see_link&amp;anchor=H627075214#H627075214\">",
"     \"Meningioma: Epidemiology, risk factors, and pathology\", section on 'Ionizing radiation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Childhood exposure to diagnostic head CTs may also be associated with an increased risk of brain tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link&amp;anchor=H244757#H244757\">",
"     \"Radiation-related risks of imaging studies\", section on 'Pediatrics'",
"    </a>",
"    .) &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Electromagnetic radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cancer was first associated with exposure to electromagnetic fields (EMF) in 1979 when it was reported that children dying from cancer resided more often in homes believed to be exposed to higher EMF than did healthy control children [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/37\">",
"     37",
"    </a>",
"    ]. The risks were as high as 2.2 for all cancers, 3.0 for leukemia and 2.4 for brain cancers. Wire configuration around houses was used as a surrogate for direct EMF exposure measurements. Twenty-one other studies of EM radiation exposure of variable methodology have reported odds ratios from 0.3 to 13.1 and standardized mortality ratios ranging from 114 to 340 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other observations have cast doubt on the possibility that EM radiation causes brain tumors. Biological plausibility has yet to be established, subsequent studies have reported conflicting results, and the probable roles of bias and confounding in these earlier studies have been emphasized. Many of the above studies have used wire configuration around houses as a surrogate for direct EMF exposure measurements. However, studies using more rigorous methodology, including direct, in-home measurement of EM radiation, have concluded that a large effect of this type of radiation on the risk of adult brain tumors can be excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/3,38\">",
"     3,38",
"    </a>",
"    ]. Similarly, there is no evidence that exposure of children or pregnant women to magnetic fields from high current power lines, electric heating sources, or electric appliances is associated with the subsequent occurrence of brain tumors in children [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/38-42\">",
"     38-42",
"    </a>",
"    ]. Analyses of occupational exposure to magnetic fields have also failed to establish a relationship to the risk of brain tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cellular telephones and radiofrequency radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cellular telephones are a source of radiofrequency radiation exposure that have received coverage in the popular media as potential risk factors for brain tumors, presumably due to exposure of the head of the user to radio frequency energy. Unlike mobile cellular phones, portable cellular phones include an antenna as part of the headset, theoretically increasing cranial exposure to RF energy. Other sources of radiofrequency radiation exposure include microwave and radar equipment and occupational exposures (sealers, plastic welders, amateur radio operators, medical personnel, and telecommunications workers). Exposures to RF energy are difficult to quantify, even under laboratory conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Numerous epidemiologic studies have looked for a possible relationship between cellular telephone use and the development of brain tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. A meta-analysis that included data from 22 case control series concluded that there was a slight increase in risk associated with cell phone use in those studies where investigators were blinded to whether the participant was a case or a control [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/45\">",
"     45",
"    </a>",
"    ]. Furthermore, the risk appeared to be associated with an induction period of 10 years or longer.",
"   </p>",
"   <p>",
"    However, many if not all of these studies could have other biases and the data are not conclusive. Furthermore, biological plausibility is lacking for such an association. The",
"    <span class=\"nowrap\">",
"     WHO/International",
"    </span>",
"    Agency for Research on Cancer (IARC) recently classified radiofrequency electromagnetic fields as possibly carcinogenic to humans (Group 2B) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     HEAD TRAUMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anecdotal descriptions of brain tumors arising after head trauma date back to the reports of Harvey Cushing in 1922 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/48\">",
"     48",
"    </a>",
"    ]. A number of other observations have implicated head trauma as a potential risk factor for brain tumors. The evidence is strongest for meningiomas and less convincing for gliomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/54/20328?source=see_link&amp;anchor=H627075263#H627075263\">",
"     \"Meningioma: Epidemiology, risk factors, and pathology\", section on 'Head trauma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evidence for other types of brain tumors includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a cohort study of 228,055 Danish residents hospitalized for head injury and followed for an average of eight years, there were increases in the risk of brain tumor with only hemangioblastoma and hemangioma reaching significance (SIR = 2.6) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Childhood brain tumors may be more common in firstborn children (higher risk of birth trauma) and in children with documented history of birth trauma (forceps delivery, prolonged labor, cesarean section) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/50\">",
"       50",
"      </a>",
"      ]. However, other studies of childhood brain tumors have not confirmed an increased risk among these groups [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Studies of head trauma and brain tumors may be confounded by ionizing radiation since individuals with a history of head trauma are more likely to have had exposure to ionizing radiation in the form of skull x-rays. Recall bias is another factor complicating interpretation of case-control studies of head trauma and risk of brain tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/51\">",
"     51",
"    </a>",
"    ]. Persons with brain tumors may be more likely to recall minor and major episodes of head injury than controls. As an example, one study reporting an overall positive association between head trauma and the risk of brain tumors found no association when the definition of head trauma was restricted to episodes which required medical attention [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One particular type of brain tumor, vestibular schwannoma (acoustic neuroma, a nerve sheath tumor of the",
"    <span class=\"nowrap\">",
"     VIII/auditory",
"    </span>",
"    cranial nerve), was associated with acoustic trauma (exposure to extremely loud noise) of 10 years duration in a case-control study (OR = 2.2) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/53\">",
"     53",
"    </a>",
"    ]. Noise exposure was based upon a blinded review of job histories. A dose relationship was observed in this study as twenty or more years of exposure was associated with an odds ratio 13.2 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/2\">",
"     2",
"    </a>",
"    ]. Experimental studies of tissue destruction and repair following acoustic trauma support the biological plausibility of this association [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ALLERGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiologic and laboratory evidence supports a decreased incidence of glioma in individuals with a reported history of allergies (eg, asthma, eczema, hay fever).",
"   </p>",
"   <p>",
"    This relationship was initially observed in large observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/56-59\">",
"     56-59",
"    </a>",
"    ]. A systematic review of the literature and meta-analysis based upon 3450 patients diagnosed with glioma provided further support for this relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/60\">",
"     60",
"    </a>",
"    ]. There was a decrease in the incidence of glioma in patients with a history of any form of allergy (relative risk 0.61, 95% CI 0.55-0.67). Similar, statistically significant risk reductions were observed when the risk of glioma was analyzed for individuals with either asthma or eczema. In comparison, significant relationship to allergy was not observed among 1070 patients with meningioma.",
"   </p>",
"   <p>",
"    Several large epidemiologic studies have examined the relationship between serum levels of immunoglobulin E (IgE) and the risk of malignant brain tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/61-64\">",
"     61-64",
"    </a>",
"    ]. In the largest prospective study to date, samples from 594 blood donors who subsequently developed a glioma (including 374 with glioblastoma) were compared with 1177 paired controls [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/63\">",
"     63",
"    </a>",
"    ]. An inverse relationship was present for total IgE and risk of glioma among men and women; elevated total IgE was associated with a 25 percent decrease in risk of glioma, compared to low total IgE level (OR = 0.75, 95% CI = 0.56 to 0.99, comparing &gt;100",
"    <span class=\"nowrap\">",
"     kU/L",
"    </span>",
"    to &lt;100",
"    <span class=\"nowrap\">",
"     kU/L",
"    </span>",
"    total IgE). &nbsp;Furthermore, the association was present for at least 20 years before the diagnosis of glioma. These findings are consistent with previous studies [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/61,62,64\">",
"     61,62,64",
"    </a>",
"    ] and provide strong support for the allergy hypothesis.",
"   </p>",
"   <p>",
"    Increased immune surveillance in patients with allergies has been postulated as a possible explanation of these observations [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/60\">",
"     60",
"    </a>",
"    ]. More research is underway to understand the underlying mechanisms which might explain these associations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIET",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary constituents associated with an increased risk of brain tumors include N-nitroso compounds (NOCs) and possibly dietary fat intake. Aspartame ingestion has been suggested as a possible risk but there are at present insufficient data to support this claim. Ingestion of antioxidants, fruits and vegetables may reduce the risk of brain tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     N-nitroso compounds",
"    </span>",
"    &nbsp;&mdash;&nbsp;N-nitroso compounds are potent neurocarcinogens in animal models [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/65\">",
"     65",
"    </a>",
"    ]. Human exposure to these agents occurs from both endogenous and exogenous sources.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Exogenous &mdash; The major exogenous sources of population exposures to N-nitroso compounds include tobacco smoke, cosmetics, automobile interiors, and cured meats [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/2\">",
"       2",
"      </a>",
"      ]. Other sources include rubber products (baby pacifiers, bottle nipples) and certain drugs including antihistamines, diuretics, oral hypoglycemic agents, antibiotics, tranquilizers, and opiates. N-nitrodiethanolamine, a carcinogen in animal models, occurs mainly as a contaminant in cosmetic products, soaps, shampoos, and hand lotions.",
"     </li>",
"     <li>",
"      Endogenous &mdash; Endogenous formation of N-nitroso compounds is a complex process that occurs in the stomach, and is dependent upon the presence of NOC precursors, gastric pH, the presence of bacteria, and other physiologic parameters [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/3\">",
"       3",
"      </a>",
"      ]. Thus, measurement of exposure to endogenous NOCs is extremely difficult.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The many epidemiologic studies that have examined the relationship between meat consumption and brain tumors in adults have produced inconsistent results.",
"   </p>",
"   <p>",
"    In the four largest case-control studies, all of which included over 200 patients diagnosed with glioma and appropriate controls, and some assessment of meat intake [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/66-69\">",
"     66-69",
"    </a>",
"    ], two reported a significant two- to threefold increased risk of glioma for high consumers of cured meat or bacon, as compared to those with a low intake [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. However, excess risks were only observed among men and, in one, the relative risks were for high intake of cured meat in combination with low fruit and vegetable intake [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/67\">",
"     67",
"    </a>",
"    ]. A meta-analysis that included nine observational studies (primarily case-control studies) reported a relative risk of 1.48 (95% CI 1.20-1.83) for adult glioma among individuals with a high intake of cured meat [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two more recent publications using data from prospective cohort studies found no associations with meat intake or dietary N-nitroso compounds [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. Both studies had over 300 glioma cases and detailed dietary assessment to examine these exposures and their potential relation to glioma risk. The lack of association in these two large prospective studies cast doubt on the N-nitroso compound hypothesis, at least in relation to adult glioma risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Antioxidants, fruits, and vegetables",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indirect support for the NOC hypothesis includes the observation that certain inhibitors of the nitrosation process, vitamins C and E, appear to reduce brain tumor risk in adults and children [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/2,52,73\">",
"     2,52,73",
"    </a>",
"    ]. Dietary studies have demonstrated a reduced risk of brain tumors in children who consume increased amounts of fruits and fruit juices [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/2\">",
"     2",
"    </a>",
"    ]. Prenatal vitamin supplementation (including vitamins A and C and folate) and increased maternal intake of vegetables have been associated with a lowered brain tumor risk in the offspring [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/73-75\">",
"     73-75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, most epidemiologic studies on adult brain tumors contain limited dietary assessment and few questions to explore the relationship between intake of fruits, vegetables and vitamins and the risk of glioma. Of the nine case-control studies that include data on vitamin C intake from dietary sources",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    supplements, two reported a statistically significant inverse association between intake of supplemental vitamin C and glioma risk [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/69,76\">",
"     69,76",
"    </a>",
"    ]. In a third report, patients who reported ever using supplemental vitamin C had a relative risk of glioma of 0.2, but this association did not reach the level of statistically significance, and vitamin C intake from foods was unrelated to risk [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/77\">",
"     77",
"    </a>",
"    ]. Others report an interaction between intake of vitamin C and cured foods, such that men with high intake of cured meat who had a low intake of foods rich in vitamin C had a significant twofold increase in glioma risk relative to those with low cured meat intake and high intake of foods rich in vitamin C [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/67\">",
"     67",
"    </a>",
"    ]. Findings were similar in women, although the increased risk (1.5) did not reach statistical significance.",
"   </p>",
"   <p>",
"    As with vitamin C intake, data regarding glioma risk and intake of fruits and vegetables are inconsistent. In some studies, a significant inverse association was observed between glioma risk and total fruit",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vegetable intake [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/66,78\">",
"     66,78",
"    </a>",
"    ] (which in one study was limited to women only [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/68\">",
"     68",
"    </a>",
"    ]), but three others report no association [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/77,79,80\">",
"     77,79,80",
"    </a>",
"    ]. Of the six studies with data on vitamin E intake, four report an inverse association with glioma risk [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/52,67,77,78\">",
"     52,67,77,78",
"    </a>",
"    ], three of which were statistically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/52,77,78\">",
"     52,77,78",
"    </a>",
"    ]. Furthermore, no associations were observed for intake of total or individual fruits and vegetables and the risk of glioma in an analysis of three prospective cohort studies which included 296 incident glioma cases [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/81\">",
"     81",
"    </a>",
"    ]. In another large prospective study, a positive association was observed for fruit and vegetable intake and glioma risk [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/71\">",
"     71",
"    </a>",
"    ]. As prospective studies are the least prone to recall and selection bias, these findings suggest that fruits and vegetables are unlikely to reduce the risk of glioma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TOBACCO",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the presence of nitrosamines in tobacco smoke has stimulated interest in tobacco exposure as a potential risk factor for brain tumors, there is little evidence that either active or passive smoking are significant risk factor for brain tumors.",
"   </p>",
"   <p>",
"    Although case control [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/2,50,82,83\">",
"     2,50,82,83",
"    </a>",
"    ] and prospective cohort [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/84,85\">",
"     84,85",
"    </a>",
"    ] studies have yielded some conflicting results, the majority of studies do not support an association between tobacco exposure and subsequent development of gliomas or meningiomas. A large, contemporary prospective study examining smoking history in detail, including dose, duration, and latency, found no association between smoking and risk of glioma.",
"   </p>",
"   <p>",
"    Studies looking at the role of active smoking or passive smoking in mothers and the risk of childhood brain tumors have yielded conflicting results [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/2,73\">",
"     2,73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ALCOHOL",
"    </span>",
"    &nbsp;&mdash;&nbsp;There has been speculation that consumption of alcoholic beverages may increase the risk of brain tumors since both beer and liquor contain nitrosamines. However, no consistent association between consumption of different types of alcoholic beverages and the risk of gliomas or meningiomas in childhood (maternal consumption) or adulthood has been demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/82,86,87\">",
"     82,86,87",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most reported associations of infection with brain tumor have been inconsistent. As an example, prior infection with tuberculosis was suggested as a possible risk factor for glioma in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/88\">",
"     88",
"    </a>",
"    ] but not in another [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/89\">",
"     89",
"    </a>",
"    ]. In one large study, subjects who reported a history of infectious diseases (eg, colds, flu), compared to those with none, had a 30 percent reduction in risk (RR = 0.72, 95% CI 0.61-0.85) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/56\">",
"     56",
"    </a>",
"    ]. Other proposed infectious risk factors have included the polyoma virus, simian virus 40 (SV40), neonatal viral infections, and infection with Toxoplasma gondii. At present, however, there is no compelling epidemiologic evidence establishing infectious agents as important factors in the etiology of brain tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Viral infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between antecedent viral infections and subsequent development of brain tumors appears to be complex. Evidence for possible interactions comes from the identification of viruses and virus-like particles in brain tumor specimens, as well as from epidemiologic studies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      SV40 &mdash; Interest in SV40 was stimulated by animal studies documenting brain tumor development after intracerebral inoculation with SV40 and by human studies which isolated SV40 from brain tumor tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/90\">",
"       90",
"      </a>",
"      ]. It was unclear, however, if SV40 contributed significantly to malignant transformation or whether certain tumors provided a microenvironment that favored replication in patients with latent SV40 infection.",
"      <br/>",
"      <br/>",
"      Poliomyelitis vaccine administered between 1955 and 1962 was contaminated with SV40, and vaccination cohorts have been the subject of study over subsequent decades [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/91-93\">",
"       91-93",
"      </a>",
"      ]. However, elevated brain tumor rates have not been observed in these cohorts. In a nested case-control study, no significant association was reported between antibodies to SV40 (or two other polyomaviruses, JC virus and BK virus) as measured in prediagnostic serum and incident primary malignant brain tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/94\">",
"       94",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CMV &mdash; Data concerning a possible etiologic role for cytomegalovirus (CMV) is conflicting. At least two studies reported a high percentage of gliomas were infected with CMV [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/95,96\">",
"       95,96",
"      </a>",
"      ], although other reports have not confirmed an association [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/97,98\">",
"       97,98",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In utero viral exposure &mdash; Whether exposure to maternal viral infection while in utero is a risk factor for brain tumors is unclear. A large case-control study found an increased risk (RR = 2.4) for all types of brain tumors after different maternal and perinatal infections [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/99\">",
"       99",
"      </a>",
"      ]. In addition, an association between influenza infection in pregnant women and childhood brain tumors (OR = 3.15) was suggested in a study in which mothers of 94 children with brain tumors or neuroblastomas and 210 controls were interviewed [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/100\">",
"       100",
"      </a>",
"      ]. However, others have failed to confirm an increased risk of brain tumors in the offspring of mothers infected with varicella, rubella, or mumps during pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/101\">",
"       101",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Varicella zoster &mdash; In contrast, a protective role for antecedent infection with varicella zoster was suggested by an analysis of 229 adults with glioma and 289 controls from the San Francisco Bay Area Adult Glioma Study [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/102\">",
"       102",
"      </a>",
"      ]. Individuals with gliomas were significantly less likely than controls to have a self-reported history of chickenpox (odds ratio [OR] 0.59) and they also had lower levels of immunoglobulins directed against varicella-zoster.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A similar inverse association was observed for self-report of history of chickenpox in a case-control study of 325 adult glioma and 600 controls (OR = 0.52) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/103\">",
"     103",
"    </a>",
"    ]. Statistically significant inverse associations also were observed for reported infections with other herpesviruses (Epstein-Barr virus, CMV, and herpes simplex virus) in that study [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/103\">",
"     103",
"    </a>",
"    ], but no association had been found for those three herpesviruses in the first study [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/100\">",
"     100",
"    </a>",
"    ]. Based upon these observations and those for allergies, immune modulation has been postulated to have a role brain tumorigenesis. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Allergies'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Toxoplasma infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection with Toxoplasma gondii has been associated with an increased risk of astrocytoma and meningioma in two case-control studies [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/104,105\">",
"     104,105",
"    </a>",
"    ]. In one, a significantly increased risk of meningioma (OR = 2.1), but not glioma, was associated with the presence of IgG antibodies to T. gondii as measured by ELISA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/105\">",
"     105",
"    </a>",
"    ]. Although this parasite has a propensity to infect the nervous system, it has not been established as a major risk factor for brain tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     GENETIC FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 1 to 5 percent of brain tumors are due to genetic syndromes that confer an increased risk of developing tumors of the nervous system [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/2,106\">",
"     2,106",
"    </a>",
"    ]. Some of these tumors are associated with neurofibromatosis and several other inherited syndromes (",
"    <a class=\"graphic graphic_table graphicRef69752 \" href=\"UTD.htm?16/28/16843\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H537377059\">",
"    <span class=\"h2\">",
"     Neurofibromatosis type 1",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurofibromatosis type I (NF1) occurs in 1 of 3000 persons and is linked to a gene on chromosome 17. The NF1 gene encodes a protein called neurofibromin that restricts cell proliferation by activating GTP hydrolysis on ras proteins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=see_link\">",
"     \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Multiple neurofibromas are seen and some undergo malignant change to neurofibrosarcoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/18/32042?source=see_link\">",
"     \"Pathogenetic factors in soft tissue and bone sarcomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other malignancies that develop in up to 5 to 10 percent of patients with NF1 include other malignant nerve sheath tumors such as malignant schwannomas and astrocytomas. The astrocytomas are usually low grade and frequently have a pilocytic histology. These lesions have a predilection for the optic pathways, hypothalamus, and cerebellum.",
"   </p>",
"   <p>",
"    It has been proposed that malignant degeneration in NF1 reflects the two-hit hypothesis in which one allele is constitutionally inactivated in the germline while the other allele undergoes somatic inactivation (the second hit) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/107\">",
"     107",
"    </a>",
"    ]. Animal models are consistent with this hypothesis but suggest that the second hit can be a mutation in the p53 gene [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/108,109\">",
"     108,109",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H537377066\">",
"    <span class=\"h2\">",
"     Neurofibromatosis type 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder predisposing to multiple neoplastic lesions. This disorder is due to a mutation in the NF2 gene, a tumor suppressor gene on chromosome 22 that encodes a membrane cytoskeletal protein called merlin or schwannomin [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/110\">",
"     110",
"    </a>",
"    ] that appears to be involved in actin-cytoskeleton organization [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/111\">",
"     111",
"    </a>",
"    ]. Other modifier genes may also be involved [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/112\">",
"     112",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20712?source=see_link&amp;anchor=H2#H2\">",
"     \"Neurofibromatosis type 2\", section on 'Molecular pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pathognomonic findings are bilateral vestibular schwannomas (acoustic neuromas). Vestibular schwannomas are seen in 90 to 95 percent of patients with NF2 and generally develop by 30 years of age. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/18/40232?source=see_link\">",
"     \"Vestibular schwannoma (acoustic neuroma)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20712?source=see_link&amp;anchor=H7#H7\">",
"     \"Neurofibromatosis type 2\", section on 'Vestibular schwannomas'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other types of brain tumors are also seen, the most frequent of which are meningiomas. Approximately one-half of individuals with NF2 have meningiomas, and multiple meningiomas are often present [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/113\">",
"     113",
"    </a>",
"    ]. The incidence of meningioma increases with age, and the lifetime risk may be as high as 75 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/114\">",
"     114",
"    </a>",
"    ]. Patients with NF2 tend to develop meningiomas at an earlier age than those with sporadic meningiomas. The meningiomas seen in patients with NF2 are more frequently atypical or anaplastic compared with sporadic tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/115,116\">",
"     115,116",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20712?source=see_link&amp;anchor=H7#H7\">",
"     \"Neurofibromatosis type 2\", section on 'Vestibular schwannomas'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     von Hippel-Lindau syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The von Hippel-Lindau syndrome is an autosomal dominant disorder associated with hemangioblastomas, pancreatic cysts and neuroendocrine tumors, renal tumors, and pheochromocytomas. The gene on chromosome 3p25 normally functions as a tumor suppressor gene. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22618?source=see_link\">",
"     \"Clinical features, diagnosis, and management of von Hippel-Lindau disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/21/14678?source=see_link\">",
"     \"Molecular biology and pathogenesis of von Hippel-Lindau disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Li-Fraumeni syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Li-Fraumeni syndrome is inherited as an autosomal dominant trait and is usually associated with a germline mutation in the TP53 gene. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12391?source=see_link\">",
"     \"Li-Fraumeni syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Li-Fraumeni syndrome is primarily characterized by sarcomas, breast cancer, leukemia, and adrenocortical cancer occurring before the age of 45. Other tumors are also seen in the Li-Fraumeni syndrome, including brain tumors. Of particular note, a high percentage of choroid plexus carcinomas are associated with germline mutations in TP53 even in the absence of another cancer or a positive family history.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Turcot's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Turcot's syndrome refers to an association between brain tumors (primarily medulloblastomas and gliomas) and two forms of colonic polyposis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/117\">",
"     117",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17016?source=see_link\">",
"     \"Clinical manifestations and diagnosis of familial adenomatous polyposis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Familial adenomatous polyposis (FAP) is an autosomal dominant condition caused by a mutation to the adenomatous polyposis coli gene on chromosome 5. The majority of FAP-associated brain tumors are medulloblastomas, but gliomas have also been described. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17016?source=see_link\">",
"       \"Clinical manifestations and diagnosis of familial adenomatous polyposis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hereditary nonpolyposis colorectal cancer (HNPCC) is characterized by germline mutations in one of several enzymes involved in DNA nucleotide mismatch repair. These patients are prone to high-grade gliomas [",
"      <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/117\">",
"       117",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link\">",
"       \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Basal cell nevus syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persons with the basal cell nevus syndrome (Gorlin syndrome, nevoid basal cell cancer syndrome), have an increased risk of medulloblastoma. The syndrome is caused by germline mutations of the patched (PTCH) gene, a tumor suppressor gene. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/5/44121?source=see_link\">",
"     \"Nevoid basal cell carcinoma syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Familial glioma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several case reports, case-control, and cohort series document the aggregation of gliomas (astrocytomas) in families [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/118-120\">",
"     118-120",
"    </a>",
"    ]. Although some families have inherited syndromes that explain these disease clusters (see above), many do not.",
"   </p>",
"   <p>",
"    In one population based study that included 2141 first degree relatives of 297 individuals with astrocytoma diagnosed over an eight year period in Sweden, 5 percent had a familial aggregation of glioma [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/121\">",
"     121",
"    </a>",
"    ]. Segregation analysis of 14 families with at least two affected first degree relatives suggested an autosomal recessive pattern of inheritance in 65 percent (9 families), while an autosomal dominant inheritance pattern was suspected in only 21 percent (3 families).",
"   </p>",
"   <p>",
"    These familial aggregations may reflect common environmental exposures among family members rather than a genetic predisposition. However, this theory was not supported by a second population-based study from these same investigators that demonstrated an increase in the risk of brain tumors among first-degree relatives but not spouses of probands with primary brain tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/42/8874/abstract/122\">",
"     122",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brain tumors are an uncommon but especially lethal form of cancer, and the incidence may be increasing. The only firmly established environmental risk factor, ionizing radiation, and genetic predisposition in identified syndromes account for only a fraction of incident cases. Possible causative factors which require further investigation include allergies, non-ionizing radiation, physical and acoustic trauma, and certain infections.",
"   </p>",
"   <p>",
"    The study of brain tumors has been complicated by a number of factors. Brain tumors are an uncommon form of cancer, making centralized reporting and multi-institutional collaboration essential for effective observational study. Such reporting and collaboration are recent developments and promise improved study design and execution in the future.",
"   </p>",
"   <p>",
"    Since brain tumors are a heterogeneous group of tumors arising from different cell types, perhaps by different molecular mechanisms, future studies of brain tumors should focus on individual tumor types such as astrocytoma and meningioma. Molecular classification of these tumors may allow even greater refinement of tumor classification. The World Health Organization (WHO) classification system is now the most widely accepted histopathologic classification system with high inter-rater reliability (94 percent) and serves as the basis of reporting to the Central Brain Tumor Registry of the United States (CBTRUS). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/17/36117?source=see_link&amp;anchor=H7347120#H7347120\">",
"     \"Classification of gliomas\", section on 'Histopathologic and molecular classification'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Future epidemiologic studies of brain tumors should explore more fully the role of allergies, physical trauma, and viral infection. Collaboration and centralized reporting should improve these studies. Understanding the molecular pathology of gliomas may allow correlation of candidate exposures with specific molecular subtypes of tumors possibly shedding light on the molecular mechanisms of disease causation and progression.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/1\">",
"      Polednak AP. Interpretation of secular increases in incidence rates for primary brain cancer in Connecticut adults, 1965-1988. Neuroepidemiology 1996; 15:51.",
"     </a>",
"    </li>",
"    <li>",
"     Preston-Martin S, Mack WJ. Neoplasms of the nervous system. In: Cancer Epidemiology and Prevention, 2nd, Shottenfeld D, Fraumeni JF (Eds), Oxford University Press, New York 1996.",
"    </li>",
"    <li>",
"     Davis FG, Preston-Martin S. Epidemiology. In: Russell and Rubinstein's Pathology of Tumors of the Nervous System, 6th, Bigner DD, McLendon RE, Bruner JM (Eds), Arnold, London 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/4\">",
"      Greenwald P, Friedlander BR, Lawrence CE, et al. Diagnostic sensitivity bias -- an epidemiologic explanation for an apparent brain tumor excess. J Occup Med 1981; 23:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/5\">",
"      Sackett DL. Bias in analytic research. J Chronic Dis 1979; 32:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/6\">",
"      Preston-Martin S. Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County. Neuroepidemiology 1989; 8:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/7\">",
"      McLaughlin JK, Malker HS, Blot WJ, et al. Occupational risks for intracranial gliomas in Sweden. J Natl Cancer Inst 1987; 78:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/8\">",
"      Lin RS, Dischinger PC, Conde J, Farrell KP. Occupational exposure to electromagnetic fields and the occurrence of brain tumors. An analysis of possible associations. J Occup Med 1985; 27:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/9\">",
"      Thomas TL, Stolley PD, Stemhagen A, et al. Brain tumor mortality risk among men with electrical and electronics jobs: a case-control study. J Natl Cancer Inst 1987; 79:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/10\">",
"      Loomis DP, Savitz DA. Mortality from brain cancer and leukaemia among electrical workers. Br J Ind Med 1990; 47:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/11\">",
"      Juutilainen J, L&auml;&auml;r&auml; E, Pukkala E. Incidence of leukaemia and brain tumours in Finnish workers exposed to ELF magnetic fields. Int Arch Occup Environ Health 1990; 62:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/12\">",
"      Schlehofer B, Kunze S, Sachsenheimer W, et al. Occupational risk factors for brain tumors: results from a population-based case-control study in Germany. Cancer Causes Control 1990; 1:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/13\">",
"      Bates MN. Extremely low frequency electromagnetic fields and cancer: the epidemiologic evidence. Environ Health Perspect 1991; 95:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/14\">",
"      Savitz DA, Loomis DP. Magnetic field exposure in relation to leukemia and brain cancer mortality among electric utility workers. Am J Epidemiol 1995; 141:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/15\">",
"      Sahl JD, Kelsh MA, Greenland S. Cohort and nested case-control studies of hematopoietic cancers and brain cancer among electric utility workers. Epidemiology 1993; 4:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/16\">",
"      Gu&eacute;nel P, Raskmark P, Andersen JB, Lynge E. Incidence of cancer in persons with occupational exposure to electromagnetic fields in Denmark. Br J Ind Med 1993; 50:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/17\">",
"      Poole C, Trichopoulos D. Extremely low-frequency electric and magnetic fields and cancer. Cancer Causes Control 1991; 2:267.",
"     </a>",
"    </li>",
"    <li>",
"     International Agency for Research on Cancer. Occupational exposures in petroleum refining; crude oil and major petroleum fuels. In: IARC Monographs on the evaluation of carcinogenic risks to humans, IARC, Lyon 1989. Vol 45.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/19\">",
"      Wong O, Raabe GK. A critical review of cancer epidemiology in the petroleum industry, with a meta-analysis of a combined database of more than 350,000 workers. Regul Toxicol Pharmacol 2000; 32:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/20\">",
"      Wong O, Raabe GK. Critical review of cancer epidemiology in petroleum industry employees, with a quantitative meta-analysis by cancer site. Am J Ind Med 1989; 15:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/21\">",
"      Musicco M, Sant M, Molinari S, et al. A case-control study of brain gliomas and occupational exposure to chemical carcinogens: the risk to farmers. Am J Epidemiol 1988; 128:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/22\">",
"      Littorin M, Attewell R, Skerfving S, et al. Mortality and tumour morbidity among Swedish market gardeners and orchardists. Int Arch Occup Environ Health 1993; 65:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/23\">",
"      Heineman EF, Gao YT, Dosemeci M, McLaughlin JK. Occupational risk factors for brain tumors among women in Shanghai, China. J Occup Environ Med 1995; 37:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/24\">",
"      Khuder SA, Mutgi AB, Schaub EA. Meta-analyses of brain cancer and farming. Am J Ind Med 1998; 34:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/25\">",
"      Bohnen NI, Kurland LT. Brain tumor and exposure to pesticides in humans: a review of the epidemiologic data. J Neurol Sci 1995; 132:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/26\">",
"      Kogevinas M, Sala M, Boffetta P, et al. Cancer risk in the rubber industry: a review of the recent epidemiological evidence. Occup Environ Med 1998; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/27\">",
"      Wong O, Whorton MD, Foliart DE, Ragland D. An industry-wide epidemiologic study of vinyl chloride workers, 1942-1982. Am J Ind Med 1991; 20:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/28\">",
"      Straif K, Weiland SK, Bungers M, et al. Exposure to high concentrations of nitrosamines and cancer mortality among a cohort of rubber workers. Occup Environ Med 2000; 57:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/29\">",
"      Thomas TL, Fontham ET, Norman SA, et al. Occupational risk factors for brain tumors. A case-referent death-certificate analysis. Scand J Work Environ Health 1986; 12:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/30\">",
"      Cocco P, Dosemeci M, Heineman EF. Brain cancer and occupational exposure to lead. J Occup Environ Med 1998; 40:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/31\">",
"      Anttila A, Heikkil&auml; P, Nykyri E, et al. Risk of nervous system cancer among workers exposed to lead. J Occup Environ Med 1996; 38:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/32\">",
"      Braganza MZ, Kitahara CM, Berrington de Gonz&aacute;lez A, et al. Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol 2012; 14:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/33\">",
"      Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006; 98:1528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/34\">",
"      Relling MV, Rubnitz JE, Rivera GK, et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999; 354:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/35\">",
"      Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/36\">",
"      Davis F, Il'yasova D, Rankin K, et al. Medical diagnostic radiation exposures and risk of gliomas. Radiat Res 2011; 175:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/37\">",
"      Wertheimer N, Leeper E. Electrical wiring configurations and childhood cancer. Am J Epidemiol 1979; 109:273.",
"     </a>",
"    </li>",
"    <li>",
"     NIEHS. Health effects from exposure to power-line frequency electric and magnetic fields. NIH publication no 99-4493, National Institute of Environmental Health Sciences; 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/39\">",
"      Kheifets LI, Sussman SS, Preston-Martin S. Childhood brain tumors and residential electromagnetic fields (EMF). Rev Environ Contam Toxicol 1999; 159:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/40\">",
"      Preston-Martin S, Navidi W, Thomas D, et al. Los Angeles study of residential magnetic fields and childhood brain tumors. Am J Epidemiol 1996; 143:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/41\">",
"      Gurney JG, Mueller BA, Davis S, et al. Childhood brain tumor occurrence in relation to residential power line configurations, electric heating sources, and electric appliance use. Am J Epidemiol 1996; 143:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/42\">",
"      Sorahan T, Hamilton L, Gardiner K, et al. Maternal occupational exposure to electromagnetic fields before, during, and after pregnancy in relation to risks of childhood cancers: findings from the Oxford Survey of Childhood Cancers, 1953-1981 deaths. Am J Ind Med 1999; 35:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/43\">",
"      Coble JB, Dosemeci M, Stewart PA, et al. Occupational exposure to magnetic fields and the risk of brain tumors. Neuro Oncol 2009; 11:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/44\">",
"      Rothman KJ, Chou CK, Morgan R, et al. Assessment of cellular telephone and other radio frequency exposure for epidemiologic research. Epidemiology 1996; 7:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/45\">",
"      Myung SK, Ju W, McDonnell DD, et al. Mobile phone use and risk of tumors: a meta-analysis. J Clin Oncol 2009; 27:5565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/46\">",
"      Corle C, Makale M, Kesari S. Cell phones and glioma risk: a review of the evidence. J Neurooncol 2012; 106:1.",
"     </a>",
"    </li>",
"    <li>",
"     IARC. IARC monographs on the evaluation of carcinogenic risks to humans. In: IARC monographs on the evaluation of carcinogenic risks to humans, IARC, Lyon  Vol 102.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/48\">",
"      Cushing H. The meningiomas (dural endotheliomas). Their source and favored seats of origin. Brain 1922; 45:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/49\">",
"      Inskip PD, Mellemkjaer L, Gridley G, Olsen JH. Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control 1998; 9:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/50\">",
"      Choi NW, Schuman LM, Gullen WH. Epidemiology of primary central nervous system neoplasms. II. Case-control study. Am J Epidemiol 1970; 91:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/51\">",
"      Wrensch M, Miike R, Lee M, Neuhaus J. Are prior head injuries or diagnostic X-rays associated with glioma in adults? The effects of control selection bias. Neuroepidemiology 2000; 19:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/52\">",
"      Burch JD, Craib KJ, Choi BC, et al. An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst 1987; 78:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/53\">",
"      Preston-Martin S, Thomas DC, Wright WE, Henderson BE. Noise trauma in the aetiology of acoustic neuromas in men in Los Angeles County, 1978-1985. Br J Cancer 1989; 59:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/54\">",
"      Ryals BM, Rubel EW. Hair cell regeneration after acoustic trauma in adult Coturnix quail. Science 1988; 240:1774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/55\">",
"      Hamernik RP, Turrentine G, Roberto M, et al. Anatomical correlates of impulse noise-induced mechanical damage in the cochlea. Hear Res 1984; 13:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/56\">",
"      Schlehofer B, Blettner M, Preston-Martin S, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999; 82:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/57\">",
"      Brenner AV, Linet MS, Fine HA, et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002; 99:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/58\">",
"      Wiemels JL, Wiencke JK, Sison JD, et al. History of allergies among adults with glioma and controls. Int J Cancer 2002; 98:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/59\">",
"      Schoemaker MJ, Swerdlow AJ, Hepworth SJ, et al. History of allergies and risk of glioma in adults. Int J Cancer 2006; 119:2165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/60\">",
"      Linos E, Raine T, Alonso A, Michaud D. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 2007; 99:1544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/61\">",
"      Wiemels JL, Wiencke JK, Patoka J, et al. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 2004; 64:8468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/62\">",
"      Calboli FC, Cox DG, Buring JE, et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst 2011; 103:1588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/63\">",
"      Schwartzbaum J, Ding B, Johannesen TB, et al. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst 2012; 104:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/64\">",
"      Schlehofer B, Siegmund B, Linseisen J, et al. Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy 2011; 66:1434.",
"     </a>",
"    </li>",
"    <li>",
"     National Research Council. The health effects of nitrate, nitrite, and N-nitroso compounds. Part 1. National Academy Press; Washington DC.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/66\">",
"      Chen H, Ward MH, Tucker KL, et al. Diet and risk of adult glioma in eastern Nebraska, United States. Cancer Causes Control 2002; 13:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/67\">",
"      Lee M, Wrensch M, Miike R. Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA). Cancer Causes Control 1997; 8:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/68\">",
"      Giles GG, McNeil JJ, Donnan G, et al. Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. Int J Cancer 1994; 59:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/69\">",
"      Preston-Martin S, Mack W. Gliomas and meningiomas in men in Los Angeles County: investigation of exposures to N-nitroso compounds. IARC Sci Publ 1991; :197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/70\">",
"      Huncharek M, Kupelnick B, Wheeler L. Dietary cured meat and the risk of adult glioma: a meta-analysis of nine observational studies. J Environ Pathol Toxicol Oncol 2003; 22:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/71\">",
"      Dubrow R, Darefsky AS, Park Y, et al. Dietary components related to N-nitroso compound formation: a prospective study of adult glioma. Cancer Epidemiol Biomarkers Prev 2010; 19:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/72\">",
"      Michaud DS, Holick CN, Batchelor TT, et al. Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult glioma. Am J Clin Nutr 2009; 90:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/73\">",
"      McCredie M, Maisonneuve P, Boyle P. Perinatal and early postnatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer 1994; 56:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/74\">",
"      Preston-Martin S, Pogoda JM, Mueller BA, et al. Prenatal vitamin supplementation and risk of childhood brain tumors. Int J Cancer Suppl 1998; 11:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/75\">",
"      Bunin GR, Kuijten RR, Buckley JD, et al. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 1993; 329:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/76\">",
"      Ahlbom A, Navier IL, Norell S, et al. Nonoccupational risk indicators for astrocytomas in adults. Am J Epidemiol 1986; 124:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/77\">",
"      Blowers L, Preston-Martin S, Mack WJ. Dietary and other lifestyle factors of women with brain gliomas in Los Angeles County (California, USA). Cancer Causes Control 1997; 8:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/78\">",
"      Hu J, La Vecchia C, Negri E, et al. Diet and brain cancer in adults: a case-control study in northeast China. Int J Cancer 1999; 81:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/79\">",
"      Boeing H, Schlehofer B, Blettner M, Wahrendorf J. Dietary carcinogens and the risk for glioma and meningioma in Germany. Int J Cancer 1993; 53:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/80\">",
"      Kaplan S, Novikov I, Modan B. Nutritional factors in the etiology of brain tumors: potential role of nitrosamines, fat, and cholesterol. Am J Epidemiol 1997; 146:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/81\">",
"      Holick CN, Giovannucci EL, Rosner B, et al. Prospective study of intake of fruit, vegetables, and carotenoids and the risk of adult glioma. Am J Clin Nutr 2007; 85:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/82\">",
"      Hurley SF, McNeil JJ, Donnan GA, et al. Tobacco smoking and alcohol consumption as risk factors for glioma: a case-control study in Melbourne, Australia. J Epidemiol Community Health 1996; 50:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/83\">",
"      Filippini G, Maisonneuve P, McCredie M, et al. Relation of childhood brain tumors to exposure of parents and children to tobacco smoke: the SEARCH international case-control study. Surveillance of Environmental Aspects Related to Cancer in Humans. Int J Cancer 2002; 100:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/84\">",
"      Silvera SA, Miller AB, Rohan TE. Cigarette smoking and risk of glioma: a prospective cohort study. Int J Cancer 2006; 118:1848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/85\">",
"      Holick CN, Giovannucci EL, Rosner B, et al. Prospective study of cigarette smoking and adult glioma: dosage, duration, and latency. Neuro Oncol 2007; 9:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/86\">",
"      Preston-Martin S, Yu MC, Henderson BE, Roberts C. Risk factors for meningiomas in men in Los Angeles County. J Natl Cancer Inst 1983; 70:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/87\">",
"      Galeone C, Malerba S, Rota M, et al. A meta-analysis of alcohol consumption and the risk of brain tumours. Ann Oncol 2013; 24:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/88\">",
"      Ward DW, Mattison ML, Finn R. Association between previous tuberculosis infection and cerebral glioma. BMJ 1973; 1:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/89\">",
"      Davis FG, Boice JD Jr, Hrubec Z, Monson RR. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res 1989; 49:6130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/90\">",
"      Huang H, Reis R, Yonekawa Y, et al. Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol 1999; 9:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/91\">",
"      Strickler HD, Rosenberg PS, Devesa SS, et al. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 1998; 279:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/92\">",
"      Engels EA, Katki HA, Nielsen NM, et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003; 95:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/93\">",
"      Strickler HD, Goedert JJ. Exposure to SV40-contaminated poliovirus vaccine and the risk of cancer--a review of the epidemiological evidence. Dev Biol Stand 1998; 94:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/94\">",
"      Rollison DE, Helzlsouer KJ, Alberg AJ, et al. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomarkers Prev 2003; 12:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/95\">",
"      Cobbs CS, Harkins L, Samanta M, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002; 62:3347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/96\">",
"      Mitchell DA, Xie W, Schmittling R, et al. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 2008; 10:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/97\">",
"      Sabatier J, Uro-Coste E, Pommepuy I, et al. Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 2005; 92:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/98\">",
"      Lau SK, Chen YY, Chen WG, et al. Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 2005; 18:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/99\">",
"      Linet MS, Gridley G, Cnattingius S, et al. Maternal and perinatal risk factors for childhood brain tumors (Sweden). Cancer Causes Control 1996; 7:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/100\">",
"      Linos A, Kardara M, Kosmidis H, et al. Reported influenza in pregnancy and childhood tumour. Eur J Epidemiol 1998; 14:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/101\">",
"      Adelstein AM, Donovan JW. Malignant disease in children whose mothers had chickenpox, mumps, or rubella in pregnancy. Br Med J 1972; 4:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/102\">",
"      Wrensch M, Weinberg A, Wiencke J, et al. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls. Am J Epidemiol 2005; 161:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/103\">",
"      Scheurer ME, El-Zein R, Thompson PA, et al. Long-term anti-inflammatory and antihistamine medication use and adult glioma risk. Cancer Epidemiol Biomarkers Prev 2008; 17:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/104\">",
"      Schuman LM, Choi NW, Gullen WH. Relationship of central nervous system neoplasms to Toxoplasma gondii infection. Am J Public Health Nations Health 1967; 57:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/105\">",
"      Ryan P, Hurley SF, Johnson AM, et al. Tumours of the brain and presence of antibodies to Toxoplasma gondii. Int J Epidemiol 1993; 22:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/106\">",
"      Bondy ML, Lustbader ED, Buffler PA, et al. Genetic epidemiology of childhood brain tumors. Genet Epidemiol 1991; 8:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/107\">",
"      Colman SD, Williams CA, Wallace MR. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 1995; 11:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/108\">",
"      Cichowski K, Shih TS, Schmitt E, et al. Mouse models of tumor development in neurofibromatosis type 1. Science 1999; 286:2172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/109\">",
"      Vogel KS, Klesse LJ, Velasco-Miguel S, et al. Mouse tumor model for neurofibromatosis type 1. Science 1999; 286:2176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/110\">",
"      Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/111\">",
"      Scoles DR, Huynh DP, Morcos PA, et al. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin. Nat Genet 1998; 18:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/112\">",
"      Bruder CE, Ichimura K, Blennow E, et al. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene? Genes Chromosomes Cancer 1999; 25:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/113\">",
"      Goutagny S, Kalamarides M. Meningiomas and neurofibromatosis. J Neurooncol 2010; 99:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/114\">",
"      Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992; 84:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/115\">",
"      Perry A, Giannini C, Raghavan R, et al. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol 2001; 60:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/116\">",
"      Larson JJ, van Loveren HR, Balko MG, Tew JM Jr. Evidence of meningioma infiltration into cranial nerves: clinical implications for cavernous sinus meningiomas. J Neurosurg 1995; 83:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/117\">",
"      Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995; 332:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/118\">",
"      Wrensch M, Lee M, Miike R, et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 1997; 145:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/119\">",
"      Malmer B, Gr&ouml;nberg H, Bergenheim AT, et al. Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer 1999; 81:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/120\">",
"      Blumenthal DT, Cannon-Albright LA. Familiality in brain tumors. Neurology 2008; 71:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/121\">",
"      Malmer B, Iselius L, Holmberg E, et al. Genetic epidemiology of glioma. Br J Cancer 2001; 84:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/42/8874/abstract/122\">",
"      Malmer B, Henriksson R, Gr&ouml;nberg H. Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer 2003; 106:260.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5214 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.150.3.100-CF9877BBA9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8874=[""].join("\n");
var outline_f8_42_8874=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OCCUPATIONAL STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      White collar professionals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Electrical workers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Oil refinery workers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Agriculture workers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Others",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      RADIATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Ionizing radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Electromagnetic radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cellular telephones and radiofrequency radiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      HEAD TRAUMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ALLERGIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      N-nitroso compounds",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Antioxidants, fruits, and vegetables",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TOBACCO",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ALCOHOL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      INFECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Viral infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Toxoplasma infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      GENETIC FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H537377059\">",
"      Neurofibromatosis type 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H537377066\">",
"      Neurofibromatosis type 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      von Hippel-Lindau syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Li-Fraumeni syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Turcot's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Basal cell nevus syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Familial glioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/5214\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/5214|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/43/20156\" title=\"table 1\">",
"      Risk primary brain tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/28/16843\" title=\"table 2\">",
"      Genetic syndromes CNS tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/17/36117?source=related_link\">",
"      Classification of gliomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=related_link\">",
"      Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22618?source=related_link\">",
"      Clinical features, diagnosis, and management of von Hippel-Lindau disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17016?source=related_link\">",
"      Clinical manifestations and diagnosis of familial adenomatous polyposis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/59/2997?source=related_link\">",
"      Incidence of primary brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12391?source=related_link\">",
"      Li-Fraumeni syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/54/20328?source=related_link\">",
"      Meningioma: Epidemiology, risk factors, and pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/21/14678?source=related_link\">",
"      Molecular biology and pathogenesis of von Hippel-Lindau disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=related_link\">",
"      Neurofibromatosis type 1 (von Recklinghausen's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20712?source=related_link\">",
"      Neurofibromatosis type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/5/44121?source=related_link\">",
"      Nevoid basal cell carcinoma syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/18/32042?source=related_link\">",
"      Pathogenetic factors in soft tissue and bone sarcomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/18/40232?source=related_link\">",
"      Vestibular schwannoma (acoustic neuroma)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_42_8875="Drug doses for oral treatment of hypertension in pregnancy";
var content_f8_42_8875=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55212&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55212&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drug doses for oral treatment of hypertension in pregnancy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methyldopa",
"       </td>",
"       <td>",
"        250 mg two to three times daily, increase every two days as needed, maximum dose 3 g/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Labetalol",
"       </td>",
"       <td>",
"        100 mg two times daily, increase by 100 mg twice daily every two to three days as needed, maximum dose 2400 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nifedipine",
"       </td>",
"       <td>",
"        30 to 60 mg once daily as a sustained release tablet, increase at 7 to 14 day intervals, maximum dose 120 mg/day",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Hydralazine can be used as an adjunctive agent to prevent reflex tachycardia. Begin with 10 mg&nbsp;four times per day; increase by 10 to 25 mg/dose every 2 to 5 days to a maximum dose of 300 mg/day.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8875=[""].join("\n");
var outline_f8_42_8875=null;
var title_f8_42_8876="ESC 2008 CM nonfamilial";
var content_f8_42_8876=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Non-familial types of cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"5\" width=\"20%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        HCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        DCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        ARVC",
"       </td>",
"       <td class=\"subtitle1\">",
"        RCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        Unclassified",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Obesity",
"        </p>",
"        <p>",
"         Infants of diabetic mothers",
"        </p>",
"        <p>",
"         Athletic training",
"        </p>",
"        Amyloid (AL/prealbumin)",
"       </td>",
"       <td>",
"        <p>",
"         Myocarditis (infective/toxic/immune)",
"        </p>",
"        <p>",
"         Kawasaki disease",
"        </p>",
"        <p>",
"         Eosinophilic (Churg Strauss syndrome)",
"        </p>",
"        <p>",
"         Viral persistence",
"        </p>",
"        <p>",
"         Drugs",
"        </p>",
"        <p>",
"         Pregnancy",
"        </p>",
"        <p>",
"         Endocrine",
"        </p>",
"        <p>",
"         Nutritional - thiamine, carnitine, selenium, hypophosphataemia, hypocalcaemia",
"        </p>",
"        <p>",
"         Alcohol",
"        </p>",
"        Tachycardiomyopathy",
"       </td>",
"       <td>",
"        Inflammation?",
"       </td>",
"       <td>",
"        <p>",
"         Amyloid (AL/prealbumin)",
"        </p>",
"        <p>",
"         Scleroderma",
"        </p>",
"        Endomyocardial fibrosis",
"        <ul>",
"         <li>",
"          Hypereosinophilic syndrome",
"         </li>",
"         <li>",
"          Idiopathic",
"         </li>",
"         <li>",
"          Chromosomal cause",
"         </li>",
"         <li>",
"          Drugs (serotonin, methysergide, ergotamine, mercurial agents, busulfan)",
"         </li>",
"        </ul>",
"        <p>",
"         Carcinoid heart disease",
"        </p>",
"        <p>",
"         Metastatic cancers",
"        </p>",
"        <p>",
"         Radiation",
"        </p>",
"        Drugs (anthracyclines)",
"       </td>",
"       <td>",
"        Tako Tsubo cardiomyopathy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ARVC: arrhythmogenic right ventricular cardiomyopathy; DCM: dilated cardiomyopathy; HCM: hypertrophic cardiomyopathy; RCM: restrictive cardiomyopathy.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Elliott P, Anderson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial disease. Eur Heart J 2008; 29:270. Copyright &copy; 2008 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8876=[""].join("\n");
var outline_f8_42_8876=null;
var title_f8_42_8877="Basic decision tree";
var content_f8_42_8877=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F80928&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F80928&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Decision tree",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 266px; height: 220px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A decision tree starts with a decision node (square), which represents the decision to be made, followed by chance nodes (circles), which represent the possible events given the choices. Each outcome is associated with a probability (p",
"    <sub>",
"     1",
"    </sub>",
"    through p",
"    <sub>",
"     4",
"    </sub>",
"    ) that represents its likelihood of occurring. Each branch eventually ends in a terminal node or outcome (boxes) representing the value of that outcome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8877=[""].join("\n");
var outline_f8_42_8877=null;
var title_f8_42_8878="Periosteal thickening of tibial stress fracture";
var content_f8_42_8878=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F69856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F69856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Periosteal thickening of tibial stress fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 256px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cortical thickening and sclerosis are evident at the site of this stress fracture. However, it is important to remember that most plain films taken during the first few weeks following injury will be negative.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Karl B Fields, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8878=[""].join("\n");
var outline_f8_42_8878=null;
var title_f8_42_8879="ST depression and troponins predict outcome in NSTACS";
var content_f8_42_8879=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54597&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54597&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    ST segment depression and troponins predict outcome in non-ST elevation ACS",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 390px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the FRISC trial of 917 patients with a non-ST elevation acute coronary syndrome (unstable angina or non-ST elevation myocardial infarction), elevated serum troponin T, obtained within 24 hours, is associated with an increased incidence of death from cardiac causes at a mean follow-up of 37 months; its effects are additive to the presence of ST segment depression.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Lindahl B, Toss H, Siegbahn A, et al. N Engl J Med 2000; 343:1139.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_42_8879=[""].join("\n");
var outline_f8_42_8879=null;
